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ABSTRACT	OF	THE	DISSERTATION		Modeling	SCN1A	Epilepsy	with	Dual	Isogenic	Pairs	of	Human	iPSC-derived	Neurons		By		Yunyao	Xie		Doctor	of	Philosophy	in	Biological	Sciences			University	of	California,	Irvine,	2019		Professor	Diane	O’Dowd,	Chair																Over	1250	mutations	in	SCN1A,	the	Nav1.1	voltage-gated	sodium	channel	gene,	are	associated	with	a	variety	of	seizure	disorders	including	Dravet	syndrome	(DS)	and	genetic	epilepsy	with	febrile	seizure	plus	(GEFS+).		Individuals	with	SCN1A	genetic	epilepsy	exhibit	a	broad	range	of	seizure	phenotypes	and	many	of	them	are	not	well	controlled	by	conventional	anti-convulsant	therapy.	How	specific	mutations	alter	sodium	channel	function	in	a	way	that	contributes	to	seizure	generation	is	still	largely	unexplored.	An	understanding	of	cellular	mechanisms	is	important	for	future	studies	targeted	at	developing	more	effective	patient-specific	therapies.		Previous	studies	in	models	including	Xenopus	oocytes,	human	embryonic	kidney	cells,	mouse,	Drosophila	and	zebrafish	have	provided	some	important	insights	into	functional	changes	in	sodium	currents	and	firing	properties	associated	with	a	number	of	
SCN1A	mutations.	However,	they	also	reveal	that	the	same	mutation	can	have	distinct	effects	in	the	different	models.		By	combining	recent	advances	in	stem	cell	reprogramming	technology	and	gene	editing	tools	it	is	now	possible	explore	how	specific	gene	mutations	alter	activity	in	human	neurons.	To	evaluate	changes	in	neuronal	activity	associated	with	a	
xiii		
specific	mutation,	independent	of	genetic	background,	we	generated	two	pairs	of	isogenic	human	iPSC	lines	by	CRISPR/Cas9	editing.	One	pair	is	a	control	line	from	an	unaffected	sibling,	and	the	mutated	control	homozygous	for	the	GEFS+	K1270T	SCN1A	mutation.	The	second	pair	is	a	GEFS+	patient	line	heterozygous	for	the	K1270T	mutation,	and	the	corrected	patient	line.														To	detect	mutation-associated	changes	by	comparing	electrophysiological	properties	between	cell	lines,	it	is	necessary	to	differentiate	iPSC	into	neurons	that	could	both	fire	action	potentials	and	form	synaptic	connections.	While	there	were	a	number	of	protocols	for	differentiation	of	iPSCs	into	neurons	in	the	literature,	there	was	a	lot	of	variability	in	the	time	course	and	degree	of	differentiation	even	from	plating	to	plating	within	one	cell	line.		Starting	with	the	published	protocols	we	identified	conditions	that	support	robust	reproducible	differentiation	from	plating	to	plating	and	between	iPSCs	lines	into	cultures	with	GABAergic	and	glutamatergic	neurons.		The	iPSC-derived	neuronal	cultures	from	both	isogenic	pairs	of	iPSCs	that	we	generated	contained	a	similar	proportion	of	GABAergic	and	glutamatergic	neurons.	By	comparing	the	electrophysiological	properties	in	inhibitory	and	excitatory	iPSC-derived	neurons	from	these	pairs,	we	found	the	K1270T	mutation	causes	gene	dosage-dependent	and	cell	type-specific	alterations	in	evoked	firing	and	sodium	currents	that	result	in	hyperactive	neural	networks.	We	also	identified	differences	associated	with	genetic	background	and	interaction	between	the	mutation	and	genetic	background.	Dual	isogenic	iPSC-derived	neuronal	cultures	provide	an	efficient	strategy	to	evaluate	the	causality	of	a	single	gene	mutation	independent	of	genetic	background	and	to	develop	patient-specific	anti-seizure	therapies. 	
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2		
1.1.	Introduction													Epilepsy	is	a	common	neurological	disorder	affecting	1.2%	of	the	U.S.	population	that	is	characterized	by	recurrent	seizures	as	a	consequence	of	hyperexcitable	and	hypersynchronous	neural	networks1–3.	The	classifications	of	etiologies	of	epilepsies	can	be	divided	into	four	groups4.	(1)	Symptomatic:	defined	as	epilepsies	that	are	acquired	through	brain	injury	and	diseases	with	structural	abnormalities	in	brain;	(2)	Idiopathic:	defined	as	epilepsies	with	genetic	or	presumed	genetic	causes	and	no	neuroanatomical	and	pathological	abnormalities.	(3)	Provoked:	defined	as	epilepsies	caused	by	specific	systemic	or	environmental	factors	that	are	not	associated	with	neuroanatomical	and	pathological	abnormalities;	(4)	Cryptogenic:	defined	as	epilepsies	in	presumed	symptomatic	nature	with	causes	unidentified.	The	idiopathic	generalized	epilepsies	are	the	most	common	epilepsies,	accounting	for	30%	of	seizure	disorders5,6.	10%	of	genes	identified	in	this	broad	group	of	epilepsies	code	for	neurotransmitter	receptors	including	NMDA,	GABAA	and	nACh	receptors,	while	17%	encode	voltage-gated	ion	channels	that	are	selectively	permeable	to	each	of	the	ions,	sodium,	potassium	and	calcium7.	A	myriad	of	mutations	in	voltage-gated	sodium	channels	(Nav)	that	play	an	important	role	in	electrical	excitability	confer	genetic	epilepsies.	However,	how	specific	mutations	cause	dysfunctional	ion	channels,	disrupt	neuronal	activity	and	overall	network	activity,	and	give	rise	to	seizures	remains	elusive.													In	excitable	cells,	voltage-gated	sodium	channels	are	activated	in	response	to	membrane	depolarization	with	sodium	ions	moving	into	cells	to	initiate	action	potential	firing8.	This	is	followed	by	inactivation	that	stops	the	flow	of	sodium	ions	and	decrease	the	membrane	potential	to	the	rest	state.	Voltage-gated	sodium	channels	have	nine	isoforms,	each	with	distinct	expression	location	and	biophysical	properties.	Nav1.1,	Nav1.2,	Nav1.3	
3		
and	Nav1.6	are	the	major	isoforms	expressed	in	the	central	nervous	system9.	Nav1.1	and	Nav1.3	are	located	at	the	cell	bodies	of	neurons,	Nav1.2	in	unmyelinated	axons	and	dendrites,	and	Nav1.6	in	myelinated	axons	and	dendrites10.	Due	to	the	large	number	of	mutations	identified,	Nav1.1	encoded	by	the	SCN1A	gene	is	the	most	common	Nav	in	relevance	to	genetic	epilepsy11.													Similar	to	all	other	isoforms,	Nav1.1	has	two	main	components,	a	large	α	subunit	and	auxiliary	β	subunits12	(Figure	I.1).	The	α	subunit	are	composed	of	four	homologous	domains	(I-IV),	each	with	six	α-helical	transmembrane	segments	(S1-S6)13.	S1-S4	segments	form	the	voltage-sensing	domain	and	the	S4	segment	acts	as	a	voltage	sensor	with	positively	charged	residues	residing	in	the	transmembrane	region	that	undergoes	an	outward	movement	upon	depolarization	of	membrane	potential14,15.	S5	and	S6	segments	form	the	pore	and	the	electronegative	extracellular	loop	between	S5	and	S6	determines	the	sodium	ion	selectivity14.		Conformational	change	of	S4	is	coupled	to	the	movement	of	S4-S5	linker	which	pulls	the	S5	and	S6	outward	to	open	the	pore,	allowing	sodium	ions	to	move	along	the	central	pore14.	The	cytoplasmic	loop	between	domain	III	and	IV	functions	as	the	inactivation	gate16,17.	The	β	subunits	are	transmembrane	segments	and	associated	with	the	α	subunit	in	a	complementary	manner	with	β1	or	β3,	and	β2	or	β418–20.	They	play	an	important	role	in	regulating	the	kinetics,	voltage	dependence	of	gating	and	cell	adhesion	of	Nav21,22.														Over	1200	mutations	throughout	the	entire	SCN1A	gene	are	associated	with	a	wide	spectrum	of	epilepsies23	(Figure	I.1).	10%	of	SCN1A	mutations	are	associated	with	genetic	epilepsy	with	febrile	seizure	plus	(GEFS+),	while	85%	accounts	for	Dravet	syndrome	(DS)24,25.	GEFS+	is	a	mild	form	of	epilepsy,	characterized	by	febrile	seizures	in	early	
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childhood	that	persist	beyond	6	years	of	age26.	DS	patients	have	seizures	at	elevated	body	temperature	in	the	first	year	of	life	and	often	progress	to	afebrile	seizures	and	development	of	co-morbidities	such	as	psychomotor	delay,	ataxia	and	cognitive	impairment27,28.	The	heterogeneity	of	disease	phenotypes	not	only	arises	from	different	mutations	in	the	same	gene,	but	also	from	the	same	mutation	between	individuals.	There	are	multigenerational	families	in	which	individuals	with	the	same	SCN1A	mutation	exhibit	a	wide	range	of	seizure	phenotypes29,30.	This	complicates	the	understanding	of	the	underlying	cellular	mechanisms	of	SCN1A	epilepsy	and	the	prescription	of	anti-epileptic	drugs	to	epilepsy	patients.													Several	model	systems	have	been	used	to	map	the	links	between	individual	SCN1A	mutations	and	their	functional	consequences,	facilitating	the	development	of	anti-epileptic	therapeutics31.	Heterologous	expression	systems	including	Xenopus	oocytes,	human	embryonic	kidney	cells,	or	Chinese	hamster	ovary	cells	were	used	in	the	earliest	work	to	demonstrate	the	biophysical	effects	of	SCN1A	mutations	associated	with	epilepsy32–36.	Exogenous	sodium	channel	genes	are	cloned	and	expressed	in	these	non-excitable	cells	which	do	not	express	endogenous	voltage-gated	sodium	channels.	These	systems	have	the	advantage	of	being	able	to	establish	good	voltage	control	over	the	membrane	potentials	which	allows	for	accurate	measurement	of	the	biophysical	properties	of	the	channels.	However,	it	fails	to	reveal	a	consistent	pathogenesis	of	SCN1A	mutations	that	predisposes	patients	to	hyperactive	neural	networks	and	seizure	behaviors,	due	to	the	lack	of	the	diversity	of	Nav	channels	and	neuronal	subtypes	as	in	vivo9,32,35,37,38.	Mouse	models	have	been	widely	used	to	investigate	SCN1A	epilepsy.	A	variety	of	tools	for	genetic	manipulations	are	available	for	generating	transgenic	mice	with	knock-in	or	knock-out	mutations.	The	heterogeneity	of	cell	types	in	mouse	central	nervous	systems	allows	for	
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examination	of	the	effect	of	SCN1A	mutations	in	different	cell	types	that	underlie	the	alterations	in	circuitry	and	behaviors	in	vivo39,40.	Although	the	similarity	in	the	mouse	and	human	genomes	makes	mice	a	useful	model	for	neurological	disorders,	challenges	of	informing	human	health	with	mouse	experimentation	remain41,42.														With	the	advent	of	induced	pluripotent	stem	cells	(iPSCs),	patient	iPSC-derived	neurons	have	become	a	promising	tool	to	study	the	cellular	mechanism	of	epilepsy-associated	SCN1A	mutations	and	to	develop	personalized	anti-epileptic	therapeutics43,44.	To	understand	disease-associated	changes	in	neuronal	function,	it	requires	the	iPSC-derived	neurons	do	not	only	have	neuronal	morphology,	but	they	are	also	capable	of	firing	action	potentials	and	forming	functional	synapses45.	In	contrast	to	plating	iPSC-derived	neural	progenitors	onto	biochemical	substrates,	co-culturing	with	mouse	astroglial	feeder	layers	supports	the	maturation	of	excitability	and	synaptic	activity	in	the	derived	neurons46–48.	Prevailing	methods	of	using	primary	mouse	astrocytes	are	likely	to	cause	contamination	of	primary	mouse	neurons	that	complicates	distinguishing	human	iPSC-derived	neurons	and	mouse	neurons	during	live	recording.	Additionally,	mouse	primary	astrocyte	cultures	have	an	unpredictable	timeline	of	growth	and	recovery,	making	it	difficult	to	coordinate	with	the	plating	of	iPSC-derived	neural	progenitors.	To	overcome	these	issues,	a	reproducible	and	reliable	method	of	generating	astroglial	feeder	layers	from	cryopreserved	mouse	primary	astrocyte	cultures	was	developed	to	support	the	functional	maturation	of	human	iPSC-derived	neurons,	as	described	in	Chapter	1	of	the	dissertation.														A	common	approach	to	model	neurological	disorders	with	human	iPSCs	is	to	use	a	large	cohort	of	control	and	patient	lines.	To	identify	subtle	alterations	between	control	and	patient	lines,	it	is	important	to	use	a	differentiation	protocol	that	can	consistently	generate	
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functionally	active	neurons.	Although	many	protocols	can	produce	neurons	that	express	neuronal	markers	and	fire	action	potentials49–51,	there	is	limited	discussion	on	the	reproducibility	in	terms	of	the	rate	and	degree	of	maturation	in	excitability	and	synaptic	activity	between	individual	platings	and	between	independent	cell	lines.	Large	variability	and	low	efficiency	of	protocols	are	likely	to	mask	the	small	changes	caused	by	the	mutation	in	the	patient	line.	In	addition,	it	remains	elusive	on	how	the	differentiation	propensity	of	stem	cells	at	different	stages	affect	the	functional	maturation	of	the	derived	neurons.	Many	studies	used	neural	stem	cells,	an	expandable	population	of	cells	as	the	starting	materials	of	neuronal	differentiation50,52,53,	while	some	directly	differentiate	human	iPSCs	into	neurons	without	the	intermediate	stage	of	expanding	neural	stem	cells51,54–60.	In	Chapter	2	of	the	dissertation,	the	efficiency	of	the	two	protocols	with	or	without	using	expandable	neural	stem	cells	was	compared,	and	the	direct	differentiation	protocol	was	modified	by	including	the	use	of	mouse	astroglial	feeder	layers49,61.	The	reproducibility	of	the	direct	differentiation	protocol	was	examined	by	tracking	the	rate	and	degree	of	maturation	of	neurons	derived	from	multiple	platings	and	two	control	cell	lines	over	a	time	course	of	5	weeks.														Using	multiple	control	and	patient	lines	can	help	understand	the	contribution	of	mutations	to	disease	phenotypes.	However,	transcriptomic	analysis	in	a	number	of	iPSC	lines	reveals	that	genetic	background	variation	accounts	for	differences	between	lines62,63.		The	genetic	background	variation	was	also	manifested	in	multigenerational	families	in	which	individuals	with	the	same	SCN1A	mutation	exhibit	a	broad	range	of	seizure	phenotypes29,30.	Differences	in	genetic	background	can	also	influence	the	underlying	cellular	phenotypes64–66.	Therefore,	subtle	differences	in	cellular	phenotypes	might	be	
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masked	by	multiple	unrelated	control	and	patient	lines	due	to	large	variation	in	genetic	background	within	each	group67.	Also,	this	strategy	does	not	allow	for	studying	the	causality	of	genetic	mutations	to	disease	phenotypes.	As	epilepsy	is	associated	with	dysfunction	of	a	variety	of	molecules	that	affect	biophysical	properties	of	neurons,	and	thus	is	susceptible	to	variations	in	genetic	background,	using	dual	isogenic	pairs	of	control	and	mutant	iPSC	lines	provides	an	efficient	strategy	to	evaluate	the	causality	of	a	single	gene	mutation	independent	of	genetic	background67–71.	Comparison	of	electrophysiological	properties	of	neurons	within	and	between	isogenic	pairs	can	identify	alterations	that	are	possibly	caused	by	one	of	the	three	factors:	mutation	alone,	genetic	background	alone,	or	interaction	between	the	mutation	and	the	background.	In	Chapter	3,	I	aim	to	understand	the	causality	of	a	missense	SCN1A	mutation	to	the	etiology	of	epilepsy.	Using	CRISPR/Cas9	editing,	dual	isogenic	pairs	of	iPSCs	were	generated:	1a)	control	(unaffected	sibling),	1b)	mutated	control,	and	2a)	patient	with	SCN1A	mutation	(patient	sibling),	2b)	corrected	patient.	Electrophysiological	properties	were	compared	in	inhibitory	and	excitatory	neurons	between	and	within	the	isogenic	pairs	to	identify	cell	type-specific	alterations	caused	by	the	mutation	and/or	genetic	background.													In	sum,	the	aims	of	my	dissertation	are	to	generate	mouse	astroglial	feeder	layers	and	functionally	active	human	iPSC-derived	neurons	using	reproducible	and	efficient	protocols,	and	to	determine	the	cellular	effect	of	a	SCN1A	mutation	in	different	neuronal	subtypes	derived	from	dual	pairs	of	isogenic	iPSCs.	In	Chapter	1,	we	developed	a	method	using	cryopreserved	primary	mouse	astroglia	to	generate	neuron-free	and	astrocyte-enriched	feeder	layers	that	promote	the	development	of	functional	neural	network	in	the	human	iPSC-derived	neuronal	cultures.	In	Chapter	2,	we	identified	a	direct	differentiation	
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protocol	that	can	reproducibly	generate	neuronal	cultures	from	iPSCs	in	which	the	majority	of	cells	not	only	have	neuronal	morphology	and	express	neuronal	markers,	but	they	can	also	fire	action	potentials	and	form	functional	synaptic	connections.	The	rate	and	degree	of	functional	maturation	is	similar	between	two	control	lines.	In	Chapter	3,	by	comparing	the	electrophysiological	properties	in	inhibitory	and	excitatory	neurons	from	the	dual	isogenic	pairs	of	iPSCs,	we	found	the	K1270T	mutation	causes	gene	dosage-dependent	and	cell	type-specific	alterations	in	sodium	current	density	and	evoked	firing,	resulting	in	hyperactive	neural	networks.	We	also	identified	differences	associated	with	genetic	background	and	interaction	between	the	mutation	and	genetic	background.													Human	iPSC-derived	neuronal	cultures	prepared	using	these	protocols	will	facilitate	identification	of	cellular	defects	in	excitability	and	synaptic	activity	associated	with	neurological	disorders	that	confer	imbalance	of	excitation	and	inhibition.	Furthermore,	dual	isogenic	pairs	of	human	iPSC-derived	neurons	cultures	provide	an	efficient	strategy	to	evaluate	the	causality	of	a	single	gene	mutation	independent	of	genetic	background	and	a	novel	platform	for	developing	patient-specific	anti-seizure	therapies.	
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Figure	I.1	Mutations	in	Nav1.1	confer	a	broad	spectrum	of	epilepsies.	The	Nav1.1	α	subunit	is	composed	of	four	homologous	domains,	each	with	six	transmembrane	segments.	The	S4	segments	(gray)	function	as	voltage	sensors.	Epilepsy-associated	SCN1A	mutations	are	represented	as	circles	throughout	the	channel,	with	DS	mutations	in	red	and	GEFS+	mutations	in	blue.		
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Chapter	II	
	
Astrocyte-enriched	feeder	layers	from	cryopreserved	cells	support	
differentiation	of	spontaneously	active	networks	of	human	iPSC-derived	
neurons	
	
	
	This	work	has	been	published	in	Schutte	RJ*,	Xie	Y*,	Ng	NN*,	Figueroa	P,	Pham	AT,	O’Dowd	DK.	Astrocyte-enriched	feeder	layers	from	cryopreserved	cells	support	differentiation	of	spontaneously	active	networks	of	human	iPSC-derived	neurons.	J	Neurosci	Methods.	2018;	294:91–101.	
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2.1.	Introduction									Human	induced	pluripotent	stem	cells	(hiPSCs)	can	be	differentiated	in	vitro	into	a	wide	variety	of	cell	types	including	central	nervous	system	neurons1.	Patient-specific	iPSC-derived	neuronal	 cultures	 have	 proven	 to	 be	 an	 important	 tool	 for	 exploring	 the	 molecular	mechanisms	 of	 a	 number	 of	 neurological	 disorders,	 including	 Parkinson’s,	 amyotrophic	lateral	sclerosis,	Huntington’s,	autism,	schizophrenia,	and	epilepsy	2–8.	A	critical	requirement	for	understanding	disease	associated	changes	in	neuronal	function	is	that	the	derived	cells	not	only	have	a	neuronal	morphology	but	that	they	are	also	capable	of	firing	action	potentials	and	forming	functional	synaptic	connections.									Recent	evidence	demonstrates	that	the	plating	substrate	can	have	significant	influence	on	the	development	of	functional	properties	of	iPSC-derived	neurons.	Common	substrates	on	which	 iPSC-derived	neural	progenitor	 cells	 are	 seeded	 include	Matrigel,	 poly-D-lysine	(PDL)	or	poly-L-ornithine	(PLO)	with	laminin,	and	rodent	astroglia2,9–12.	Several	studies	have	shown	that	compared	to	plating	on	cell-free	extracellular	matrices,	co-culturing	iPSC-derived	neural	 progenitors	 onto	 rodent	 astroglial	 feeder	 layers	 promotes	 a	 greater	 degree	 of	morphological	development	and	functional	maturation	of	neuronal	excitability	and	synaptic	transmission13–15.										In	 most	 published	 protocols	 astroglial	 feeder	 cultures	 are	 prepared	 from	 the	 early	postnatal	 rodent	 brain10,12,15,16.	 As	 this	 tissue	 source	 contains	 both	 neurons	 and	 glia,	protocols	 have	 been	 developed	 to	 enrich	 the	 cultures	 for	 glia	 and	 eliminate	 neurons.	Enrichment	 protocols	 often	 rely	 on	differences	 in	 neuronal	 and	 glial	 response	 to	 culture	media	supplements	and	adherence	to	the	substrate17,18.	Harsh	trituration	of	cortical	tissue	in	 the	 absence	 of	 glutamate	 receptor	 blockers	 can	 also	 be	 used	 to	 inhibit	 neuronal	
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survival19,20.	 While	 glial	 cells	 survive	 these	 enrichment	 protocols,	 an	 extended	 and	unpredictable	period	of	time	is	typically	required	for	recovery	and	glial	proliferation.	The	variability	in	the	growth	rate	of	primary	astroglia	to	form	feeder	layers	makes	it	difficult	to	coordinate	their	availability	concurrent	with	the	hiPSCs-derived	neuronal	progenitors	at	the	appropriate	stage	of	patterning	for	terminal	differentiation.	In	addition,	the	possibility	that	some	rodent	neurons,	even	a	small	population,	are	present	in	the	primary	astroglial	feeder	layers	 complicates	 distinguishing	 between	 hiPSC-derived	 and	 rodent	 neurons	 in	 live	cultures.		Cryopreservation	of	cells	harvested	from	rodent	primary	astroglial	cultures	has	been	shown	to	be	an	effective	way	to	eliminate	neurons,	while	the	astroglia	retain	the	ability	to	proliferate	 when	 replated21,22.	 Therefore,	 we	 asked	 whether	 astroglial	 feeder	 layers	generated	 from	 cryopreserved	 cells	 would	 support	 differentiation	 of	 functionally	 active	hiPSC-derived	neurons.	Here	we	describe	an	efficient	method	using	cryopreserved	primary	mouse	 astroglia	 to	 generate	 neuron-free,	 astrocyte-enriched	 feeder	 layers	 in	 4-6	 days.	Immunostaining	demonstrated	that	the	feeder	cultures	were	composed	primarily	of	GFAP	positive	astrocytes	with	no	evidence	of	β-III	tubulin	positive,	GFAP	negative	neurons.	iPSC-derived	 neural	 progenitors	 plated	 onto	 the	 astrocyte-enriched	 feeder	 layers	 formed	spontaneously	active	networks	of	hiPSC-derived	neurons	within	21	days.	In	contrast,	neural	progenitors	 plated	 on	 biochemical	 substrates	 alone	 or	 when	 supplemented	 with	 glial	conditioned	medium	were	less	effective	in	supporting	functional	neuronal	differentiation	in	the	same	time	frame.	There	was	also	a	positive	correlation	between	support	layer	confluence	at	 the	 time	 of	 progenitor	 plating	 and	 the	 degree	 of	 synaptic	 connectivity.	 This	 efficient	
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method	for	preparation	of	astrocyte-enriched	cultures	will	be	of	great	value	for	neurological	disease	modeling	and	drug	screening	using	hiPSC-derived	neuronal	cultures.		
	
2.2.	Methods	
2.2.1	Preparation	of	frozen	astroglia	stocks	from	mouse	brain	primary	cultures									Dissection	of	neonatal	mouse	brains	was	performed	in	adherence	with	approved	animal	use	protocols	and	was	consistent	with	a	previously	published	protocol19.	Postnatal	cortical	rinds	were	digested	and	triturated	into	a	single	cell	suspension	and	seeded	onto	PDL-coated	(Sigma-Aldrich,	P7886)	plastic	60	mm	tissue	culture	dishes	at	1	dish	per	brain.	Cultures	were	maintained	 in	 minimal	 essential	 medium	 (MEM;	 Life	 Technologies,	 11090-081)	supplemented	 with	 10%	 heat-inactivated	 fetal	 bovine	 serum	 (vol/vol)	 (Sigma-Aldrich,	G8270),	2%	1	M	D-(+)-glucose	(vol/vol)	(Sigma-Aldrich	G8270),	1%	penicillin/streptomycin	(vol/vol)	(Life	Technologies,	15070-063)	until	100%	confluent	(approximately	8-10	days).	Confluent	dishes	were	washed	once	with	sterile	Dulbecco’s	calcium-	and	magnesium-free	phosphate-buffered	saline	(D-PBS;	Gibco,	14190-144),	then	incubated	for	8-10	minutes	in	3	ml	of	37°C	TrypLE	Express	Enzyme	(Life	Technologies,	12604-021).	TrypLE	was	then	diluted	with	an	additional	50%	supplemented	MEM	(vol/vol)	per	dish	before	detaching	 the	cells	with	gentle,	repetitive	pipetting.	Cells	were	then	centrifuged	at	156	g	for	5	min	and	gently	resuspended	at	a	concentration	of	106	cells/ml	in	4°C	filtered	freezing	media	containing	45%	supplemented	MEM	 (vol/vol),	 45%	 conditioned	 stock	MEM	 (vol/vol),	 and	10%	dimethyl	sulfoxide	(vol/vol)	(DMSO;	Sigma-Aldrich,	D2650).	Aliquots	of	cell	suspension	(1.5	ml)	were	stored	 in	 1.8	 ml	 polypropylene	 cryovials	 (Sigma-Aldrich,	 V7634)	 and	 immediately	transferred	into	a	2-propanol	 jacketed	freezing	container	(Nalgene,	5100-0001)	to	slowly	
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cool	at	a	rate	of	-1°C/min	to	a	final	temperature	of	-80°C.	The	entire	process	of	expansion	and	cryopreservation	was	defined	as	a	single	passage.	Frozen	cell	suspension	was	stored	for	a	minimum	of	24	hours	and	a	maximum	of	2	months	prior	to	use.	All	media	were	equilibrated	in	a	37°C	incubator	with	5%	CO2	before	use	on	the	same	day.		
2.2.2	Preparation	of	astroglial	 feeder	cultures	 from	frozen	stocks	and	astroglial	conditioned	
media	(GCM)	Cryovials	of	the	frozen	astroglial	cell	suspension	were	defrosted	in	a	37°C	water	bath	with	gentle	swirling	until	only	a	small	ice	crystal	remained.	37°C	supplemented	MEM	(vol/vol)	(sMEM)	was	added	to	the	cryovial	in	a	dropwise	manner	to	a	volume	of	approximately	2	ml	before	 being	 transferred	 to	 a	 15	 ml	 conical	 with	 3	 ml	 warmed	 sMEM.	 Cells	 were	 then	centrifuged	 at	 156	 g	 for	 5	 minutes	 and	 re-suspended	 in	 37°C	 sMEM.	 Cell	 suspension	concentration	was	determined	using	Trypan	Blue	exclusion	staining	(Trypan	Blue	0.4%;	Life	Technologies,	15250-061).	5×104	cells	were	then	seeded	onto	individual	PDL-coated	12	mm	round	glass	coverslips	(Bellco	Glass,	1943-10012A)	contained	in	the	wells	of	a	24-well	plate.	Cultures	were	maintained	 in	 sMEM	 in	 a	 5%	 CO2	 incubator	 at	 37°C,	 with	 half	 the	media	exchanged	every	2	days.	All	media	were	equilibrated	in	a	37°C	incubator	with	5%	CO2	before	use	on	the	same	day.	A	flow	chart	of	the	full	procedure	and	the	corresponding	timeline	are	illustrated	in	Figure	II.1.	To	 generate	 astroglial-conditioned	 media,	 frozen	 astroglia	 were	 seeded	 onto	 PDL-coated,	tissue-treated	75	cm2	cell	culture	flasks	(Corning,	430641U).	Flasks	were	grown	to	100%	 confluence	 over	 a	 period	 of	 5-7	 days	 in	 30	 ml	 total	 sMEM.	 After	 reaching	 full	confluence,	the	MEM	was	exchanged	for	neural	differentiation	media	(NDM),	prepared	in	a	
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separate	 protocol9,	 for	 24	 hours,	 before	 exchanging	 back	 to	 sMEM	 for	 48	 hours.	 Flasks	underwent	a	maximum	of	2	NDM	exchanges.								To	study	the	effect	of	feeder	layer	percent	confluence	on	iPSC-derived	neurons,	neural	progenitors	were	plated	in	six	conditions:	PDL,	PDL	supplemented	with	GCM,	PDL/laminin,	and	astroglial	cultures	of	20%,	50%	and	100%	confluence.			
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Figure	II.1.	Culture	process	work	flow	from	collection	of	tissue	to	plating	of	astrocyte-
enriched	cultures	for	iPSC-derived	neuron	differentiation.	(A)	Cortical	rinds	are	isolated	from	 P0-P2	mouse	 coronal	 slices,	 triturated	 into	 a	 single	 cell	 suspension,	 and	 grown	 to	confluence	on	PDL-coated	dishes.	Cells	harvested	from	confluent	cultures	are	resuspended	in	media	and	frozen	for	later	use.	(B)	4-6	days	prior	to	need	for	astrocyte-enriched	feeder	layers	the	cells	are	thawed,	plated	onto	PDL-coated	coverslips,	and	grown	to	desired	level	of	confluence.	(C)	iPSCs	are	patterned	into	neural	progenitors,	which	are	plated	onto	astrocyte-enriched	 feeder	 layers	 for	 the	 final	 stage	 of	 neuronal	 differentiation.	 (D)	 Timeline	 of	astroglial	cultures	and	neural	differentiation	from	iPSCs.		
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2.2.3	Immunostaining														Astroglial	 feeder	 cultures	 were	 fixed	 in	 4%	 paraformaldehyde	 (wt/vol)	 (Sigma-Aldrich,	P6148)	for	15	minutes	at	room	temperature	and	washed	three	times	with	PBS.	Cells	were	permeabilized	and	blocked	using	PBS	with	4%	bovine	serum	albumin	(wt/vol)	(BSA;	Sigma-Aldrich,	 A4919),	 0.25%	 Triton	 X-100	 (vol/vol)	 (Sigma-Aldrich,	 X100),	 and	 0.02%	sodium	azide	(wt/vol)	(Sigma-Aldrich,	S2002)	in	1×	PBS	(Sigma-Aldrich,	P3813)	for	1	h	at	room	temperature.	Cultures	were	exposed	to	primary	antibody	and	incubated	overnight	at	4°C.	Coverslips	were	then	washed	three	times	with	PBS	and	incubated	in	5%	normal	goat	serum	(vol/vol)	(ThermoFisher	Scientific,	16210-064),	0.25%	Triton	X-100,	0.02%	sodium	azide	 in	 1×	 PBS	 containing	 a	 1:1000	 dilution	 of	 secondary	 antibody	 (Alexa-Fluor;	 Life	Technologies)	for	2	h	at	room	temperature.	Coverslips	were	washed	twice	with	PBS	before	counter-staining	 with	 4’,6-diamidino-2-phenylindole	 (DAPI;	 Life	 Technologies,	 D9542).	Fluoromount	G	(SouthernBiotech,	0100-01)	was	used	to	mount	coverslips	on	glass	slides.	Images	were	 taken	using	 a	 Zeiss	M2	 Imager	microscope	 and	processed	by	Zen	 software.	Primary	 antibodies	 used	 were	 β-III	 tubulin	 (Sigma-Aldrich,	 T8660;	 1:1000	 dilution)	 to	identify	 neurons,	 glial	 fibrillary	 acidic	 protein	 (GFAP;	 DAKO	 Z0334;	 1:1500	 dilution)	 to	identify	astroglial	cells,	and	DAPI	(1:40000	dilution)	to	identify	nuclei	of	all	cells.	
	
2.2.4	iPSC	culture													The	 iPSC	cell	 line	used	 in	 this	paper	 is	Line	173	 (SC173.1-SF6-2I2.M16,	passages	9	through	 21).	 Line	 naming	 followed	 National	 Stem	 Cell	 Resource	 Center	 nomenclature.	Fibroblasts	were	 isolated	from	a	skin	biopsy	of	a	56-year-old	male	donor	with	no	known	clinical	diagnoses.	Skin	fibroblasts	were	reprogrammed	by	the	National	Stem	Cell	Resource	
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Center	(Laboratory	of	Phillip	H.	Schwartz)	using	a	previously	published	protocol20.	 	 iPSCs	were	maintained	using	feeder-free	conditions	based	on	published	protocols20,23.			
2.2.5	Plating	of	hiPSC-derived	neural	progenitors	onto	astroglial	feeder	layers													The	differentiation	protocol	was	adapted	from	Liu	et	al.,	2013	24with	modifications	as	briefly	 outlined.	 On	 day	 0,	 embryoid	 bodies	were	 generated	 from	 confluent	 human	 iPSC	cultures	by	manual	scraping25.	Detached	culture	fragments	from	15	wells	were	collected	in	a	conical	tube	and	centrifuged	at	156	g	for	5	min.	Pellets	were	gently	resuspended	in	15	ml	human	iPSC	medium	(hiPSCM;9)	with	DMH-1	(Tocris,	4126),	SB-431542	(Stemgent,	04-0010)	and	rho-associated	protein	kinase	 inhibitor	Y27632	(ROCK	inhibitor;	Stemgent,	04-0012)	and	 then	 transferred	 to	a	T25	non-tissue	 treated	 flask	 (Thermofisher	Scientific,	169900).	Neural	 induction	 and	 patterning	 procedures	 were	 followed	 according	 to	 the	 original	protocol	9.	On	day	16,	neural	rosettes	were	isolated	and	collected	following	1	h	incubation	with	 STEMDiff	Neural	 Rosette	 Selection	Reagent	 (STEMCELL	Technologies,	 05832).	 Cells	were	patterned	 into	neural	progenitor	cells	 (NPCs)	using	 the	ventralizing	small	molecule	purmorphamine	(Stemgent,	04-0009)	following	the	original	protocol	until	day	259.												On	day	26,	neurospheres	of	NPCs	were	pre-treated	with	ROCK	inhibitor,	dissociated	using	 Accutase	 (Life	 Technologies,	 A1110501),	 centrifuged	 at	 156	 g	 for	 5	 minutes,	 and	resuspended	 in	 fresh	 neural	 induction	 medium	 (NIM)	 containing	 ROCK	 inhibitor.	 After	counting	cells	with	Trypan	Blue	exclusion,	2.5×104	cells	were	plated	on	PDL,	PDL/laminin,	and	20%,	50%,	or	100%	confluent	mouse	astroglial	feeder	layers	grown	on	PDL.	24	h	after	plating,	 50%	 of	 the	 NIM	was	 replaced	 by	 neural	 differentiation	medium	 (NDM)	 or	 GCM	containing	0.4	µM	γ-secretase	inhibitor	XXI	(Compound	E,	Calbiochem,	565790),	10	ng/ml	BDNF	(Peprotech,	450-02),	10	ng/ml	GDNF	(Peprotech,	450-10),	10	ng/ml	IGF-1	(Peprotech,	
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100-11),	and	0.5	g/ml	membrane	permeable	cyclic	AMP	(Sigma-Aldrich,	D0260).	48	h	after	plating,	all	media	were	exchanged	with	NDM	or	GCM	with	0.2	µM	Compound	E.	96	h	after	plating,	all	media	were	exchanged	for	NDM	or	GCM	without	Compound	E.	From	this	point,	50%	culture	media	exchange	with	fresh	NDM	or	GCM	without	Compound	E	was	performed	every	other	day.	All	media	were	equilibrated	in	a	37°C	incubator	with	5%	CO2	before	use	on	the	same	day.		 To	 prepare	 PDL-	 and	 laminin-coated	 (PDL/L)	 coverslips,	 50	 µl	 of	 natural	 mouse	laminin	(Invitrogen,	23017-015)	was	added	onto	each	PDL-coated	coverslip	2	hours	prior	to	neural	progenitor	plating.	PDL/L	coverslips	were	then	incubated	at	37°C	until	use.	
	
2.2.6	Electrophysiological	recording													Whole-cell	recordings	were	performed	on	human	iPSC-derived	neurons	between	days	21-24	post	plating	using	unpolished	borosilicate	glass	pipettes	with	an	open	tip	resistance	of	4-7	MΩ	(VWR	International,	53432-921).	External	solution	contained	(in	mM):	NaCl	120,	KCl	5.4,	MgCl2	0.8,	CaCl2	1.8,	glucose	15,	HEPES	20,	at	pH	7.2-7.4	with	osmolarity	between	290	and	295	mOsm.	Internal	solution	contains	(in	mM):	potassium	gluconate	120,	NaCl	20,	CaCl2	0.1,	MgCl2	2,	EGTA	1.1,	HEPES	10,	Na2ATP	4.5	at	pH	7.2	with	osmolarity	~280	mOsm.	Voltages	were	corrected	for	a	-5	mV	junction	potential.														While	 holding	 the	 membrane	 potential	 at	 -75	 mV	 with	 hyperpolarizing	 current,	evoked	action	potentials	(APs)	were	recorded	from	600	ms	depolarizing	current	injections	under	current-clamp,	and	spontaneous	post-synaptic	currents	(sPSCs)	were	recorded	for	at	least	1	minute	under	voltage-clamp	at	-75	mV.	Data	were	acquired	with	an	EPC7	amplifier	
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(List	Medical),	 a	 Digidata	 1320A	 D-A	 converter	 (Axon	 Instruments),	 and	 a	 Dell	 Optiplex	GX110	computer	running	pClamp8	software	(Axon	Instruments).		
2.2.7	Data	Analysis	and	Statistics													Phase-contrast	micrographs	were	imaged	with	EVOS™	XL	Core	Cell	Imaging	System	(ThermoFisher	 Scientific,	 AMEX1000).	 Visual	 estimations	 of	 astroglial	 confluence	 were	based	on	n	=	5	independent	experiments.	Fluorescent	micrographs,	imaged	with	Zeiss	Axio	Imager	M2	and	processed	using	Zen	software,	were	used	to	quantify	astroglial	confluence	and	marker	 expression.	 Immunofluorescence	 analyses	were	based	on	n	=	3	 independent	experiments.														Electrophysiological	 data	 were	 analyzed	 using	 Clampfit	 10.6	 software	 (Axon	Instruments).	Only	recorded	cells	with	a	stable	resting	membrane	potential	(no	greater	than	±	5	mV	deviation)	more	hyperpolarized	than	-30	mV,	input	resistance	>	400	MΩ,	and	stable	sPSC	 voltage-clamp	 recording	 were	 accepted	 for	 analysis.	 Evoked	 APs	 were	 defined	 as	regenerative	events	where	the	first	AP	in	the	train	was	at	least	20	mV	in	amplitude	and	any	subsequent	 events	 were	 scored	 as	 APs	 if	 they	 were	 at	 least	 15	 mV	 in	 amplitude.	Spontaneously	firing	cells	were	classified	as	those	in	which	at	least	one	spontaneous	action	potential	 (sAP)	 above	 -10	mV	was	 observed	 in	 the	 first	 30	 seconds	 of	 recording	 in	 the	absence	of	holding	current.	Mini	Analysis	Program	6.0.7	(Synaptosoft)	was	used	to	identify	sPSC	events	with	an	amplitude	threshold	of	10	pA	(4×	RMS	noise	level	of	2.5	pA)	and	an	area	threshold	of	15	pA·ms	(1.5×	amplitude	 threshold).	 sPSCs	 identified	by	 the	software	were	then	verified	individually,	with	double	peaks	manually	included.	Recordings	with	a	baseline	shifted	by	more	than	50	pA	or	events	with	a	10-90%	rise	time	larger	than	3	ms	were	excluded.		
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												Statistical	analyses	were	performed	in	Prism	7	(GraphPad)	and	figures	were	generated	using	DeltaGraph	7.1	(Red	Rock	Software).			
2.3.	Results	
2.3.1	Rapid	reproducible	growth	of	feeder	layers	from	defrosted	primary	astroglia.	
													In	previous	studies	we	used	astroglial	feeder	layers	from	primary	cultures	of	neonatal	mouse	brains	to	support	differentiation	of	hiPSC-derived	neurons.	Significant	cell	loss	in	the	primary	astroglial	feeder	cultures	was	observed	during	the	first	week.	Proliferation	of	the	remaining	cells	 typically	 reached	confluences	of	50-100%	in	14-21	days	when	 they	were	used	 plating	 of	 neuronal	 progenitors.	 The	 extended	 and	 variable	 time	 period	 made	coordinating	progenitor	production	and	astroglial	support	layer	availability	challenging.													In	this	study	we	instead	used	cryopreserved	primary	astroglial	cells	to	prepare	feeder	layers.	Astroglial	feeder	layers	were	prepared	by	seeding	5×104	defrosted	primary	astroglial	cells	onto	PDL-coated	glass	coverslips.	The	percentage	of	surface	area	covered	by	astroglial	cells	(%	confluence)	was	tracked	and	visually	estimated	from	phase-contrast	imaging	of	live	cultures	between	2	and	10	days	after	plating.	At	day	2	post	plating,	a	small	number	of	cells	were	observed	and	the	majority	of	the	surface	area	was	cell-free	(Figure	
II.2A).	Astroglia	proliferation	was	clearly	apparent	by	day	4,	with	an	increased	number	of	cells	and	reduction	in	cell-free	space	observed.	By	day	8,	the	majority	of	the	coverslip	surface	area	was	covered	by	cells.	There	was	a	steady	and	reproducible	increase	in	%	confluence	from	~10%	at	2	days	after	plating	to	~100%	by	8	days	(Figure	II.2B).	These	data	demonstrate	the	reproducible	recovery	and	growth	of	defrosted	primary	astroglial	
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cells,	greatly	facilitating	coordination	of	hiPSC-derived	neuronal	progenitor	plating	and	astroglial	feeder	layer	availability.	
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Figure	II.2.	Rapid	and	reproducible	growth	of	cells	in	cultures	prepared	from	stocks	
of	 frozen	 primary	 astroglial	 cells.	 (A)	 Phase-contrast	 images	 of	 cells	 in	 live	 astroglial	cultures	at	2,	4,	and	8	days	after	plating	5×104	cells	onto	PDL-coated	coverslips.	Scale	bars	represent	50	µm.	(B)	The	percentage	of	surface	area	covered	by	astroglial	cells	was	visually	estimated	from	live	cultures	between	2	and	10	days	after	plating.	Each	point	represents	the	mean	±	SEM	from	5	independent	platings	with	3	coverslips/plating.			
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2.3.2	Feeder	layers	are	composed	of	primarily	GFAP	positive	astrocytes	and	are	neuron-free.													To	evaluate	the	contribution	of	astrocytes	and	neurons	to	the	feeder	layers	prepared	from	the	cryopreserved	stocks,	cultures	were	fixed	8	days	after	plating	and	co-stained	with	the	nuclear	marker	DAPI,	neuronal	marker	β-III	tubulin,	and	astrocytic	marker	GFAP.	The	total	number	of	 cells	 in	a	 single	 field	was	defined	by	 the	number	of	DAPI	positive	nuclei	(Figure	II.3A).	A	GFAP	stained	image	of	the	same	field	of	view	revealed	that	almost	all	of	the	nuclei	were	surrounded	by	GFAP	staining	indicating	the	majority	of	the	cells	were	astrocytes	(Figure	II.3B).	While	there	was	also	one	cell	stained	with	the	neuronal	marker	β-III	tubulin	(Figure	II.3C),	the	merged	image	revealed	that	the	cell	was	also	GFAP	positive	so	it	was	not	classified	 as	 neuronal	 (Figure	 II.3D,	 white	 arrowhead).	 Quantitative	 analysis	 of	 stained	cultures	 demonstrated	 that	 over	 94%	 of	 the	 total	 cells	 in	 culture	 were	 GFAP	 positive	astrocytes	(Figure	II.3E).	The	absence	of	β-III	tubulin	positive,	GFAP	negative	cells	indicate	that	no	mouse	neurons	were	present	in	these	feeder	layers.	The	remaining	6%	of	the	total	cells	 fall	 into	 two	 groups,	 2%	 were	 positive	 for	 both	 GFAP,	 and	 β-III	 tubulin	 possibly	representing	 early	 neuroglial	 progenitors	 (Figure	 II.3D,	 white	 arrowheads),	 and	 the	remaining	 4%	 were	 not	 stained	 with	 either	 GFAP	 or	 β-III	 tubulin	 (Figure	 II.3D,	 pink	arrowheads).		
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Figure	II.3.	Feeder	layers	derived	from	cryopreserved	astroglia	are	composed	of	GFAP	
positive	 astrocytes	 and	 are	 devoid	 of	 neurons.	 An	 immunofluorescent	 image	 of	 the	astroglial	feeder	layer	from	a	single	field	of	view.	(A)	Nuclei	of	cells	labeled	by	the	nuclear	marker	DAPI.	(B)	The	vast	majority	of	the	cells	in	the	feeder	layer	were	of	astrocytic	identity	as	indicated	by	their	staining	with	anti-	GFAP	antibodies.	(C,	D)	A	cell	labeled	by	the	neuronal	marker	β-III	tubulin	indicated	by	the	white	arrowhead	is	also	GFAP	positive	indicating	it	was	unlikely	to	be	a	neuron.	A	small	proportion	of	cells	were	not	labeled	with	either	marker	(pink	arrowheads).	(E)	The	number	of	total	cells	in	each	field	of	view	was	determined	by	counting	the	DAPI	positive	nuclei.	The	cells	stained	for	GFAP	alone,	β-III	tubulin	alone,	both,	or	neither	were	determined	for	each	field	were	expressed	as	a	percentage	of	total	cells.	Analysis	was	performed	on	9	 randomly	 selected	 fields	 from	 three	 coverslips	within	 each	plating.	Bars	indicate	mean	+	SEM,	n	=	3		independent	platings.		
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2.3.3	 Astrocyte-enriched	 feeder	 layers	 from	 cryopreserved	 cells	 facilitate	 the	morphological	
and	functional	differentiation	of	iPSC-derived	neurons		 Previous	 studies	 have	 shown	 that	 primary	 astroglial	 feeder	 layers	 promote	development	of	neuritic	processes	and	excitability	of	hiPSC-derived	neurons13,16.	One	study	used	50%	confluent	glia	for	their	experiments	to	promote	functional	maturation26.However,	the	 effect	 of	 different	 degrees	 of	 glia	 confluence	was	 not	 reported.	 To	 evaluate	 how	 the	presence	and	confluence	of	astrocyte-enriched	feeder	layers	prepared	from	cryopreserved	cells	 affect	 differentiation	 of	 hiPSC-derived	 neurons,	 progenitors	 were	 plated	 onto	 a	monolayer	of	20%,	50%,	or	100%	confluent	feeder	layers.	These	were	compared	to	those	plated	 on	 PDL,	 PDL	 supplemented	 with	 astroglial-conditioned	 medium	 (GCM),	 or	 a	combination	of	PDL/laminin	(PDL/L).		When	examined	at	21	days	post	plating,	qualitative	differences	between	the	culture	conditions	were	apparent	in	fluorescence	images.	As	revealed	by	immunostaining	with	βIII-tubulin	antibody,	typically	progenitors	in	the	PDL	and	GCM	conditions	resulted	in	fewer	cells	with	neuronal	morphology	and	relatively	limited	branching	of	the	neurites	(Figure	II.4A,	B).	Those	plated	onto	PDL/laminin	resulted	in	more	cells	with	neurites	than	PDL	alone	(Figure	
II.4C).	 The	 most	 consistent	 and	 robust	 differentiation	 of	 neurons	 with	 highly	 branched	processes	was	observed	when	progenitors	were	plated	on	feeder	layers	enriched	for	GFAP-positive	 astroglia	 (Figure	 II.4D).	 Cultures	 plated	 on	 20%	 confluent	 astrocyte-enriched	feeder	layers	predominantly	formed	a	lattice	pattern	on	the	glass	coverslips.	These	hiPSC-derived	neurons	were	isolated	into	islands	of	various	sizes	and	connected	to	each	other	by	neurite	bundles	(Figure	II.4E).	Cultures	plated	on	50%	and	100%	confluent	astroglia	had	neurons	and	branching	neurites	more	evenly	distributed	over	the	confluent	astroglial	layer	
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(Figure	II.4F,	G).	Cell	size	was	also	evaluated	by	determining	the	cell	capacitance	through	whole-cell	recordings.	There	was	no	effect	of	feeder	layer	confluence	on	average	whole	cell	capacitance	 but	 hiPSC-derived	 neurons	 grown	 without	 feeder	 layers	 had	 a	 significantly	smaller	mean	capacitance	than	those	grown	on	feeder	layers	(Table	II.1).	Furthermore,	the	input	resistance	of	the	cells	grown	without	feeder	layers	was	higher.	Both	of	these	electrical	measurements	 are	 consistent	 with	 the	 visual	 observations	 that	 feeder	 layers	 facilitate	growth	of	hiPSC-derived	neurons.														Active	membrane	properties	of	neurons	grown	in	the	different	conditions	were	also	evaluated	 by	whole-cell	 recordings.	 In	 all	 six	 growth	 conditions	 over	 75%	 of	 the	 hiPSC-derived	neurons	fired	at	 least	one	action	potential	 in	response	to	a	depolarizing	stimulus	(Figure	II.5A,	B).	However,	 the	peak	firing	frequency	was	significantly	higher	 in	neurons	grown	on	astroglial	feeder	layers	compared	to	those	grown	in	PDL,	GCM,	and	PDL/laminin	conditions,	despite	having	similar	resting	membrane	potentials	(Figure	II.5C,	Table	II.1).	This	 is	 consistent	with	 the	 astroglial	 feeder	 layers	 supporting	more	 rapid	maturation	 of	excitability.	While	 there	was	considerable	variability	 in	maximal	evoked	 firing	 frequency,	this	 was	 significantly	 higher	 in	 the	 neurons	 grown	 on	 the	 20%	 confluent	 feeder	 layers	compared	to	those	on	50	and	100%	confluent	feeder	layers.			
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Figure	 II.4.	Astroglial	 feeder	 layers	prepared	 from	cryopreserved	primary	cultures	
facilitate	 the	 morphological	 differentiation	 of	 hiPSC-derived	 neurons.	 (A-C)	Immunostaining	of	βIII-tubulin-positive	and	GFAP-negative	derived	neurons	at	21-24	days	after	plating	on	PDL,	PDL	supplemented	with	GCM	and	PDL/laminin.	(D)	Immunostaining	of	βIII-tubulin-positive	derived	neurons	grown	on	top	of	GFAP-positive	astroglial	feeder	layers.	Scale	bars	represent	20	µm.	(E-G)	Phase-contrast	images	of	iPSC-derived	neurons	at	21-24	days	after	plating	on	astroglial	feeder	layers	of	20%,	50%	and	100%	confluence,	respectively.	Scale	bars	represent	100	µm.		
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Table	 II.	 1.	 Passive	 membrane	 properties	 of	 neurons	 plated	 on	 PDL,	 PDL	
supplemented	with	GCM,	PDL/laminin,	 and	 astroglial	 cultures	 of	 20%,	 50%,	
and	100%	confluence.		
ú 	Cell	capacitance	(pF)	 Input	resistance	(GΩ)	 RMP	(mV)	PDL	 24.1	±	2.8	(14)	 3.3	±	0.5	(16)	 -47.5	±	2.6	(16)	GCM	 23.1	±	3.4	(14)	 3.6	±	0.5	(14)	 -52.3	±	2.6	(14)	PDL/laminin	 17.6	±	1.6	(9)	 2.2	±	0.3	(12)	 -43.7	±	2.8	(12)	20%	confluence	 33.6	±	2.9	(16)	c1	 1.5	±	0.1	(16)	a3,	b4	 -46.9	±	1.8	(16)	50%	confluence	 31.6	±	2.0	(16)	 1.3	±	0.2	(17)	a3,	b4	 -47.3	±	2.3	(17)	100%	confluence	 37.5	±	3.5	(18)	a1,	b1,	c3	 1.1	±	0.1	(18)	a4,	b4	 -45.0	±	1.7	(17)	Data	 reported	 as	 mean	 ±	 SEM.	 Number	 of	 included	 cells	 indicated	 in	 parentheses.	 a,	 b	 and	 c	superscripts	 represent	 significance	 to	PDL,	GCM	and	PDL/laminin	groups,	 respectively.	1,	3,	 and	4	superscripts	 denote	 p	 <	 0.05,	 0.001,	 and	 0.0001,	 respectively	 (one-way	 ANOVA	 with	 post	 hoc	Bonferroni	test).		
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Figure	II.5.	Astroglial	feeder	layers	facilitate	maturation	of	intrinsic	firing	properties	
of	hiPSC-derived	neurons.	 (A)	Traces	of	AP	 firing	(APs)	evoked	by	depolarizing	current	injections	 in	 neurons	 plated	 on	 the	 indicated	 substrate	 at	 21-24	 days	 post	 plating.	 (B)	Percentage	of	recorded	neurons	that	fire	≥	1	AP.	No	significant	difference	in	%	of		firing	APs	between	groups	(p=0.12,	Chi-square	test).	(C)	Peak	firing	frequency	is	significantly	higher	in	neurons	grown	on	astroglial	 feeder	 layers	 compared	 to	 the	other	 three	groups	 (one-way	ANOVA	with	post	hoc	Bonferroni	test.	*,**,	****	denote	p	<	0.05,	0.01,	and	0.0001	respectively.	Data	are	represented	as	mean	+	SEM.	Numbers	in	the	parentheses	represent	the	number	of	recorded	neurons.		
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2.3.4	Astroglial	feeder	layers	from	cryopreserved	cells	support	the	development	of	spontaneous	
firing	and	synaptic	activity	in	iPSC-derived	neurons	Spontaneous	firing	was	evaluated	by	gap-free	current-clamp	recordings	for	at	least	1	minute	in	the	absence	of	applied	holding	current	(Figure	II.6A).	None	of	the	neurons	grown	in	 PDL,	 GCM,	 and	 PDL/laminin	 conditions	 fired	 spontaneous	 action	 potentials	 (sAPs),	whereas	many	 of	 the	 neurons	 on	 feeder	 layers	 fired	 sAPs	 (Figure	 II.6A).	 The	 sAP	 firing	frequency	 was	 quite	 variable	 and	 there	 was	 no	 significant	 association	 with	 the	 percent	confluence	of	the	feeder	layers	for	the	sample	evaluated	(Figure	II.6B).		Assessment	 of	 spontaneous	 postsynaptic	 activity	 was	 based	 on	 gap-free	 voltage-clamp	recordings	from	a	holding	potential	of	-75	mV	for	at	least	1	minute.		There	was	very	little	 synaptic	 activity	 in	 the	 neurons	 without	 astroglial	 feeder	 layers,	 with	 the	 average	frequency	of	spontaneous	postsynaptic	currents	(sPSCs)	being	less	than	0.1	Hz,	while	cells	grown	 on	 feeder	 layers	 exhibited	 significantly	 higher	 sPSC	 frequencies	with	 the	 average	frequency	 increasing	 from	0.8	Hz	 in	the	20%	confluence	condition	to	~7	Hz	 in	the	100%	confluence	condition	(Figure	II.6C,	D).	This	suggests	that	astroglial	feeder	layers	prepared	from	cryopreserved	astroglia	support	functional	development	of	synaptic	activity	in	iPSC-derived	 neurons	 via	 physical	 contact,	 in	 addition	 to	 astrocyte-secreted	 factors13.	 One	drawback	 to	 plating	 on	 100%	 confluent	 feeder	 layers	 in	 our	 study	 was	 an	 increased	incidence	of	detachment	of	the	underlying	astroglial	layer	from	the	glass	coverslips	during	transfer	 to	 the	 recording	 chamber,	which	 resulted	 loss	 of	 the	 overlying	 neurons	 as	well.	However,	there	was	no	obvious	feeder	layer	detachment	or	difficulty	obtaining	recordings	in	cultures	of	20%	and	50%	confluence.			
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Figure	 II.6.	 Astroglial	 feeder	 layers	 support	 spontaneous	 firing	 and	 spontaneous	
synaptic	 activity	 in	 hiPSC-derived	 neurons.	 (A)	 Representative	 traces	 of	 spontaneous	action	potentials	(sAPs)	at	rest	membrane	potentials	recorded	from	iPSC-derived	neurons	grown	on	indicated	substrate	at	21-24	days	post	plating.	(B)	sAP	frequency	at	RMP,	one-way	ANOVA	with	post	hoc	Bonferroni	test.	(C)	Overlay	of	two	traces	of	spontaneous	postsynaptic	currents	 (sPSCs)	 recorded	 from	 neurons	 on	 indicated	 substrate	 held	 at	 -75	 mV	 under	voltage-clamp	to	illustrate	the	relative	differences	in	sPSC	frequencies.		(D)	sPSC	frequency	of	neurons,	one-way	ANOVA	test	with	post	hoc	Bonferroni	test.	Data	are	represented	as	mean	+	SEM.	Numbers	in	the	parentheses	represent	the	number	of	recorded	neurons.	***	and	****	denote	p	value	<	0.001,	and	0.0001	respectively.				
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2.4.	Discussion		Our	results	demonstrate	more	rapid	morphological	and	functional	differentiation	of	hiPSC-derived	 neurons	 on	 astroglial	 feeder	 layers	 prepared	 from	 cryopreserved	 cells	compared	with	 those	 plated	 in	 the	 absence	 of	 feeder	 layers.	 This	 protocol	 offers	 several	advantages	over	using	primary	astroglia	cultures:	elimination	of	mouse	neurons	without	a	significant	increase	in	time	or	effort,	the	ability	to	store	cell	suspension	stocks	for	generation	of	feeder	cultures	at	a	later	date,	and	significant	reduction	in	the	number	of	animals	required.	While	previous	studies	have	shown	that	primary	astroglial	 feeder	 layers	prepared	from	mouse	 brain	 tissue	 can	 support	 rapid	 differentiation	 of	 functionally	 active	 neurons	from	human	stem	cell20,26,	one	of	the	drawbacks	is	the	potential	for	the	presence	of	mouse	neurons.	These	are	not	easily	distinguished	from	human	neurons	 in	 live	cultures	without	introducing	an	exogenous	marking	system	or	requiring	post-recording	staining	to	confirm	identity.	 Passaging	 glia	 cultures	multiple	 times	 prior	 for	 use	 in	 neuronal	 derivation	 is	 a	common	practice	 to	eliminate	neurons2,12,15.	While	effective,	 this	requires	additional	 time	and	resources	to	grow	glia	and	does	not	address	the	difficulty	in	synchronizing	the	timing	of	glia	 culture	 and	 neuronal	 progenitor	 availability.	 Protocols	 resulting	 in	 isolation	 of	astrocytes	 based	 on	 differential	 adherence	 are	 also	 an	 option17,18;	 however,	 they	 involve	vigorous	shaking	and	careful	timing	of	passaging.	In	contrast,	cryopreservation	of	astroglial	cells	efficiently	removes	neurons	as	shown	by	the	absence	of	β-III	tubulin	positive	and	GFAP	negative	cells	in	the	cultures,	meanwhile	allowing	for	rapid	and	reproducible	recovery.	In	addition,	cryopreserved	astroglial	cells	can	be	banked	and	used	at	a	future	date	to	generate	astroglial	support	layers	within	a	week,	which	enables	thawing	of	the	stocks	at	a	relatively	late	stage	of	hiPSC	patterning.		
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The	protocol	described	in	this	paper	can	also	significantly	reduce	the	number	of	mice	required	to	generate	the	astroglial	feeder	layers	and	the	time	required	to	prepare	them.	By	expanding	and	passaging	primary	cultures	on	dishes	for	cryopreservation,	the	same	number	of	newborn	mice	can	be	used	to	prepare	2-5	times	as	many	astrocyte-enriched	cultures	as	those	from	primary	tissue.	The	efficacy	of	later	passages	has	not	been	tested	systematically	but	initial	studies	suggested	that	later	passages	were	not	as	reliable	in	supporting	functional	maturation.	Whether	the	astroglial	passage	number	definitively	affects	the	rate	of	functional	development	 in	 derived	 neurons,	 however,	 will	 require	 additional	 investigation.	Additionally,	although	the	current	protocol	uses	an	initial	glial	seeding	density	of	5×104	cells,	lower	seeding	densities	can	also	be	used,	for	example	2.5×104	cells.	This	typically	requires	an	extra	two	days	of	culturing	but	effectively	doubles	the	number	of	coverslips	generated	from	a	single	vial	of	cryopreserved	cells.	When	taken	together,	this	protocol	contributes	to	resource	management	and	the	ability	to	reproducibly	generate	neuron-free	astroglial	feeder	layers.		It	 has	 been	 shown	 that	 a	 variety	 of	 biochemical	 substrates	 including	 PDL,	 PLO,	fibronectin,	integrins,	and	Matrigel	can	influence	survival,	proliferation	and	differentiation	iPSC-derived	neurons16,27–31.	A	combination	of	PDL/laminin	has	also	been	used	to	support	functional	 differentiation	 of	 iPSC-derived	 neurons32–36.	 A	 study	 using	 high-resolution	multielectrode	arrays	(MEAs)	have	shown	increased	spontaneous	firing	rate	in	iPSC-derived	neurons	without	 the	 use	 of	 astrocytes37.	While	 this	may	 indicate	 that	 astrocytes	 are	 not	required	 for	 network	maturation,	 future	MEA	 studies	may	 benefit	 by	 further	 evaluating	synaptic	 maturation	 using	 functional	 analyses	 in	 neurons	 cultured	 with	 and	 without	astrocytes38,39.	In	addition,	astroglial	feeder	layers	with	confluences	between	20-100%	are	
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more	 effective	 at	promoting	maturation	of	 functional	properties	 than	PDL	 supplemented	with	GCM.	This	indicates	that	astrocytes	in	our	cultures	may	possibly	regulate	the	functional	development	of	derived	neurons	through	a	contact-dependent	mechanism13,16.	Plating	neural	progenitors	onto	astroglial	cultures	resulted	in	cultures	where	~50%	of	the	neurons	fired	spontaneous	action	potentials	and	100%	received	postsynaptic	input.	This	indicates	the	astroglial	cells	support	formation	of	spontaneously	active	neural	networks	in	 culture.	 Future	 studies	 using	 MEAs	 and	 multisite	 calcium	 imaging	 will	 be	 useful	 in	evaluating	the	spatiotemporal	changes	 in	neuronal	network	dynamics	 that	occur	 in	 these	cultures.	Developmental	changes	in	spontaneous	burst	firing	rate	have	been	detected	using	MEA	 to	 detect	 spikes	 in	 hiPSC-derived	 neurons	 co-cultured	 with	 rodent	 primary	astrocytes39,40.		The	consequence	of	plating	on	fully	confluent	astroglia	 in	our	system	is	the	loss	of	neurons	when	they	are	transferred	to	the	recording	chamber.	In	these	cultures,	the	astroglia	occupy	 the	 vast	 majority	 (over	 95%)	 of	 the	 coverslip’s	 surface	 area	 while	 the	 derived	neurons	on	top	are	not	themselves	confluent.	The	underlying	astrocytes	behave	as	a	sheet	and	when	coverslips	are	removed	from	their	culture	well	the	astroglial	sheet	can	lift	off	the	coverslip	removing	the	network	of	neurons	with	it.	Additional	studies	will	be	necessary	to	determine	the	underlying	cause	of	this	detachment.			For	studies	focused	on	functional	analysis	of	excitability	and	synaptic	transmission	in	iPSC-derived	neurons	carrying	different	disease-causing	mutations,	our	data	 indicate	that	50%	 confluence	 provides	 an	 appropriate	 balance	 for	 functional	 studies,	 supporting	spontaneously	active	neuronal	networks	while	preserving	the	integrity	of	cell	layer	during	transfer	 that	 is	 required	 for	 electrophysiological	 recording.	 Finally,	 the	 ability	 to	 reliably	
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generate	astroglial	 cultures	 from	the	same	stock	allows	enhanced	control	of	 the	 terminal	differentiation	environment,	 important	 for	assaying	differences	between	neurons	derived	from	different	iPSC	clones	or	lines.			
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Chapter	III	
	
Reproducible	and	efficient	generation	of	functionally	active	neurons	
from	human	hiPSCs	for	preclinical	disease	modeling	
	
	This	work	has	been	published	in	Xie	Y*,	Schutte	RJ*,	Ng	NN*,	Ess	KC,	Schwartz	PH,	O’Dowd	DK.	Reproducible	and	efficient	generation	of	functionally	active	neurons	from	human	hiPSCs	for	preclinical	disease	modeling.	Stem	Cell	Res.	2018;26:	84–94.	
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3.1.	Introduction				 Neuronal	cultures	derived	from	human	hiPSCs	are	a	useful	model	system	for	exploring	cellular	mechanisms	underlying	the	pathogenesis	of	neurological	disorders	and	for	developing	novel	therapies.	Analyses	of	hiPSC-derived	neurons	from	patients	with	defined	neurological	diseases	have	identified	a	variety	of	abnormalities.	These	include	 alterations	 in	 neuronal	 morphology,	 excessive	 excitability,	 dysfunctional	synaptic	 connections,	 and	 altered	mitochondrial	 function,	 many	 that	 are	 likely	 to	contribute	 to	different	disease	phenotypes1–9.	hiPSC-derived	neuronal	cultures	can	also	 serve	 as	 a	 valuable	 platform	 for	 evaluating	 the	 effect	 of	 a	 drug	 or	 drug	combinations	on	gene-specific	deficits	in	neuronal	differentiation	and/or	function2,10.	However,	disease	modeling	 in	 vitro	with	hiPSC-derived	neurons	 is	 still	 at	 an	early	stage	 and	 there	 are	 a	 number	 of	 outstanding	 questions	 about	 the	 properties	 of	neurons	generated	by	a	variety	of	differentiation	protocols.		It	 is	 important	 that	 consistent	 criteria	 are	 used	 to	 define	 hiPSC-derived	neurons	in	culture.	Similar	to	criteria	for	characterizing	induced	neuronal	(iN)	cells	reviewed	by	Yang	et	al.,	cells	designated	as	neurons	differentiated	from	hiPSCs	should	not	only	have	neuronal	morphology	and	express	neuron	specific	markers,	but	should	also	 be	 electrically	 excitable11.	 In	 addition,	 the	 formation	 of	 functionally	 active	synapses	 between	 neurons	 facilitates	 the	 use	 of	 cultures	 to	 explore	 how	 gene	mutations	 potentially	 affect	 network	 activity.	 Second,	 there	 are	 a	 number	 of	differentiation	 protocols	 used	 by	 different	 groups	 but	 little	 is	 known	 about	 the	comparative	efficiency	with	which	these	produce	excitable	cells12–15.	In	addition,	it	is	not	clear	how	the	differentiation	potentials	of	stem	cells	at	different	stages	affect	the	
45		
formation	 of	 functionally	 active	 neurons.	 Some	 protocols	 incorporate	 the	 use	 of	neural	stem/progenitor	cells,	a	self-renewing	multipotent	population	derived	from	hiPSCs,	as	starting	source	for	neuronal	differentiation15–17.	Other	protocols	start	from	the	 hiPSC	 stage,	 and	 directly	 differentiate	 cells	 into	 neurons	 without	 using	 an	expandable	 population	 of	 multipotent	 cells4,8,13,18–24.	 Finally,	 when	 considering	 a	single	protocol	there	has	been	limited	discussion	of	reproducibility	in	terms	of	the	rate	and	degree	of	maturation	of	firing	properties	and	synaptic	connectivity	between	platings	 and	between	 independently	 generated	hiPSC	 lines.	 Low	efficiency	 and/or	high	 variability	 can	 hamper	 the	 identification	 of	 altered	 functional	 properties	 of	neurons	between	control	and	mutant	groups.			 The	goal	of	this	study	was	to	identify	a	protocol	that	could	reliably	produce	cultures	from	hiPSCs	in	which	the	majority	of	cells	with	neuronal	morphology	also	fire	 action	 potentials	 and	 form	 synaptic	 connections.	 The	 efficiency	 of	 generating	functionally	active	neurons	from	one	hiPSC	line	obtained	from	a	control	patient	was	evaluated	using	 two	different	 protocols.	 The	 first	 protocol	 included	 generating	 an	expandable	 neuronal	 stem	 cell	 population	 that	 was	 plated	 onto	 astroglial	 feeder	layers	 for	 differentiation.	 In	 our	 previous	 experience	 this	 resulted	 in	 cultures	containing	 functionally	 active	 neurons	 but	 the	 efficiency	 was	 low15,25.	 This	 was	compared	 to	a	direct	differentiation	strategy	 that	 first	patterns	hiPSCs	 into	neural	progenitors	 (NPCs)	 that	 are	 differentiated	without	 expansion20.	 The	 protocol	was	modified	 to	 include	 the	 use	 of	 astroglial	 feeder	 layers	 for	 differentiation.	 Direct	differentiation	resulted	in	production	of	functionally	active	neurons	at	a	faster	rate	and	with	higher	efficiency	than	the	protocol	 including	an	expandable	 intermediate	
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population.	 In	 addition,	 the	 direct	 differentiation	 strategy	 resulted	 in	 cultures	 in	which	 the	 rate	 and	 degree	 of	 neuronal	 maturation	 was	 similar	 between	multiple	platings	 from	one	control	hiPSC	 line,	and	between	 two	hiPSC	 lines	 from	unrelated	individuals	with	no	known	neurological	disorders.	hiPSC-derived	neuronal	cultures	prepared	 using	 this	 direct	 differentiation	 will	 greatly	 facilitate	 identification	 of	cellular	 defects	 in	 excitability	 and	 synaptic	 transmission	 associated	 with	 specific	disease-causing	mutations	and	drug	discovery.	
	
3.2.	Methods	
3.2.1	Preparation	and	maintenance	of	hiPSCs						Two	human	iPSC	cell	lines:	Line	210	(SC210.12-SF6-2I3.M11S8	through	S31)	and	Line	173	(SC173.1-SF6-2I2.M16S9	through	S21).	Both	lines	were	generated	by	the	Schwartz	laboratory	using	a	previously	published	protocol15	from	skin	fibroblasts	provided	by	the	labs	of	Alfred	George,	Jr.	and	Kevin	Ess	(210	line)	and	Philip	Schwartz	(173	line).	Both	fibroblast	donors	were	males	with	no	known	clinical	diagnoses.	Age	at	time	of	biopsy	was	23	years	(210	line)	and	56	years	(173	line).							hiPSCs	were	maintained	in	feeder-free	conditions	using	published	protocols15,26.	Briefly,	hiPSCs	were	grown	on	Matrigel	(BD	Sciences)	and	fed	every	day	with	basal	hiPSC	medium	supplemented	with	2%	(vol/vol)	StemPro	(StemPro	SFM	Kit,	including	50×	supplement,	D-MEM/F12+GlutaMax	and	25%	BSA	solution,	Life	Technologies)	and	20	ng/ml	(basic	fibroblast	growth	factor,	Stemgent).	For	basal	medium,	the	final	concentration	of	BSA	and	beta-mercaptoethanol	(Life	Technologies)	in	D-MEM/F12+GlutaMax	were	1.8%	and	100	µM.	Complete	medium	was	equilibrated	at	37	°C	and	5%	CO2	before	use.		
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				hiPSCs	were	passaged	upon	reaching	100%	confluence.	Falcon	6-well	plates	were	coated	with	a	1:30	dilution	of	Matrigel	in	D-MEM/F12+Glutamax	and	incubated	for	at	least	20	minutes.	hiPSCs	were	incubated	with	10µm	ROCK	inhibitor	(RI;	rho-associated	protein	kinase	inhibitor	Y27632,	Stemgent)	one	hour	prior	to	dissociation	with	Accutase	(Millipore)	for	1	minute	at	room	temperature.	Cells	were	dislodged	and	collected	in	Dulbecco’s	calcium-	and	magnesium-free	phosphate-buffered	saline	(D-PBS;	Gibco,	14190-144).	The	cell	suspension	was	gently	triturated,	collected	in	conical	tubes	and	centrifuged	at	156×	g	for	5	minutes.	Cell	pellets	were	gently	re-suspended	in	complete	hiPSC	medium	plus	RI.	Excess	Matrigel	solution	was	removed	from	pre-incubated	wells.	The	cell	suspension	was	added	to	each	well	and	then	flooded	with	complete	hiPSC	media	with	RI	to	a	final	volume	of	2	ml	per	well.	Typical	splits	were	1	well	to	3	or	6	wells.				
3.2.2	NSC	culturing	and	neuronal	differentiation						The	210	hiPSC	line	was	also	used	to	generate	an	expandable	neural	stem	cell	(exNSC	210)	line.	Line	naming	follows	National	Human	Neural	Stem	Cell	Resource	nomenclature15.	NSCs	were	maintained	and	passaged	according	to	a	previously	published	protocol	with	no	alterations15.	To	prepare	for	neuronal	differentiation,	confluent	NSC	cultures	were	lifted	using	Enzyme	Free	Dissociation	Buffer,	dislodged,	and	collected	using	D-PBS.	The	cell	suspension	was	then	gently	triturated,	collected	in	conical	tubes	and	centrifuged	at	156×	g	for	5	min.	After	re-suspension	in	fresh	NSC	media	(see	published	protocol)	cell	suspension	was	passed	through	a	37	µm	reversible	strainer	(STEMCELL	Technologies,	27215).		This	revised	step	to	the	protocol	removes	the	large	non-dissociated	clusters	of	NSCs	and	allows	plating	of	single	cells	on	50%	confluent	mouse	glia	at	a	density	2.2×104	cells/cm2	per	
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coverslip.	Neuronal	differentiation	was	also	performed	as	per	the	original	protocol,	but	with	the	addition	of	0.2	µM	Compound	E	during	the	first	3	days	of	differentiation.	Neuronal	differentiation	media	contained	20	ng/ml	BDNF	and	GDNF,	1	mM	dibutyryl	cAMP,	and	200	nM	freshly	made	ascorbic	acid	(Sigma-Aldrich).	Feeding	cultures	involved	a	50%	exchange	every	48	h	for	the	duration	of	the	culture’s	life.	All	media	was	prepared	immediately	prior	to	use	and	equilibrated	at	37°C	and	5%	CO2.	
	
3.2.3	Direct	differentiation	of	hiPSCs	into	neurons					The	strategy	used	to	pattern	hiPSCs	into	neurons	was	adapted	from	a	previously	published	protocol20.	On	day	0,	embryoid	bodies	were	generated	from	100%	confluent	hiPSC	cultures	grown	in	a	6-well	falcon	plate	by	manual	scraping	in	a	parallel	direction	using	a	1	ml	pipette	tip.	Tissue	fragments	from	15	wells	were	collected	in	a	conical	tube.	After	centrifugation	at	156×	g	for	5	min	the	pellet	was	re-suspended	in	15	ml	hiPSCM	(human	iPSC	medium)	and	then	transferred	to	a	T25	non-tissue	culture	treated	flask	(Thermofisher	Scientific).	Neural	induction	and	culturing	protocols	were	followed	as	per	the	original	protocol.	On	day	16,	neural	rosettes	were	collected	using	STEMDiff	Neural	Rosette	Selection	reagent	(STEMCELL	Technologies)	based	on	vendor’s	protocol.	MGE	patterning	was	done	using	the	ventralizing	factors	purmorphamine	(Stemgen)	and/or	recombinant	human	sonic	hedgehog	(SHH;	Peprotech)	following	the	original	protocol	until	day	25.	Experiments	using	purmorphamine	with	SHH	and	purmorphamine	alone	were	included	in	this	study.					Neuronal	differentiation	was	initiated	on	day	26,	when	progenitor	neurospheres	were	dissociated	using	Accutase	(Life	Technologies),	centrifuged	at	156×	g	for	5	min,	and	
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re-suspended	in	neural	induction	medium	(NIM)	containing	Rho	kinase	(ROCK)	inhibitor.	These	were	plated	at	2.2×104	cells/cm2	per	coverslip	on	50%	confluent	mouse	astroglial	cultures.	24	h	after	plating,	50%	of	the	NIM	was	replaced	with	complete	NDM	(Neural	differentiation	medium)	containing	0.4	µM	γ-secretase	inhibitor	XXI	(Compound	E;	Calbiochem),	10	ng/ml	BDNF	(Peprotech),	10	ng/ml	GDNF	(Peprotech),	10	ng/ml	IGF-1	(Peprotech),	and	0.5	g/ml	membrane	permeable	cyclic	AMP	(Sigma-Aldrich).	48	h	after	plating,	all	of	the	culture	medium	was	replaced	by	complete	NDM	supplemented	with	0.2	µM	Compound	E.	96	h	after	plating,	culture	medium	was	replaced	with	complete	NDM	and	a	50%	exchange	with	fresh	complete	NDM	performed	every	48	h	for	the	duration	of	the	culture’s	life.	All	media	was	prepared	immediately	prior	to	use	and	equilibrated	at	37°C	and	5%	CO2.	
	
3.2.4	Astroglia	Cultures											Astroglial	cultures	were	generated	using	a	previously	published	protocol27,28.	Briefly,	cortical	rinds	were	dissected	from	the	brains	of	P0-P2	ICR	(CD-1)	mouse	pups	(Envigo),	enzymatically	digested,	and	triturated	into	a	single	cell	suspension.		Suspension	was	plated	on	poly-d-lysine	(PDL,	Sigma)	coated	60mm	tissue	culture	dishes	and	allowed	to	grow	to	confluence.		Once	confluent,	cultures	were	trypsinized	(TrypLE,	Life	Tech),	lifted,	re-suspended	in	freezing	media	(Glia	Culture	Medium	with	10%	DMSO)	and	stored	at	-80°C.		When	needed,	cells	were	defrosted	and	4.4×104	cells/cm2	per	coverslip	viable	(identified	by	trypan	blue	staining)	cells/cm2	were	plated	onto	PDL	coated	12mm	glass	coverslips	(Bellco).	Astroglial	feeder	cultures	were	grown	for	5-6	days	to	approximately	50%	visually	
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determined	confluence	prior	to	seeding	with	neural	progenitors	for	neuronal	differentiation.		
3.2.5	Immunostaining	and	imaging				Coverslips	containing	hiPSC-	or	exNSC-derived	neurons	were	fixed	in	4%	paraformaldehyde	(in	PBS)	for	15	min	at	room	temperature	and	washed	three	times	with	PBS.	Cells	were	permeabilized	and	blocked	using	PBS	with	4%	bovine	serum	albumin	(wt/vol)	(BSA;	Sigma-Aldrich),	0.25%	Triton	X-100	(vol/vol)	(Sigma-Aldrich),	and	0.02%	sodium	azide	(wt/vol)	(Sigma-Aldrich)	in	1×	PBS	(Sigma-Aldrich)	for	1	h	at	room	temperature.	Cultures	were	exposed	to	primary	antibody	and	incubated	overnight	at	4°C.	After	washing	3	times	with	PBS,	coverslips	incubated	in	5%	normal	goat	serum	(vol/vol)	(ThermoFisher	Scientific),	0.25%	Triton	X-100,	0.02%	sodium	azide	(wt/vol)	in	1×	PBS	containing	a	1:1000	dilution	of	secondary	antibody	(Alexa-Fluor;	Life	Technologies)	for	2	h	at	room	temperature.	Coverslips	were	washed	twice	with	PBS	before	staining	nuclei	with	4’,6-diamidino-2-phenylindole	(DAPI;	Life	Technologies).	Fluoromount	G	(SouthernBiotech)	was	used	to	mount	coverslips	on	glass	slides.	Images	were	taken	using	a	Zeiss	M2	Imager	microscope	and	processed	by	Zen	software.	HuNu	(1:250;	Millipore),	βIII-tubulin	(1:2000;	BioLegend)	and	GFAP	(glial	fibrillary	acidic	protein;	1:1500;	DAKO)	were	used	to	characterize	composition	of	cells	generated	from	hiPSCs	by	the	direct	differentiation	protocol.	βIII-tubulin	(Sigma-Aldrich)	and	GABA	(Sigma-Aldrich)	primary	antibodies	were	used	at	1:1000	and	1:4000	dilutions	respectively	for	identification	of	GABAergic	neurons.	Neurons	were	identified	by	morphology,	expression	of	βIII-tubulin	in	the	soma	and	neurites,	and	nuclear	localization	of	DAPI.		
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3.2.6	Whole-cell	recording				Whole	cell	recordings	were	obtained	from	hiPSC-derived	neurons	at	5	different	time	points:	4-5,	10-11,	15-16,	21-23,	and	35-38	days	post	plating.		exNSC-derived	neurons	were	examined	at	21-23	days	post	plating.	Electrophysiological	recordings	were	performed	with	unpolished	borosilicate	glass	pipettes	with	open	tip	resistance	of	4-7	MΩ	(VWR	International).	External	solution	contained	(in	mM):	NaCl	120,	KCl	5.4,	MgCl2	0.8,	CaCl2	1.8,	glucose	15,	HEPES	20,	at	pH	7.2-7.4.	Osmolality	was	adjusted	to	290	-	295	mOsm.	Internal	solution	contained	(in	mM):	potassium	gluconate	120,	NaCl	20,	CaCl2	0.1,	MgCl2	2,	EGTA	1.1,	HEPES	10,	Na2ATP	4.5	with	pH	at	7.2	and	osmolality	around	280	mOsm.	Voltages	were	corrected	for	a	-5	mV	junction	potential.	Spontaneous	action	potential	firing	was	recorded	both	at	resting	membrane	potential	and	at	-75	mV	using	a	gap	free	protocol	under	current	clamp.	For	evoked	action	potentials,	membrane	potential	was	held	at	-75	mV	and	cells	were	depolarized	by	a	series	of	current	injections.	Spontaneous	postsynaptic	currents	(sPSCs)	were	examined	under	voltage	clamp	at	-75	mV.				Spontaneous	excitatory	and	inhibitory	postsynaptic	currents	(sEPSCs	and	sIPSCs)	were	separated	at	reversal	potentials	(-49	mV	and	-2	mV)	with	the	same	external	solution	mentioned	above	and	CsGluconate	internal	solution	containing	(in	mM):		Cs+	gluconate	130,	EGTA	0.2,	MgCl2	2,	CsCl	6,	HEPES	10,	adenosine	5’	triphosphate	sodium	salt	2.5,	guanosine	5’	triphosphate	sodium	0.5	and	phosphocreatine	disodium	10.	The	identity	of	sEPSCs	and	sIPSCs	were	confirmed	pharmacologically	using	50	µM	(2R)-amino-5-phosphonovaleric	acid	(APV;	Tocris	Bioscience),	10	µM	6-cyano-7-nitroquinoxaline-2,3-dione	(CNQX;	Sigma-Aldrich),	10	µM	bicuculline	methochloride	(BMC;	Tocris	Bioscience),	and/or	100	nM	
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strychnine	(Sigma-Aldrich)	bath	applied	in	external	solution.	External	solution	was	perfused	through	the	chamber	at	a	speed	of	0.6	to	1	ml/min	during	recording.		
	
3.2.7	Data	Analysis	and	Statistics					Fluorescent	micrographs	processed	using	Zen	software	were	used	to	quantify	the	percentage	of	GABAergic	neurons.	For	each	coverslip,	at	least	3	fields	with	equally	distributed	cells	observed	via	DIC	were	chosen	for	counting.	Counting	was	performed	blind	with	respect	to	cell	line.	Represented	data	were	based	on	n	=	10	coverslips	(Line	210)	and	n	=	4	coverslips	(Line	173).	 											Electrophysiological	data	were	acquired	with	a	List	EPC7	amplifier,	a	Digidata	1320A	D-A	converter	(Axon	Instruments),	and	a	Dell	Optiplex	GX110	computer	running	pClamp8	(Axon	Instruments)	software	at	room	temperature.	Clampfit	10.6	software	(Axon	Instruments)	was	used	to	analyze	electrophysiological	data.												Cells	that	were	included	in	analyses	had	an	input	resistance	≥	400	MΩ,	whole-cell	capacitance	≥	5	pF,	stable	(no	greater	than	a	±	5	mV	deviation)	resting	membrane	potentials	more	hyperpolarized	than	-30	mV,	and	stable	sPSC	voltage-clamp	recordings.	We	characterized	evoked	action	potentials	as	regenerative	events	with	a	peak	depolarization	of	greater	than	or	equal	to	-5	mV	on	the	first	AP	and	-15	mV	in	subsequent	APs	within	the	train.	sPSCs	recorded	under	voltage-clamp	were	analyzed	using	Mini	Analysis	6.0.7	(Synaptosoft).	sPSCs	identified	by	the	software	had	an	amplitude	≥	10	pA	(2×	RMS	noise	of	2.5	pA)	and	were	then	manually	verified	individually.	sPSC	recordings	in	which	the	baseline	shifted	by	more	than	50	pA	were	excluded.	Electrophysiological	data	were	represented	based	on	n	=	number	of	independent	experiments.	All	statistical	analyses	were	
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performed	with	Prism	7.0.2	(GraphPad	Software)	and	all	figures	were	generated	using	DeltaGraph	7.1	(Red	Rock	Software).		
3.3.	Results		
3.3.1	hiPSCs-derived	neurons	mature	more	rapidly	than	those	generated	from	an	expandable	
NSC	intermediate	stage.		 			Our	 initial	 studies	 focused	on	 the	 comparison	of	 neurons	derived	using	 two	different	 protocols	 from	 the	 same	 human	 control	 hiPSC	 line	 (Line	 210)	 (Figure	
III.1A).	The	 first	protocol	 involved	generating	an	expandable	population	of	neural	stem	 cells	 (exNSCs)	 from	 the	 hiPSCs15	 (Figure	 III.1B,	 top).	 The	 exNSCs	 were	maintained	as	a	renewable	population	and	plated	at	a	density	of	2.2×104	cells/cm2	onto	50%	confluent	 astrocyte-enriched	 feeder	 layers	 to	 begin	differentiation	 (D0)	into	exNSC-neurons.	The	second	protocol	was	based	on	patterning	hiPSCs	into	neural	progenitor	cells	(NPCs)	over	a	period	of	26	days	followed	by	immediate	plating	at	a	density	 of	 2.2×104	 cells/cm2	 onto	 the	 astrocyte-enriched	 feeder	 layers	 to	 begin	differentiation	(D0)	into	hiPSC-derived	neurons	(Figure	III.1B,	bottom).	By	the	3rd	week	of	differentiation	(D21-23	post	plating),	cultures	prepared	using	both	protocols	contained	 cells	with	neurites	 that	 also	 expressed	 the	neuron	 specific	marker	 βIII-tubulin	(Figure	III.1C,	top).	The	cultures	generated	via	direct	differentiation	typically	had	a	more	extensive	network	of	branched	neurites	compared	to	cultures	generated	through	an	exNSC	intermediate	stage	(Figure	III.1C,	bottom).										Electrical	excitability	following	21	days	of	differentiation	was	compared	in	neurons	derived	using	the	two	protocols.	The	typical	exNSC-neuron	displayed	
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passive	changes	in	membrane	potential	or	small	failed	spikes	in	response	to	depolarizing	current	injection	(Figure	III.1D,	top).	In	contrast,	the	typical	hiPSC-derived	neuron	fired	multiple	action	potentials	in	response	to	stimulation	(Figure	
III.1D,	bottom).	Evaluation	of	over	20	neurons	using	the	two	protocols	demonstrated	a	significantly	higher	percentage	of	hiPSC-derived	neurons	firing	at	least	one	AP	in	response	to	a	depolarizing	current	injection	compared	to	exNSC-neurons	(p	<	0.0001;	Chi-square	test;	Figure	III.1E).	These	data	demonstrate	that	the	rate	of	maturation	of	excitability	is	faster	in	neurons	generated	by	the	direct	differentiation	protocol	compared	to	those	generated	from	an	expandable	NSC	intermediate	stage.			 		Consistent	 with	 more	 extensive	 neuritic	 arbors,	 the	 average	 whole-cell	capacitance	 (Cm)	of	 the	hiPSC-derived	neurons	generated	via	direct	differentiation	was	 2.5	 times	 larger	 than	 exNSC-neurons	 (Table	 III.1).	 However,	 there	 was	 no	significant	 difference	 in	 the	 input	 resistance	 (Rin)	 or	 resting	 membrane	 potential	(RMP)	between	neurons	generated	from	the	two	protocols	at	D21	post	plating	(Table	
III.1,	p	>	0.2,	unpaired	t-test	with	Welch’s	correction).																
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Figure	III.1.	Maturation	of	excitability	is	faster	in	hiPSC-derived	neurons	than	
in	expandable	NSC-derived	neurons.	(A)	Flowchart	of	the	two	protocols	utilized	to	generate	neurons	derived	from	the	control	hiPSC	line	210.	(B)	The	expandable	NSC	protocol	includes	generating	an	intermediate,	regenerative	population	of	neural	stem	cells	 (exNSCs)	 from	 the	hiPSCs	 that	 are	 expanded	before	being	differentiated	 into	neurons.	 In	 the	 direct	 differentiation	 protocol,	 hiPSCs	 are	 patterned	 into	 neural	progenitor	 cells	 (NPCs)	 that	 are	 directly	 differentiated,	 without	 expansion,	 into	neurons.	exNSCs	and	NPCs	are	both	plated	at	the	same	density	onto	mouse	cortical	astroglia	feeder	layers	to	promote	neuronal	differentiation.	(C)	Immunostaining	(D21	post	plating)	with	a	neuronal	marker	βIII-tubulin	and	a	nuclei	marker	DAPI	in	exNSC-	and	hiPSC-derived	cultures.	 	(D)	Representative	recordings	of	typical	evoked	firing	from	exNSC-	and	hiPSC-derived	neurons	(D21	post	plating).	 (E)	The	proportion	of	neurons	that	 fired	no	AP,	a	single	AP	or	multiple	APs	was	significantly	different	 in	exNSC-	and	hiPSC-derived	neurons	(p	<	0.0001,chi-square	test,	n	=	22	exNSC-derived	neurons	and	n	=	26	hiPSC-derived	neurons	recorded	at	D21	post	plating).			
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Table	 III.1.	 Passive	 membrane	 properties	 of	 neurons	 generated	 by	 an	
expandable	NSC	protocol	and	a	direct	differentiation	protocol.		 exNSC-derived	neurons	 hiPSC-derived	neurons	Rm	(GΩ)	 1.9	±	2	 1.8	±	1.0	RMP	(mV)	 -59	±	12	 -57	±	10	Cm	(pF)	 12	±	4	 32	±	7***	Data	reported	as	mean	±	SD.	***	represents	p	<	0.0001,	unpaired	t-test	with	Welch’s	correction.	n	=	22	for	exNSC-derived	neurons	and	26	for	hiPSC-derived	neurons.																																												
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3.3.2	Direct	differentiation	protocol	produces	primarily	neurons										Since	the	direct	differentiation	protocol	results	in	a	faster	maturation	of	functionally	active	neurons	than	the	exNSC	protocol,	the	remainder	of	this	work	focuses	on	cultures	prepared	by	direct	differentiation.	To	determine	if	the	hiPSCs	give	rise	to	astroglial	cells	as	well	as	neurons	we	prepared	cultures	from	the	210	line	and	from	a	second	hiPSC	control	line	(173)	from	an	unrelated	donor	with	no	known	neurological	disorders.	Cultures	were	fixed	and	immunostained	at	3	weeks	post	plating.	As	hiPSC-derived	NPCs	are	plated	onto	astrocyte	feeder	layers	of	mouse	origin,	human	derived	cells	were	identified	by	immunostaining	with	HuNu,	a	marker	for	human	nuclei.	HuNu	positive	cells	that	were	also	positive	for	the	neuronal	maker	βIII-tubulin	had	classic	neuronal	morphology	with	branched	neuritic	processes	and	cell	bodies	that	appeared	to	have	volume	in	DIC	optics	(white	arrows	indicate	the	cell	body	of	one	neuron	on	both	the	overlay	panel	and	the	DIC	panel	for	each	cell	line	in	Figure	III.2A).	There	was	also	a	small	population	of	cells	with	irregularly	shaped,	flattened	cell	bodies	that	expressed	HuNu	but	were	not	β-III	tubulin	positive	(light	blue	arrowhead	indicates	one	non-neuronal	cell,	on	overlay	panel	and	DIC	panel	for	each	cell	line	in	Figure	III.2A).	When	cultures	were	immunostained	with	antibodies	of	HuNu	and	GFAP,	a	small	population	of	flattened,	irregularly	shaped	cells	were	positive	for	both,	identifying	these	as	hiPSC	derived	astroglia	(orange	arrowhead	indicates	one	astroglial	cell	for	each	cell	line	in	Figure	III.2C).	The	mouse	astroglial	cells	in	the	feeder	layer	were	identified	as	the	DAPI	positive,	HuNu	negative	cells	stained	with	GFAP.	Quantitative	analysis	on	3	individual	coverslips	from	2	independent	platings	from	both	control	lines	revealed	98%	of	the	human-derived	cells	were	neurons	and	2%	were	astroglia	(p	>	0.75,	unpaired	t-test	with	Welch’s	correction,	Figure	III.2B	and	D).	These	
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data	demonstrate	that	two	independent	control	lines	both	give	rise	to	predominantly	neurons	using	the	direct	differentiation	protocol.																										
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Figure	III.2.	Direct	differentiation	of	hiPSCs	results	in	primarily	neurons.	(A)	Immunostaining	of	control	210	and	173	hiPSC-derived	cultures	by	DAPI,	HuNu	and	βIII-tubulin	antibodies	at	3	weeks	post	plating.	HuNu	positive,	βIII-tubulin	positive	cells	are	indicated	by	white	arrows.	HuNu	positive,	βIII-tubulin	negative	cells	indicated	by	light	blue	arrowheads.	(B)	The	proportion	of	hiPSC-derived	neurons	in	cultures	of	control	210	and	173	at	3	weeks	post	plating.	(C)	Immunostaining	of	control	210	and	173	hiPSC-derived	cultures	by	DAPI,	HuNu	and	GFAP	antibodies	at	3	weeks	post	plating.	HuNu	positive,	GFAP	positive	cells	are	indicated	by	orange	arrowheads.	DAPI+	HuNu-	identifies	nuclei	of	mouse	cells	in	the	feeder	layers	that	are	enriched	for	astrocytes	stained	by	GFAP.	(D)	The	proportion	of	hiPSC-derived	astrocytes	in	cultures	of	control	210	and	173	at	3	weeks	post	plating.	Data	represented	as	mean	+	s.e.m.	Three	coverslips	from	each	of	the	two	individual	platings	of	each	line	were	included.	No	significant	difference	in	the	percentage	of	hiPSC-derived	neurons	and	astrocytes	in	the	two	lines,	p	>	0.75,	unpaired	t-test	with	Welch’s	correction.		
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3.3.3	Intrinsic	firing	properties	of	hiPSC-derived	neurons	evaluated	in	multiple	platings	from	
two	independent	control	hiPSC	lines.												To	evaluate	the	rate	of	neuronal	maturation	and	determine	if	this	is	consistent	across	multiple	platings	from	one	hiPSC	line	and	between	different	hiPSC	lines,	we	generated	neuronal	cultures	prepared	from	two	control	hiPSC	lines	(210	and	173)	using	the	direct	differentiation	protocol.	Multiple	independent	platings	of	each	hiPSC	line	were	evaluated	over	the	course	of	5	weeks	post	plating.	All	firing	properties	are	presented	as	averages	from	4	or	more	platings,	with	n	representing	number	of	platings.	There	were	5	or	more	individual	neurons	examined	in	each	plating	at	each	time	point.												Cultures	from	both	lines	contained	cells	with	βIII-tubulin	positive	neurites	and	the	degree	of	neurite	complexity	increased	with	time	in	culture	(Figure	III.3A).	The	cultures	also	contained	cells	that	fired	action	potentials	in	response	to	depolarizing	current	injections	as	early	as	D4-5	post	plating	and	at	each	time	point	examined	up	through	D35-38	post	plating	(Figure	III.3B).	Quantitative	analysis	of	evoked	firing	focused	on	three	properties:	the	percentage	of	cells	capable	of	firing	at	least	one	AP	(Figure	III.3C),	percentage	of	cells	firing	repetitively	(2	or	more	APs)	(Figure	III.3D)	and	the	average	peak	evoked	firing	frequency	(Figure	III.3E).	There	was	a	significant	increase	in	all	three	properties	as	a	function	of	time	in	culture	in	both	cell	lines	(age	effect:	p	<	0.0001;	two-way	ANOVA;	Figures	III.3C-E).	The	variance	between	plating	was	the	lowest	for	the	percentage	of	cells	firing	at	least	one	AP	as	evidenced	by	the	smaller	error	bar	representing	standard	deviation	(Figure	III.3C).	The	highest	variance	between	platings	was	seen	in	percentage	of	cells	firing	repetitively	and	firing	frequencies,	most	prominently	at	the	intermediate	time	periods	between	D10	and	D23	post	plating	(Figure	III.3D	and	E).	However,	there	was	no	
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difference	in	any	of	these	properties	between	the	control	lines	(cell	line	effect:	p	>	0.98,	p	>	0.10,	p	>	0.17,	respectively;	Figures	III.3C-E;	Table	III.3).											Taken	together,	these	data	demonstrate	that	the	direct	differentiation	protocol	reliably	produces	cultures	from	hiPSCs	in	which	a	high	percentage	of	cells	with	neuronal	morphology	are	electrically	excitable	and	the	rate	of	maturation	of	firing	properties	is	similar	from	plating	to	plating.																					
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Figure	 III.3.	 Intrinsic	 firing	properties	of	hiPSC-derived	neurons	mature	at	 a	
similar	rate	from	plating	to	plating	in	control	lines,	and	between	control	hiPSC	
lines	 210	 and	 173.	 (A)	 Immunostaining	with	 βIII-tubulin	 antibody	 and	 DAPI	 on	neurons	derived	from	control	hiPSC	210	and	173	at	D4-5	and	D21-23	post	plating.	(B)	Representative	traces	of	action	potentials	evoked	in	control	hiPSC	210-	and	173-derived	neurons	in	response	to	a	600ms	depolarizing	current	pulse	at	five	recording	windows	between	4	and	38	days	post	plating.	(C)	The	percentage	of	neurons	capable	of	 evoked	 firing,	 (D)	 repetitive	 firing	 (more	 than	 2	 APs)	 and	 (E)	 the	 peak	 firing	frequency	as	a	function	of	age.	Data	are	reported	as	mean	+	SD.	Number	of	individual	platings	 at	 each	 time	window	 from	 2	 lines	 is	 reported	 in	 the	 bottom	 of	 C-E	with	number	of	neurons	in	parentheses.	All	three	properties	were	significantly	different	as	a	function	of	age	(two-way	ANOVA	with	post	hoc	Bonferroni	test,	results	in	Table	3).	a,	b,	c	and	d	denote	significance	from	D10-11,	D15-16,	D21-23	and	D35-38	post	plating	 respectively	 within	 the	 same	 line.	 Numbers	 next	 to	 the	 letters	 represent	degrees	of	significance	with	1,	2,	3	and	4	denoting	p	value	<	0.05,	0.01,	0.001	and	0.0001	 respectively.	 There	was	 no	 significant	 difference	 between	 cell	 lines	 (Table	III.3).	
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3.3.4	Formation	of	spontaneously	active	networks	of	excitatory	and	inhibitory	cells												Neurons	in	both	the	control	210	and	173	cultures	exhibited	spontaneous	firing	patterns	that	were	classified	as	irregular	tonic	firing	with	single	spikes	(Figure	
III.4Ai	and	ii)	or	burst	firing	(≥	2	sAPs	within	a	single	depolarization)	(Figure	
III.4Aiii	and	iv).	In	the	absence	of	applied	holding	current	a	small	percentage	of	hiPSC-derived	neurons	from	both	lines	fired	spontaneously	in	one	of	the	two	patterns	as	early	as	D4-5	post	plating	and	this	increased	significantly	as	a	function	of	age	in	culture	(p	<	0.0001;	two-way	ANOVA	with	post	hoc	Bonferroni	test;	Figure	
III.4B).	In	the	control	210	cultures,	the	percentage	of	hiPSC-derived	neurons	firing	spontaneously	continued	to	increase	steadily	until	D35-38.	In	contrast,	in	the	control	173	derived	neurons,	there	was	no	further	increase	in	the	percentage	of	cell	firing	spontaneously	beyond	D15-16	and	this	property	was	significantly	different	between	the	two	control	lines	at	the	later	time	points	(age	effect:	p	<	0.0001;	two-way	ANOVA;	Figure	III.4B;	Table	III.3).	About	half	of	the	spontaneously	firing	cells	were	spontaneously	burst	firing	in	both	lines.	The	percentage	of	cells	exhibiting	burst	firing	significantly	increased	with	age	(p	<	0.001;	two-way	ANOVA)	and	there	was	no	significant	difference	between	lines	(cell	line	effect:	p	>	0.63;	two-way	ANOVA	with	post	hoc	Bonferroni	test;	Figure	III.4C;	Table	III.3).	When	compared	to	evoked	firing,	spontaneous	firing	was	marked	by	greater	variability	between	platings	within	each	line,	indicated	by	larger	standard	deviations.							
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Figure	III.4.	hiPSC-derived	neurons	in	both	210	and	173	lines	are	spontaneously	
active.	(A)	Spontaneous	firing	patterns	classified	as	irregular	tonic	firing	(i	and	ii)	or	burst	firing	(iii	and	iv)	in	hiPSC	210-	and	173-derived	neurons.	RMP	is	indicated	at	the	baseline	of	each	trace.	(B)	The	percentage	of	neurons	exhibiting	spontaneous	firing	(C)	or	the	subset	with	burst	firing	(D)	at	5	time	windows	over	5	weeks.	Data	are	represented	as	mean	+	SD.	Number	of	individual	platings	at	each	time	window	from	2	lines	is	reported	in	the	bottom	of	B	and	C	with	number	of	neurons	in	parentheses.	Two-way	ANOVA	(results	in	Table	III.3)	with	post	hoc	Bonferroni	test.	c	and	d	denote	significance	from	D21-23	and	D35-38	post	plating	respectively	within	the	same	line.	Numbers	next	to	the	letters	represent	degree	of	significance	with	1	and	2	denoting	p	value	<	0.05	and	0.01	respectively.		
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            Spontaneous	synaptic	activity	was	also	observed	in	neurons	derived	from	both	control	hiPSC	lines	(Figure	III.5A).	To	quantify	the	degree	of	synaptic	connectivity,	the	 percentage	 of	 neurons	 with	 spontaneous	 PSPs	 or	 PSCs	 was	 determined	 at	 a	holding	 potential	 of	 -75	mV.	Over	 40%	of	 cells	 from	both	 control	 hiPSC	 lines	 had	detectable	 sPSP	 and/or	 sPSCs	 at	 the	 earliest	 time	 point,	 D4post	 plating	 (Figure	
III.5B).	 Assessment	 of	 the	 sPSC	 frequency	 demonstrated	 a	 steady	 and	 significant	increase	from	0.02	Hz	for	D4-5	cells	to	a	mean	of	4-5	Hz	by	D35-38	post	plating	(age	effect:	p	<	0.001;	two-way	ANOVA	with	post	hoc	Bonferroni	test;	Figure	III.5C).	The	variance	in	this	property	between	platings	became	larger	over	time,	with	the	greatest	variance	at	D35-38	post	plating	when	the	sPSC	frequencies	ranged	from	1	to	13	Hz.	There	was	no	significant	difference	between	 the	control	 lines	 in	 the	percentage	of	cells	with	spontaneous	synaptic	input	or	the	sPSC/P	frequency	(cell	line	effect:	p	>	0.13	 and	 p	 >	 0.85,	 respectively;	 two-way	 ANOVA	 with	 post	 hoc	 Bonferroni	 test;	Figures	III.5B	and	C).											A	subpopulation	of	neurons	derived	from	control	hiPSC	line	210	and	173	was	examined	to	determine	the	identity	of	the	receptors	mediating	synaptic	transmission.	At	 the	 reversal	 potential	 for	 chloride	 mediated	 currents	 (-49	 mV),	 all	 of	 the	 fast	decaying	 currents	 were	 completely	 blocked	 by	 50	 µM	 APV	 and	 10	 µM	 CNQX,	indicating	they	were	spontaneous	excitatory	postsynaptic	currents	(sEPSC)	mediated	by	 AMPA	 and	 NMDA	 receptors	 (Figure	 III.5D).	 At	 the	 reversal	 potential	 for	glutamatergic	currents	(-2	mV),	 the	 large	majority	of	slow	decaying	currents	were	blocked	 by	 a	 GABAA	 receptor	 antagonist	 BMC	 in	 10	 µM.	 A	 small	 percentage	 was	insensitive	 to	 BMC,	 but	 could	 be	 blocked	 by	 an	 antagonist	 of	 glycine	 receptors	
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strychnine	 in	 100	 nM	 (Figure	 III.5D).	 This	 suggests	 the	 cultures	 from	 both	 lines	contain	a	predominantly	glutamatergic	neurons	and	GABAergic	neurons,	and	a	small	proportion	of	glycinergic	neurons.	Over	75%	of	neurons	derived	from	hiPSC	lines	210	and	173	 received	 both	 excitatory	 and	 inhibitory	 synaptic	 input	 at	 day	 21-23	post	plating,	 demonstrating	 a	 functional	 neural	 network	 with	 both	 excitation	 and	inhibition	(p=0.16,	chi-square	test;	Figure	III.5E).																						
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Figure	III.5.		Functionally	active	networks	of	synaptically	connected	excitatory	and	
inhibitory	cells	in	cultures	from	both	control	hiPSC	lines.	(A)	Representative	traces	of	sPSCs	in	neurons	derived	from	control	hiPSC	lines	210	and	173.	Holding	potential	-75	mV.	(B)	The	percentage	of	neurons	exhibiting	sPSCs	as	a	function	of	age	in	culture.	(C)	Developmental	increase	in	sPSC	frequency	in	neurons	from	control	hiPSC	210	and	173.	Data	are	reported	as	mean	+	SD.	Number	of	individual	platings	at	each	time	window	from	2	lines	is	reported	in	the	bottom	of	B	and	C	with	number	of	neurons	in	parenthesis.	Two-way	ANOVA	with	post	hoc	Bonferroni	test	(results	in	Table	III.3).	b,	c,	and	d	denote	significance	from	D15-16,	D21-23	and	D35-38	post	plating,	respectively,	within	the	same	line.	Numbers	next	to	the	letters	represent	degrees	of	significance	with	1	and	2	denoting	p	value	<	0.05	and	0.01	respectively.	(D)	Characterization	of	sEPSCs	at	the	presence	of	glutamate	receptor	blockers	APV	and	CNQX	at	-49	mV	and	sIPSCs	at	the	presence	of	GABAA	receptor	blocker	BMC	and	glycine	receptor	blocker	strychnine	at	-2	mV	in	neurons	from	210	(top)	and	173	(bottom)	lines	at	D21-23	post	plating.	(E)	Proportion	of	neurons	from	210	and	173	hiPSC	lines	with	both	sEPSCs	and	sIPSCs	at	D21-23	post	plating.	n=	25	and	27		neurons	from	210	and	173	respectively.			
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												There	was	a	steady	decrease	 in	 input	 resistance	over	 time	between	2	and	5	weeks	in	culture	and	this	property	was	similar	between	the	two	lines	(Table	III.2).	In	 both	 the	 210	 and	 173	 hiPSC-derived	 neurons	 the	mean	whole	 cell	 capacitance	increased	 steadily	 over	 time	 and	 there	 was	 no	 change	 in	 the	 resting	 membrane	potential	(Cm	age	effect:	p	<	0.0001;	RMP	age	effect:	p	>	0.18;	two-way	ANOVA	with	
post	hoc	Bonferroni	test;	Table	2;	Table	III.3).	Although	a	two-way	ANOVA	identified	that	 the	 resting	 membrane	 potential	 was	 slightly	 more	 hyperpolarized	 in	 210	compared	to	173	(cell	 line	effect:	p	<	0.05;	 two-way	ANOVA);	subsequent	post	hoc	analyses	were	 unable	 to	 resolve	 any	 significant	 time	 points	 between	 lines	 (Table	
III.2;	Table	III.3).	The	whole	cell	capacitance	was	larger	in	210	cells	(cell	line	effect:	p	<	0.0001;	two-way	ANOVA	with	post	hoc	Bonferroni	test),	and	this	was	significant	at	 D15-16	 and	 D21-24	 post	 plating	 (Table	 III.2;	Table	 III.3).	 Overall,	 these	 data	demonstrate	that	the	direct	differentiation	protocol	results	 in	a	rate	and	degree	of	maturation	in	excitability	and	synaptic	transmission	that	is	consistent	from	plating	to	plating,	 and	 similar	 for	 most	 properties	 examined	 between	 two	 different	 control	hiPSC	lines.									
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Table	III.2．Passive	membrane	properties	of	directly	differentiated	neurons	
from	control	hiPSC	line	210	and	173.	
	 Line	 Days	post-plating	4-5	 10-11	 15-16	 21-24	 35-38		 	 	 	 	 	 	
Rm	(GΩ)	 210	 2.6	±	0.4	4(36)	 2.5	±	0.2	5(51)	 2.2	±	0.4	5(81)	 1.6	±	.0.5	7(131)	 1.4	±	0.4	4(101)		 	 	 	 	 	173	 2.7	±	0.6	4(39)	 2.3	±	0.4	6(47)	 1.9	±	0.3	6(48)	 1.7	±	0.2	6(65)	 1.2	±	0.2	6(52)		 	 	 	 	 	 		 	 	 	 	 	 	
RMP	(mV)	 210	 -53.5	±	8.4	4(36)	 -50.8	±	6.4	5(51)	 -55.1	±	4.5	5(81)	 -54.1	±	3.6	7(131)	 -53.4	±	4.1	4(101)		 	 	 	 	 	173	 -50.2	±	2.3	4(39)	 -50.0	±	3.2	6(47)	 -54.7	±	5.0	6(48)	 -50.1	±	2.5	6(65)	 -48.6	±	2.7	6(52)		 	 	 	 	 	 		 	 	 	 	 	 	
Cm	(pF)	 210	 25.5	±	3.0	4(36)	 25.2	±	3.2	5(51)	 33.0	±	5.2a	5(81)	 37.0	±	8.5b	7(131)	 43.5	±	15.9	4(101)		 	 	 	 	 	173	 15.1	±	1.8	4(31)	 19.0	±	2.2	6(58)	 19.1	±	3.2a	6(50)	 23.4	±	1.8b	6(63)	 34.4	±	3.7	6(69)		 	 	 	 	 	 	Data	reported	as	Mean	±	SD	with	number	of	individual	platings	(total	number	of	neurons).	ap	<	0.01,	bp	<	0.001,	denotes	significance	between	cell	lines	at	given	time	point	post	plating	(two-way	ANOVA	with	Bonferroni	post	hoc	test).	 	
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Table	 III.3.	 Summary	 of	 two-way	 ANOVA	 statistical	 analyses	 on	 directly	
differentiated	neurons	from	control	hiPSC	line	210	and	173.		 Age	 Line	 Interaction	Evoked	firing	(%	total)	 ****	(p	<	0.0001)	 ns	(p	=	0.98)	 ns	(p	=	0.40)	Multiple	firing	(%	total)	 ****	(p	<	0.0001)	 ns	(p	=	0.10)	 ns	(p	=	0.92)	Firing	frequency	 ****	(p	<	0.0001)	 ns	(p	=	0.17)	 ns	(p	=	0.59)	sAP	(%	total)	 ****	(p	<	0.0001)	 *	(p	=	0.03)	 ns	(p	=	0.22)	Burst	sAP	(%	total)	 **	(p	=	0.0014)	 ns	(p	=	0.63)	 ns	(p	=	0.84)	sPSC/PSPs	(%	total)	 ****	(p	<	0.0001)	 ns	(p	=	0.13)	 ns	(p	=	0.67)	sPSC	frequency	 ***	(p	=	0.0004)	 ns	(p	=	0.85)	 ns	(p	=	0.97)	Rm	 ****	(p	<	0.0001)	 ns	(p	=	0.33)	 ns	(p	=	0.55)	RMP	 ns	(p	=	0.18)	 *	(p	=	0.04)	 ns	(p	=	0.72)	Cm	 ****	(p	<	0.0001)	 ****	(p	<	0.0001)	 ns	(p	=	0.53)	Two-way	ANOVA	utilized	to	examine	effects	of	age	(days	post	plating),	cell	line	identity,	and	interaction	between	both.	*,	**,	***,	and	****	reflect	p	<	0.05,	0.01,	0.001	and	0.0001	respectively.																				
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3.3.5	Identification	of	GABAergic	neurons			 				The	 observation	 of	 both	 glutamatergic	 and	 GABAergic	 synaptic	 currents	indicated	 that	 despite	 the	 use	 of	 ventralizing	 factors	 our	 protocol	 supports	differentiation	of	excitatory	and	inhibitory	neurons.	 	To	quantify	the	percentage	of	total	hiPSC-derived	neurons	that	are	GABAergic,	cultures	were	fixed	at	D21-23	and	stained	 with	 anti-βIII-tubulin	 and	 anti-GABA	 antibodies	 (Figure	 III.6A).	Approximately	30%	of	the	neurons	were	GABA-positive	and	there	was	no	significant	difference	in	the	percent	of	total	neurons	that	were	GABA-positive	in	the	210	and	173	hiPSC-derived	neuronal	cultures	(p	>	0.14,	unpaired	t-test	with	Welch’s	correction;	
Figure	 III.6B).	 These	 data	 in	 conjunction	 with	 the	 synaptic	 current	 recordings	confirm	that	our	direct	differentiation	protocol	produced	mixed	cultures	with	both	inhibitory	GABAeric	and	excitatory	glutamatergic	neurons.																
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Figure	III.6.		Cultures	from	210	and	173	contain	a	similar	percentage	of	GABAergic	
neurons.	(A)	Cultures	differentiated	from	the	control	210	and	173	hiPSC-derived	neurons	were	stained	with	nuclei	marker	DAPI,	βIII-tubulin	and	GABA	antibodies	to	identify	GABAergic	neurons	at	D21	post	plating.	(B)	The	proportion	of	GABAergic	neurons	in	neuronal	cultures	of	control	210	and	173	at	D21	post	plating.	Data	represented	as	mean	+	s.e.m.	Number	of	coverslips	from	each	line	indicated	on	the	graph.	There	was	no	significant	difference	in	the	percentage	of	GABAergic	neurons	in	the	two	lines,	p	>	0.14,	unpaired	t-test	with	Welch’s	correction.		
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3.4.	Discussion	
3.4.1	Difference	in	maturation	of	excitability	in	expandable	intermediate	population	vs	direct	
differentiation		In	 our	 study,	 neurons	 generated	 by	 the	 direct	 differentiation	 protocol	were	more	electrically	 excitable	 than	 the	expandable	NSC-derived	neurons	over	 the	 first	 5	weeks	of	neuronal	differentiation.	From	previous	studies	in	our	lab	we	know	that	neurons	in	cultures	from	 expandable	 NSCs	 at	 later	 times	 are	 able	 to	 develop	 repetitive	 firing	 properties15.	Another	study	using	expandable	NPC-derived	neurons	also	reported	an	extended	timeline	of	maturation,	with	the	large	majority	of	the	cells	capable	of	firing	multiple	action	potentials	in	NPC	 cultures	 by	 6	 weeks	 post	 plating29.	 Therefore,	 it	 is	 likely	 that	 at	 least	 some	 of	 the	difference	between	 the	 expandable	NSC	or	NPC	 strategy	versus	 the	direct	differentiation	protocol	 is	 the	 rate	 as	 opposed	 to	 capacity	 for	 maturation.	 A	 recent	 study	 predicting	functional	states	of	expandable	NPC-derived	neurons	with	RNA-seq	and	electrophysiology	reports	a	decline	in	degree	of	maturation	with	increased	passage	number	of	the	intermediate	population30.	However,	by	day	30	post	plating,	the	differentiation	of	excitability	and	synaptic	activity	in	the	neurons	was	similar	to	neurons	generated	by	the	direct	differentiation	in	the	present	paper.	Enhanced	neuronal	function	observed	in	the	Bardy	study	may	be	due	to	the	BrainPhys	 growth	 medium	 that	 has	 been	 shown	 to	 support	 action	 potential	 firing	 and	synaptic	 transmission	 in	 hiPSC-derived	 neurons31.	 Future	 studies	 will	 be	 important	 to	determine	 if	 the	 BrainPhys	 medium	 can	 further	 increase	 the	 rate	 and/or	 the	 degree	 of	maturation	in	directly	differentiated	neurons.		
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3.4.2	Reproducibility	in	rate/degree	of	functional	maturation	between	platings	and	between	
hiPSC	lines		The	direct	differentiation	protocol	results	in	a	high	percentage	of	functionally	active	cells	in	each	plating	from	two	different	hiPSC	lines.	However,	there	were	differences	in	the	degrees	of	 variance	 and	 in	 the	 rate	of	maturation	between	properties.	 In	 general,	 hiPSC-derived	neurons	from	both	lines	exhibited	a	lower	degree	of	variability	in	evoked	firing	vs	spontaneous	activity	at	each	time	point.	This	suggests	that,	 in	order	to	identify	functional	changes	 associated	 with	 a	 specific	 mutation,	 the	 direct	 differentiation	 protocol	 is	 better	suited	to	resolving	differences	in	intrinsic	excitability,	and	small	differences	in	spontaneous	firing	 or	 synaptic	 transmission	 will	 require	 a	 larger	 number	 of	 trials	 establish	significance4,6,32,33.			The	control	lines	in	the	present	study	were	from	donors	of	different	ages,	23	and	56.	The	similarly	high	percentage	of	neurons	to	glial	cells	derived	from	both	hiPSCs	lines	in	the	direct	differentiation	protocol	suggest	donor	age	does	not	affect	the	efficiency	of	producing	neuronal	 cells.	 This	 is	 consistent	 with	 a	 previous	 study	 using	 a	 different	 differentiation	protocol	demonstrating	donor	age	did	not	influence	the	percentage	of	hiPSC-derived	cells	positive	for	ISL,	a	motor	neuron	marker34.	In	addition,	while	donor	age	does	not	appear	to	influence	the	rate/degree	of	the	majority	of	functional	properties	examined	we	cannot	rule	out	the	possibility	that	donor	age	affects	the	two	properties	that	were	different	between	the	line:	maturation	of	the	percentage	of	cells	firing	spontaneous	action	potentials	and	resting	membrane	 potential.	 It	would	 be	 interesting	 to	 systematically	 study	 the	 effect	 of	 age	 on	functional	development	of	neurons	using	multiple	iPSCs	lines.		
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Whole-cell	 capacitance	 increased	 steadily	 as	 a	 function	 of	 age	 in	 neurons	 derived	from	 both	 cell	 lines.	 However,	 while	 the	 173	 vs	 the	 210	 derived	 neurons	 had	 a	 smaller	capacitance	 at	 each	 time	 point,	 indicative	 of	 lower	 total	 membrane	 surface	 area,	 the	differentiation	of	functional	properties	was	comparable.	This	indicates	that	cell	size	in	this	case	 is	 not	 highly	 correlated	with	 functional	 differentiation.	 In	 addition	 the	 difference	 in	whole	cell	capacitance	does	not	appear	to	be	a	property	of	the	specific	hiPSC	cell	line	because	a	 set	of	neurons	derived	 from	 the	173	 line	 in	our	previous	 study	had	capacitance	values	similar	to	those	of	the	210	line	in	the	current	study28.	One	possibility	is	that	a	variance	in	the	size	of	embryoid	bodies	and	neurospheres	during	the	initial	phase	of	patterning,	could	affect	exposure	to	morphogens	and	result	in	variance	in	the	starting	cell	size.	This	could	be	further	examined	 using	 Aggrewell™	 plating	 methods	 to	 control	 the	 size	 of	 embryoid	 bodies	 by	plating	a	similar	amount	of	dissociated	cells	into	pocket-like	microwells35.			
3.4.3	Neuronal	subtypes	in	culture		The	ability	to	generate	well-defined,	populations	of	excitatory	or	inhibitory	neurons	is	 an	 important	 prerequisite	 for	 use	 of	 pluripotent	 stem	 cells	 in	 human	 transplantation	studies.	A	recent	study	demonstrated	that	exposure	to	different	levels	of	purmorphamine	can	produce	nearly	pure	yields	of	glutamatergic,	GABAergic,	or	medium	spiny	neurons36.	Having	precise	control	over	 the	 terminal	phenotype	of	grafted	cells	bypasses	concerns	of	unintended	integration	of	other	subtypes	and	can	balance	excitatory	and	inhibitory	neuronal	network	activity	in	the	recipient37–39.	Therefore	it	was	surprising	that	only	30-40%	of	the	neurons	 generated	 in	 the	 direct	 differentiation	 protocol	 were	 GABAergic,	 using	 a	concentration	 of	 SMAD	 inhibitors	 and	 purmorphamine	 that	 in	 other	 similar	 protocols	
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yielded	 cultures	 in	which	 80-90%	 of	 the	 neurons	were	 GABAergic13,20,36.	 This	 difference	could	 have	 arisen	 from	 variations	 in	 the	 size	 of	 embryoid	 bodies	 and	 neuroepithethelial	tissue	 generated	 during	 the	 patterning	 process,	 in	 which	 the	 generation	 of	 distinct	morphogen	 gradients	 may	 contribute	 to	 regional	 specification	 of	 neurons40.	 Another	difference	could	have	arisen	from	the	use	of	astroglial	feeder	layers	for	the	differentiation	phase	in	the	present	study.	Previous	studies	have	shown	that	astrocytes	are	important	for	regulating	 the	microenvironment	 of	 differentiating	 neurons	 through	 cell-cell	 contact	 and	secreted	factors41,42.		There	are	important	advantages	in	having	mixed	cultures	of	excitatory	and	inhibitory	neurons	 for	 disease	 modeling.	 First,	 the	 mix	 of	 functional	 glutamatergic	 and	 GABAergic	neurons	more	accurately	 reflects	a	native	neural	network,	with	 the	number	of	excitatory	cells	outnumbering	GABAergic.	Second,	both	excitatory	and	inhibitory	inputs	are	essential	for	 maintaining	 a	 stable	 E/I	 ratio	 in	 neurons,	 which	 play	 an	 important	 role	 in	 cortical	functions	 in	 mammalian	 cerebral	 cortex43.	 Imbalance	 of	 E/I	 is	 associated	 with	 epilepsy,	autism	 and	 fragile	 X	 syndrome44,45.	 Therefore,	 generating	 neuronal	 cultures	 with	 both	excitatory	and	inhibitory	neurons,	instead	of	pure	population	of	certain	cell	types,	facilitates	understanding	in	the	altered	relationship	of	E/I	in	the	disease	models	in	vitro.		In	 conclusion,	 direct	 differentiation	 of	 neurons	 from	 hiPSC	 lines	 resulted	 in	 the	reproducible	and	efficient	generation	of	electrophysiologically	active	neuronal	cultures	from	independent	donors.	The	establishment	of	baseline	parameters	concerning	the	development	and	maturation	of	derived	neurons	is	critical	for	interpretation	of	data	obtained	using	this	rapidly	evolving	platform.	In	particular,	for	investigations	utilizing	non-isogenic	iPSC	lines	from	affected	individuals	and	related	(or	unrelated)	controls,	a	quantitative	characterization	
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of	electrophysical	properties	and	their	variation	resulting	from	the	selected	differentiation	protocol	is	required.	The	functional	outcomes	of	the	differentiation	protocol	utilized	in	this	study	establishes	a	platform	for	the	identification	of	mutational	or	drug-induced	functional	alternations,	which	is	at	the	core	of	pre-clinical	disease	modeling.		
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4.1. Introduction 												Genetic	epilepsy	with	febrile	seizure	plus	(GEFS+)	is	a	form	of	epilepsy	with	febrile	seizures	that	persists	beyond	six	years	of	age1.	The	clinical	phenotype	of	GEFS+	is	characterized	by	febrile	seizures	beginning	in	infancy	that	persist	beyond	6	years	of	age	and	in	some	cases	individuals	also	experience	myoclonic,	atonic	and/or	absence	seizures2.	Mutations	in	a	variety	of	genes	that	encode	ion	channels	and	neurotransmitter	receptors	have	been	identified	in	individuals	with	GEFS+3–12.	One	hot	spot	for	mutations	causing	GEFS+	is	the	SCN1A	gene	which	encodes	the	alpha	subunit	of	the	Nav1.1	voltage-gated	sodium	channel.	Approximately	50	missense	mutations	at	locations	throughout	SCN1A	are	associated	with	different	individuals	diagnosed	with	GEFS+13.	There	are	also	multigenerational	families	in	which	individuals	with	the	same	SCN1A	mutation	exhibit	a	broad	range	of	seizure	phenotypes14,15.														The	heterogeneity	of	disease	phenotypes	arising	from	different	mutations	in	the	same	gene,	and	from	the	same	mutation	between	individuals	complicates	understanding	of	the	underlying	cellular	mechanisms.	Model	systems	that	aid	in	mapping	the	links	between	individual	SCN1A	mutations	and	their	cellular	effects	can	facilitate	development	of	more	effective	patient-specific	drug	therapies.	Zebrafish,	knock-in	Drosophila	and	mouse	models	have	all	been	important	tools	in	this	endeavor16	but	evolutionary	distances	leading	to	species-specific	mechanisms	may	lead	to	failed	therapies	in	patients17,18.													In	recent	years,	patient-derived	induced	pluripotent	stem	cells	(iPSCs)	that	can	be	differentiated	into	neurons	have	emerged	as	a	new	model	to	explore	how	epilepsy-associated	SCN1A	mutations	affect	activity	and	sodium	channel	properties	in	human	neurons.	These	studies	have	focused	on	mutations	associated	with	Dravet	syndrome	(DS),	a	
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form	of	epilepsy	that	is	typically	more	severe	than	GEFS+.	Previous	studies	in	iPSC-derived	neurons	have	shown	that	nonsense	R1645X,	and	missense	S1328P	and	Q1923R	mutations	in	SCN1A	associated	with	DS	confer	impaired	excitability	and	reduced	sodium	current	density	in	inhibitory	neurons,	giving	rise	to	hyperactivity	in	neural	networks19–21.	However,	examination	of	the	DS-associated	SCN1A	missense	mutations,	Q1923R	and	F1415I,	revealed	increased	excitability	and	increased	sodium	current	amplitudes	in	excitatory	neurons22.	Further,	the	IVS14+3A>T	mutation	which	causes	truncation	of	DIIS2	and	S3	of	Nav1.1	affects	both	excitatory	and	inhibitory	neurons23.													In	addition	to	alterations	caused	by	discrete	mutations,	differences	in	genetic	background	represent	a	major	source	of	variability	that	complicates	interpretation	of	any	experimental	findings	as	they	can	influence	phenotypic	differences24,25.	Evaluation	of	a	large	cohort	of	control	and	patient	iPSC	lines	can	help	assess	the	contribution	of	mutations	to	disease	phenotypes26.	This	is	problematic	when	evaluating	potential	changes	in	electrophysiological	properties	that	require	examination	at	the	single	cell	level	in	multiple	cells	from	a	large	number	of	cell	lines.	However,	a	more	direct	way	to	examine	the	effect	of	a	mutation	independent	of	genetic	background	is	to	compare	the	cellular	changes	caused	by	a	single	mutation	in	isogenic	pairs	of	control	and	mutant	iPSC	lines20,26–29.	A	recent	study	of	the	DS-associated	SCN1A	Q1923R	mutation	used	transcription	activator-like	effector	nucleases	(TALENs)	to	generate	an	isogenic	corrected	line	by	removing	the	SCN1A	mutation.	Comparison	of	the	isogenic	corrected	versus	the	patient	line	revealed	a	decrease	in	sodium	current	density	in	inhibitory	neurons	in	the	patient	line.	Comparison	of	the	isogenic	corrected	line	with	a	control	line	from	a	different	genetic	background	revealed	additional	alterations	in	the	voltage	dependence	of	sodium	current	activation	and	action	
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potential	(AP)	threshold	suggesting	these	might	be	associated	with	the	genetic	background	of	the	patient.	An	isogenic	mutant	line	in	which	the	mutation	had	been	introduced	into	the	control	would	have	been	able	to	distinguish	whether	this	was	due	to	genetic	background	or	interaction	between	the	mutation	and	the	genetic	background.													The	current	study	focuses	on	assessing	the	contribution	of	the	autosomal	dominant	
SCN1A	K1270T	mutation	identified	in	a	GEFS+	family	to	the	etiology	of	the	disease14.	Two	isogenic	pairs	of	iPSC	lines	generated	by	CRISPR/Cas	9	gene	editing	were	used:	1a)	control	(unaffected	sibling),	1b)	mutated	control	homozygous	for	the	K1270T	mutation,	and	2a)	patient	heterozygous	for	the	K1270T	SCN1A	mutation	(GEFS+	sibling),	2b)	corrected	patient.	All	4	iPSC	lines	in	the	two	isogenic	pairs	can	be	differentiated	into	functional	mixed	neuronal	cultures	containing	both	GABAergic	and	glutamatergic	neurons	that	expressed	Nav1.1.	Comparison	of	electrophysiological	properties	of	neurons	within	and	between	pairs	identified	mutation-dependent	alterations	independent	of	genetic	background.	There	were	also	differences	found	to	be	associated	with	the	genetic	background	and	others	the	result	of	interactions	between	the	mutation	and	the	background.	Such	CRISPR/Cas9-based	disease	modeling	strategy	with	dual	isogenic	pairs	of	iPSC-derived	neurons	represents	a	promising	platform	for	studying	the	causality	of	mutations	related	to	genetic	diseases	and	developing	patient-specific	therapies	based	on	disease	mechanisms.	
 
4.2. Methods 
4.2.1	Preparation	and	maintenance	of	hiPSCs													Skin	fibroblasts	were	collected	from	two	male	siblings	of	the	GEFS+	family	by	Kevin	Ess	(Vanderbilt	University	Medical	Center)	after	obtaining	informed	consent	using	IRB	
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approved	protocol	#080369.	The	control	fibroblast	donor	had	no	known	clinical	diagnoses;	the	patient	sibling	had	four	febrile	seizures	beginning	at	6	months	of	age	and	four	generalized	atypical	absence	seizures	since	the	age	of	two14.	Age	at	time	of	biopsy	the	control	sibling	was	23	years	and	the	patient	sibling	was	21	years	old.														Skin	fibroblasts	were	reprogrammed	into	iPSCs	using	nonintegrating	Sendai	virus	by	the	Schwartz	laboratory	as	published30.	Two	human	iPSC	lines	were	generated,	SC210.12-SF6-2I3.M11S8	(control)	and	SC215.19-SF4-2I8.M10S6	(patient).	iPSCs	were	maintained	in	feeder-free	conditions	following	published	protocols30,31.	
	
4.2.2	CRISPR/Cas9	editing	on	iPSCs	derived	from	two	siblings													To	generate	a	mutated	control	line,	the	K1270T	mutation	was	knocked	into	an	iPSC	line	generated	from	the	unaffected	sibling	(SC210.12-SF6-2I3-M11S8-S4-S6-S2).	The	20-nt	guide	RNA	(sgRNA)	5’-CTTCTAAAATGGGTGGCATA-3'	was	designed	using	the	CRISPR	design	tool	(http://crispr.mit.edu)	from	the	Zhang	laboratory	and	cloned	into	plasmid	pSpCas9(BB)-2A-Puro	(Px459)	V2.0	(Addgene,	62988).	Plasmid	constructs	were	purified	with	the	Endo-free	Plasmid	Maxiprep	kit	(Qiagen).	The	140-nt	repair	template	ssODN1	5’-GATTAAGACGATGTTGGAATATGCTGACAAGGTTTTCACTTACATTTTCATTCTGGAAATGC	TTCTAACATGGGTGGCATATGGATATCAAACATATTTCACCAATGCCTGGTGTTGGCTGGACTTCTTAATTGTTGATG-3'	(Integrated	DNA	Technologies)	was	designed	with	two	homologous	arms	flanking	the	Cas9	cleavage	site,	the	threonine	codon	(ACA)	at	the	mutation	site	and	an	addition	of	a	silent	EcoRV	mutation.														To	generate	a	corrected	patient	line,	the	mutation	was	removed	from	a	patient	iPSC	line	(SC215.19-SF4-2I8.M10S6-S2-S2).	sgRNA	(5’-CTTCTAACATGGGTGGCATA-3')	
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complementary	to	the	target	sequence	of	mutated	allele	was	cloned	into	the	same	plasmid.	The	140-nt	repair	template	ssODN2	5’-	GATTAAGACGATGTTGGAATATGCTGACAAGGTTT	TCACTTACATTTTCATTCTGGAAATGCTTCTAAAATGGGTGGCATATGGCTATCAAACATATTTCACCAATGCCTGGTGTTGGCTGGACTTCTTAATTGTTGATG-3'	(Integrated	DNA	Technologies)	was	similar	to	ssODN1	but	with	the	lysine	codon	at	the	mutation	site	(AAA)	and	without	EcoRV	silent	mutation.	8	x	105	cells	were	co-transfected	with	3	µg	plasmid-sgRNA	construct	and	ssODN	(0.6	µM	final	concentration)	with	Amaxa	Human	Stem	Cell	Nucleofector	Kit	1	(Lonza)	and	program	A-023	for	the	Amaxa	Nucleofector	Device	II.	To	obtain	low	seeding	density,	the	transfected	cell	suspension	was	diluted	in	a	1:6	-	1:8	ratio	and	plated	into	Matrigel	(BD	Biosciences)-coated	wells	of	6-well	plates.	24	hours	post-transfection,	cells	were	treated	with	2	µg/ml	puromycin	(Sigma-Aldrich)	in	StemPro	complete	media	containing	0.58	µl/ml	SMC4	(Corning).	48	hours	post-transfection,	cells	were	switched	to	normal	StemPro	complete	media	containing	0.58	µl/ml	SMC4.	Continued	maintenance	required	media	that	included	50%	conditioned	media	from	70-90%-confluent	unedited	iPSC	cultures	and	50%	StemPro	complete	media	with	55	µM	β-mercaptoethanol	(Invitrogen),	1×StemPro	(Invitrogen),	20	ng/ml	bFGF	(Stemgent)	and	0.58	µl/ml	SMC4.	6-8	days	post-nucleofection,	isolated	iPSC	colonies	with	20-30	cells	were	formed,	picked	manually	using	customized	glass	hooks,	and	transferred	to	single	wells	in	96-	or	48-well	plates	with	pre-wet	20	µl	barrier	micropipette	tips.	StemPro	complete	media	supplemented	with	0.58	µl/ml	SMC4	was	used	for	daily	feeding.	At	100%	confluence,	clones	were	split	with	pre-warmed	62	µl	(96-well	plate)	or	125	µl	(48-well	plate)	of	Accutase	(Millipore)	in	a	1:2	ratio.	Cells	were	eventually	expanded	into	two	wells	in	a	48-well	plate	to	be	used	for	freezing	as	well	as	sequencing	and/or	restriction	digestion,	
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respectively.	All	media	for	feeding	and	splitting	were	prepared	immediately	prior	to	use	and	equilibrated	at	37°C	and	5%	CO2.														A	protocol	for	freezing	iPSCs	in	low	density	was	modified	from	Stover	et	al	31.	Cells	at	100%	confluence	were	cryopreserved	with	pre-chilled	freezing	medium	containing	40%	conditioned	medium	from	70-90%	confluent	culture,	40%	StemPro	complete	medium,	10%	DMSO	(Sigma-Aldrich),	10%	bovine	serum	albumin	(25%	BSA,	Gibco)	with	addition	of	0.58	µl/ml	SMC4.	To	increase	viability	of	cells	during	defrosting,	clones	from	48-well	plates	were	frozen	with	50-250	µl	of	freezing	medium	depending	on	the	size	of	pellets	after	centrifugation	and	were	stored	in	1.2	ml	cryo-vials	at	-80°C.														Genomic	DNA	was	extracted	with	10-13	µl	of	QuickExtract	DNA	Extraction	Solution	(Epicentre).	Fragments	around	the	intended	mutation	sites	were	amplified	by	PCR	in	50	µl	reactions	with	Taq	DNA	polymerase	(Invitrogen),	forward	primer	5'-CTACCATAGATTCCAT	CCCCCAA	-3'	and	reverse	primer	5'-	TTCCACCAATAGTCTTTCCCCTG	-3'.	PCR	products	were	confirmed	by	gel	electrophoresis	and	purified	with	MinElute	PCR	Purification	Kit	(Qiagen)	prior	to	sequencing	(Retrogen).	MacVector	software	was	used	to	analyze	sequencing	data.													Additionally,	a	subset	of	mutated	control	clones	was	subject	to	restriction	digestion	by	EcoRV	prior	to	sequencing	analysis.	As	we	observed	the	absence	of	EcoRV	mutation	in	some	of	the	positive	clones	with	K1270T	mutation,	direct	sequencing	was	used	to	screen	the	remaining	clones.													The	top	five	potential	off-target	sites	from	CRISPR/Cas9	editing	as	identified	by	the	CRISPR	design	tool	(http://crispr.mit.edu)	from	the	Zhang	laboratory,	were	SCN7A,	FLII,	
SCN2A,	SCN3A	and	SCN9A.	To	determine	if	any	of	these	were	also	affected	by	the	editing	in	the	mutated	control	or	the	patient	corrected	line,	primers	were	used	to	interrogate	the	
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relevant	region	of	homology	in	each	gene.	PCR	conditions	were	94	°C,	45	s,	60	°C,	33	s	and	72	°C,	55	s	for	35	cycles.														To	evaluate	the	expression	level	of	off	targets,	mRNA	was	extracted	from	neuronal	cultures	of	another	control	iPSC	cell	line	173	(SC173.1-SF6-2I2.M16S9	through	S21)	that	shows	similar	rate	and	degree	of	functional	maturation	to	our	current	control	line	at	D21-24	post	plating32.	cDNA	was	synthesized	following	the	instructions	of	TRIzol	(Thermo	Fisher)	and	SuperScript™	III	First-Strand	Synthesis	SuperMix	for	qRT-PCR	kit	(Thermo	Fisher),	followed	by	nested	PCR.	Expression	of	the	off-target	gene	was	compared	to	SCN1A	and	normalized	to	ACTB.	Nested	PCR	conditions	were	94	°C,	45	s,	60	°C,	33	s	and	72	°C,	60	s	for	35	cycles	for	all	primers.	Primers	for	sequencing	and	nested	PCR	are	in	Table	IV.1.														All	4	iPSC	lines	were	karyotyped	and	cell	lines	at	low	passage	were	expanded	for	cryopreservation.	When	samples	were	thawed	for	expansion	and	use	in	differentiation	studies,	the	SCN1A	gene	was	sequenced	every	20-30	passages.	Research	was	approved	by	hSCRO	(#2011-1023)	and	IBC	protocols	(#2011-1377).	
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Table	IV.1.	Primers	for	off-target	gene	sequencing	and	expression		Gene	 Reference	 Direction	 Sequence	Off-target	gene	sequencing		
SCN7A	 NG_031928.1	 Fwd	 5'	ACAAGCATAGTGAACCAGCCCT	3'	Rev	 5'	GATCAGCCCTGCACTTGTGAAC	3'	
FLII	 NG_023243.1	 Fwd	 5'	GGCTGCAGACAAGAGCAAGAAA	3'	Rev	 5'	CACAGCTGTTCTTTCTGCCCAG	3'	
SCN9A	 NG_012798.1	 Fwd	 5'	CAGCACTGGTGAGAAGGCTAGA	3'	Rev	 5'	ACTTGATGTGCCCCTCATCCTC	3'	
SCN2A	 NG_008143.1	 Fwd	 5'	CCCTTGGTTGACTGAAATGCCC	3'	Rev	 5'	TGCGAAATGTGAGTGTGCAAAA	3'	
SCN5A	 NG_008934.1	 Fwd	 5'	GGAGAATCACTTGAACCCGGGA	3'	Rev	 5'	GGCAGGACCCTGTCTCCTATTT	3'	
SCN3A	 NG_042289.1	 Fwd	 5'	TTCCCTGCCAGCATTTTCACAC	3'	Rev	 5'	ACAATTCTCCCTGTGTTTGCTCT	3'	Off-target	gene	expression		
SCN1A	 NM_001165963.2	 Fwd	(ext)	 5'	TCCTTCGGGATCCATGGAACTG	3'	Rev	(ext)	 5'	CGTTTTCCCAGCAGCACGTAAT	3'	Fwd	(int)	 5'	TGTCTCGGCATTGAGAACATTC	3'	Rev	(int)	 5'	ATTGGTGGGAGGCCATTGTAT	3'	
SCN7A	 NM_002976.3	 Fwd	(ext)	 5'	AGCTGAGGGAAAACTAGTGCCC	3'	Rev	(ext)	 5'	GTGGATCAGGACCCCTACAAGG	3'	Fwd	(int)	 5'	AGAACCTAAGGGCCTTGTTCCC	3'	Rev	(int)	 5'	ACACAAGATGGAAGCCGCATTG	3'	
ACTB	 NM_001101.5	 Fwd	 5'	CCACCATGTACCCTGGCATT	3'	Rev	 5'	ACTCCTGCTTGCTGATCCAC	3'	a.	Off-target	gene	expression	was	examined	by	nested	PCR	that	uses	two	sets	of	primers.		b.	Fwd,	rev,	ext	and	int	are	abbreviated	for	forward,	reverse,	external	set	and	internal	set	of	primers.		
 
 
 
 
 
 
 
 
 
91		
4.2.3	Differentiation	of	two	pairs	of	isogenic	iPSCs	into	neurons													Two	pairs	of	isogenic	iPSCs	(4	lines	total)	within	40	passages	of	the	original	generation	were	patterned	into	neurons	as	described32.	Neural	progenitor	cells	derived	from	iPSCs	were	plated	on	top	of	50-70%	confluent	mouse	astroglial	feeder	layers	that	were	prepared	following	a	published	protocol33.														At	D17	post-plating,	excitatory	and	 inhibitory	neurons	were	 labeled	by	transfection	with	CaMKII-eGFP	(Addgene,	50469)	and	GAD1-mCherry	(Genecopoeia,	HPRM15652-PM02)	plasmids	in	Opti-MEM	(Gibco)	and	DNA-in	(MTI-GlobalStem)	or	ViaFect	(Promega)	reagents.			
4.2.4	Immunostaining	and	imaging													To	evaluate	the	expression	of	pluripotency	markers,	iPSCs	were	plated	onto	glass	coverslips	coated	with	Matrigel	diluted	1:30	in	DMEM/F-12	+	Glutamax	(Gibco).	iPSCs	were	maintained	using	StemPro	medium	(section	2.2).	When	grown	to	~70%	confluence,	coverslips	were	fixed	and	stained	as	described	32.	Primary	antibodies	OCT-3/4	(1:100;	Santa	Cruz	Biotechnology,	sc-5279),	SOX2	(1:100;	Santa	Cruz	Biotechnology,	sc-365823)	and	NANOG	(1:50;	Santa	Cruz	Biotechnology,	sc-293121)	were	used	to	characterize	the	pluripotency	of	the	iPSCs.	4’,6-diamidino-2-phenylindole	(DAPI;	Life	Technologies)	staining	was	added	to	visualize	nuclei.													iPSC-derived	neurons	were	stained	with	antibodies	of	βIII-tubulin	(1:1000;	Sigma-Aldrich,	T8660)	and	GABA	(1:4000;	Sigma-Aldrich,	A2052)	to	assess	the	proportion	of	GABAergic	neurons.	Neurons	were	identified	by	morphology,	expression	of	βIII-tubulin	in	the	cell	bodies	and	neuronal	processes,	and	nuclear	localization	of	DAPI.	Identities	of	neurons	labeled	by	GAD1-mCherry	and	CaMKII-eGFP	plasmids	were	verified	by	staining	
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with	antibodies	of	GABA	and	CaMKII	(1:800;	Cell	Signaling	Technology,	3362)	respectively.	Expression	of	Nav1.1	was	examined	in	GABA+	(1:100;	Aldrich-Sigma,	A0310)	and	CaMKII-eGFP+	cells	by	staining	with	anti-Nav1.1	antibody	(1:800;	Alomone	Labs,	ASC-001).													Images	were	taken	by	a	Zeiss	M2	Imager	fluorescence	microscope	and	processed	using	the	supplied	Zen	software.		
4.2.5	Whole-cell	recording													Whole-cell	recordings	were	obtained	from	iPSC-derived	inhibitory	and	excitatory	neurons	at	D21-23	post-plating	at	room	temperature.	This	time	period	was	selected	based	on	studies	in	two	control	cell	lines	demonstrating	that	a	high	percentage	of	neurons	were	functionally	active	by	this	age32.	Patch	pipettes	were	pulled	from	unpolished	borosilicate	glass	(VWR	International)	by	PC-10	pipette	puller	(Narishige).	Open	tip	resistance	was	6-8	MΩ.	External	solution	contained	(in	mM):	120	NaCl,	5.4	KCl,	0.8	MgCl2,	1.8	CaCl2,	15	glucose,	20	HEPES,	with	pH	at	7.2-7.4.	Osmolality	was	adjusted	to	290	-	295	mOsm.	Internal	solution	contained	(in	mM):	120	potassium	gluconate,	20	NaCl,	0.1	CaCl2,	2	MgCl2,	1.1	EGTA,	10	HEPES,	4.5	Na2ATP	with	pH	at	7.2.	Osmolality	was	around	280	-	283	mOsm.	Voltages	were	corrected	for	a	5	mV	junction	potential.	To	record	evoked	action	potentials,	membrane	potential	was	held	at	-75	mV	by	injecting	sub-threshold	currents	and	cells	were	depolarized	by	a	series	of	current	injections.														Excitatory	and	inhibitory	postsynaptic	currents	(EPSCs	and	IPSCs)	were	separated	at	reversal	potentials	(-49	mV	and	-2	mV)	with	a	gap-free	protocol	under	voltage	clamp.	Recordings	of	spontaneous	PSCs	(sPSCs)	were	performed	with	the	standard	external	solution	and	a	cesium	gluconate	internal	solution	containing	(in	mM):	130	Cs+	gluconate,	
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0.2	EGTA,	2	MgCl2,	6	CsCl,	10	HEPES,	2.5	adenosine	5’	triphosphate	sodium	salt,	0.5	guanosine	5’	triphosphate	sodium	and	10	disodium	phosphocreatine.	Voltages	were	corrected	for	a	7	mV	junction	potential.	Miniature	postsynaptic	currents	(mPSCs)	were	recorded	in	external	solution	containing	1	µM	TTX	(tetrodotoxin;	Alomones	Labs).													Isolated	sodium	currents	were	recorded	with	external	solution	containing	(in	mM):	120	NaCl,	5.4	KCl,	0.8	CoCl2,	15	glucose,	20	HEPES,	2.5	tetraethylammonium	and	1.0	4-aminopyridine.	The	same	cesium	gluconate	internal	solution	for	PSC	recording	was	used	for	sodium	current	recording.	Voltages	were	corrected	for	a	10	mV	junction	potential.	P/N	leak	subtraction	was	turned	on.	The	voltage	dependence	of	activation	was	determined	with	a	step	protocol.	Cell	membrane	potential	was	increased	from	a	holding	potential	of	-100	mV	to	a	range	of	potentials	between	-100	mV	and	30	mV	for	45	s	with	a	step	interval	of	5	or	10	mV.	Currents	recorded	at	the	shared	voltage	steps	were	included	for	current	density	analysis	and	G-V	graph	plotting.	Peak	transient	currents	were	plotted	against	holding	potentials	and	fit	with	the	following	equation:																									I = ($%$&'()×+,-./0123	(%565789:; )			(1)	where	I	is	the	peak	current	amplitude,	V	is	the	holding	potential	of	each	pulse,	Vrev	is	the	reversal	potential,	Gmax	is	the	maximal	conductance,	Vhalf	is	the	voltage	with	50%	channels	activated,	and	k	is	the	slope.	Current	data	in	5	mV	and	10	mV	step	intervals	were	used	for	fitting.	Conductance	was	calculated	with	the	following	equation:																															G = =$%$&'(				(2)	where	G	is	conductance,	and	I,	V,	Vrev	were	as	described	in	equation	(1).	
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												The	voltage	dependence	of	steady-state	inactivation	was	analyzed	with	a	two-step	protocol.	It	began	with	a	holding	potential	of	-100	mV.	Next	the	conditioning	pulse	was	increased	through	a	series	of	voltage	steps	from	-100	mV	to	30	mV	for	90	ms	with	a	step	interval	of	5	or	10	mV.	Currents	recorded	at	the	shared	voltage	steps	were	included	for	G-V	graph	plotting.	A	test	pulse	at	-10	mV	for	90	ms	was	immediately	applied	and	followed	by	a	holding	potential	of	-100	mV.	The	peak	current	amplitude	during	test	pulses	were	normalized	to	that	during	the	first	test	pulse	and	then	plotted	against	the	holding	potential	of	the	conditioning	pulse.	The	I-V	curves	were	fitted	to	the	following	equation:																							I = //0'.>565789:; 				(3)	where	I	is	the	normalized	peak	current	amplitude	during	the	test	pulses,	Vhalf	is	the	voltage	with	50%	channels	inactivated,	and	k	is	the	slope.	Current	data	in	5	mV	and	10	mV	step	intervals	were	used	for	fitting.													The	recovery	from	steady-state	inactivation	was	determined	using	a	second	two-pulse	protocol.	Following	a	holding	potential	of	-100	mV	for	27	ms,	two	test	pulses	at	-10	mV	for	90	ms	were	separated	by	a	time	interval	with	a	range	of	1-10	ms	with	an	increment	of	1	ms	in	the	first	protocol,	and	10-50	ms	with	an	increment	of	5	ms	in	the	subsequent	protocol.	Peak	current	amplitude	from	the	second	pulse	was	normalized	to	the	average	current	amplitude	from	the	first	pulse	to	calculate	the	fractional	recovery.	The	data	of	recovery	were	fitted	using	the	following	equation:																						I = A × exp C− EFG + 𝐵				(4)	where	I	is	the	normalized	current	amplitude,	A	is	the	relative	percentage	of	recovered	currents,	t	is	the	time	interval,	and	τ	is	the	time	constant	of	recovery.	
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												Electrophysiological	data	were	collected	with	a	List	EPC7	amplifier	and	a	Digidata	1320A	D-A	converter	(Axon	Instruments),	or	a	MultiClamp	700B	amplifier	and	a	Digidata	1440A	D-A	converter	(Axon	Instruments).	Recordings	were	obtained	by	pClamp8	or	pClamp10	(Axon	Instruments)	software	with	a	Bessel	filter	at	2	kHz	and	a	low-pass	filter	at	10	kHz.						
4.2.6	Data	Analysis	and	Statistics														Counting	from	fluorescent	micrographs	was	conducted	in	a	blinded	fashion	with	respect	to	cell	line.	For	each	coverslip,	at	least	3	fields	with	evenly	distributed	cells	observed	via	DIC	were	chosen	for	counting.	3	coverslips	each	from	individual	plating	of	an	iPSC	cell	line	were	included	for	counting	the	number	of	cells	expressing	pluripotency	markers.														Electrophysiological	data	were	analyzed	using	Clampfit	10.6	(Molecular	Devices).	Cells	that	were	included	in	electrophysiological	analyses	had	an	amplitude	of	leak	current	smaller	than	50	pA	at	a	holding	potential	of	-75	mV.	Evoked	action	potentials	(APs)	recorded	under	current	clamp	were	included	if	they	had	a	stable	baseline	at	-65	~	-85	mV	with	sub-threshold	current	injection,	a	peak	amplitude	≥	-5	mV	on	the	first	AP	and	≥	-15	mV	in	subsequent	APs	within	the	train.	AP	events	were	excluded	if	the	maximum	firing	frequency	deviated	from	mean	by	more	than	±	2SD.	Rheobase	data	were	excluded	if	the	resting	membrane	potentials	(RMP)	were	more	depolarized	than	-35	mV.	AP	properties	were	examined	in	the	first	AP	at	rheobase	that	first	elicited	AP	firing.	AP	threshold	was	identified	as	the	first	derivative	of	the	membrane	potential	(dV/dt)	5%	or	higher	than	the	peak	rate	of	change.	AP	amplitude	was	defined	as	the	change	of	membrane	potential	from	
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the	threshold	to	the	peak.	AP	amplitude	and	half-width	data	were	not	included	if	the	cell	did	not	fire	evoked	AP.	PSCs	recorded	under	voltage-clamp	were	analyzed	using	Mini	Analysis	6.0.7	(Synaptosoft).	PSCs	were	identified	as	events	with	an	amplitude	≥	5	pA	(2×	RMS	noise	of	2.5	pA)	and	were	then	manually	verified	individually.	Cells	were	excluded	from	sodium	current	analysis	if	their	current	density	in	the	range	of	-10	-	40mV	was	2SD	beyond	the	mean.														Electrophysiological	data	are	presented	with	n	=	number	of	recorded	cells	and	the	number	of	individual	platings	shown	in	parentheses.	All	data	were	analyzed	with	D'Agostino-Pearson	normality	test.	Statistical	tests	were	selected	based	on	the	normality	test	results	and	performed	in	Prism	7.0.2	(GraphPad	Software).	Figures	were	generated	using	DeltaGraph	7.1	(Red	Rock	Software).	
 
4.3. Results 
4.3.1	Two	pairs	of	isogenic	iPSCs	generated	by	CRISPR/Cas9	editing	The	autosomal	dominant	K1270T	SCN1A	mutation	identified	in	a	GEFS+	family	results	in	a	lysine-to-threonine	conversion	in	the	second	transmembrane	segment	of	the	third	homologous	domain	in	the	α	subunit	of	the	human	Nav1.1	protein14	(Figure	IV.1A).	Skin	fibroblasts	were	collected	from	two	male	siblings	(an	unaffected	control	and	a	GEFS+	patient)	and	both	were	reprogrammed	into	iPSC	lines	using	the	nonintegrating	Sendai	virus	(Figure	IV.1B).	To	examine	the	contribution	of	the	K1270T	mutation	to	disease	phenotypes,	two	pairs	of	isogenic	lines	were	included	in	this	study.	In	the	first	pair,	the	GEFS+	K1270T	mutation	(c.4227A>C)	was	knocked	into	the	unaffected	sibling	derived	control	line	using	CRISPR/Cas9.	For	the	second	isogenic	pair,	the	K1270T	mutation	in	the	
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patient	line	was	corrected	(c.4227C>A;	Figure	IV.1C).	The	mutated	control	clone	with	desired	sequence	was	homozygous,	likely	the	result	of	the	short	distance	(9	bp)	between	the	Cas9	cut	site	and	the	K1270T	mutation	locus34.														Sequencing	of	DNAs	from	the	iPSC	lines	in	the	2	isogenic	pairs	confirmed	that	the	control	line	did	not	have	the	mutation	at	site	1270	(SCN1A+/+).	The	mutated	control	was	homozygous	for	the	mutation	(SCN1AKT/KT)	based	on	sequencing	and	this	was	further	confirmed	by	the	presence	of	the	silent	EcoRV	mutation	from	the	repair	template	in	only	one	allele,	demonstrating	that	the	editing	process	did	not	also	result	in	loss	of	one	allele	and	therefore,	a	hemizygous	clone.	The	patient	line	was	confirmed	to	be	heterozygous	for	the	mutation	(SCN1AKT/+)	and	the	mutation	was	absent	in	the	corrected	patient	lines	(SCN1A+/+;	Figure	IV.1D).	Comparison	of	the	heterozygous	patient	lines	with	the	engineered	homozygous	isogenic	mutant	provides	a	unique	opportunity	to	evaluate	gene	dosage-dependent	effects	since	two	copies	of	SCN1A	mutations	are	usually	lethal	to	organisms	in	vivo35,36.														Karyotypes	of	four	iPSC	lines	were	verified	normal	with	46,	XY	chromosomes	(Figure	IV.1E).	Pluripotency	of	each	of	the	4	cell	lines	was	confirmed	by	staining	for	expression	of	OCT-3/4,	SOX2	and	NANOG37	(Figure	IV.1F).	The	top	five	potential	off-target	sites	for	mutations	were	evaluated,	including	SCN7A,	FLII,	SCN2A,	SCN3A	and	SCN9A	(Figure	IV.2A).	There	were	no	off-target	mutations	in	candidate	genes	in	the	corrected	patient	line.	In	the	homozygous	mutated	control	line,	there	was	a	mutation	in	SCN7A,	in	addition	to	the	K1270T	knock-in	mutation.	Since	SCN7A	encodes	a	non-voltage-gated,	TTX-insensitive	Nax	sodium	channel,	it	is	unlikely	to	affect	evaluation	of	sodium	currents	and	firing	properties	that	are	both	completely	eliminated	by	addition	of	TTX	to	the	recording	solution	(Figure	
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IV.2B).	In	addition,	this	gene	is	expressed	in	astrocytes,	and	neurons	in	circumventricular	organs38,39	and	there	is	no	evidence	that	this	gene	is	expressed	in	our	iPSC-derived	neurons	based	on	nested	PCR	reactions	that	resulted	in	clear	amplification	of	SCN1A	transcripts	with	undetectable	levels	of	SCN7A	(Figure	IV.2C).						
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Figure	IV.1.	Isogenic	pairs	of	iPSCs	generated	by	CRISPR/Cas9	editing.	(A)	The	K1270T	mutation	is	located	in	the	second	transmembrane	segment	of	the	third	homologous	domain	of	Nav1.1	alpha	subunit.	(B)	CRISPR/Cas9	editing	was	used	to	generate	two	isogenic	pairs	from	iPSCs	derived	from	two	siblings	in	the	GEFS+	family	(control	and	patient)	followed	by	differentiation	into	functional	neurons.	(C)	Scheme	of	CRISPR/Cas9	editing	design.	Additional	silent	mutation	introduced	by	ssODN1	resulted	in	an	EcoRV	restriction	site	for	clone	screening	when	knocking	in	the	K1270T	mutation.	(D)	Sequencing	of	two	isogenic	iPSC	pairs	confirmed	the	absence	and	the	presence	of	the	mutation.	(E)	All	four	lines	had	normal	karyotypes	(46,	XY).	(F)	iPSCs	of	two	isogenic	pairs	were	stained	with	nuclei	marker	DAPI	and	pluripotency	markers	OCT-3/4,	SOX2	and	NANOG	individually.	The	percentage	of	cells	positive	for	each	of	the	pluripotency	markers.	Scale	bar	represents	50	µm.	Data	represented	as	mean	+	s.e.m.	Data	represent	counts	from	three	fields	in	three	coverslips	from	three	platings	for	each	genotype.			
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Figure	IV.2.	Off-target	analysis	in	the	lines	generated	by	CRISPR/Cas9	editing.	(A)	Sequences	of	the	top	five	predicted	off-target	sites	in	SCN7A,	FLII,	SCN2A,	SCN3A	and	
SCN9A.	Off-target	mutation	was	identified	in	the	SCN7A	gene	of	the	mutated	control	line.	Regions	highlighted	in	blue	are	the	sites	predicted	to	be	modified	by	non-specific	CRISPR/Cas9	editing.	(B)	Isolated	sodium	current	recording	in	the	derived	neurons	of	the	control	line	at	D54	post	plating.	Sodium	currents	were	completely	eliminated	in	the	presence	of	1	µM	TTX.	(C)	Expression	of	SCN1A,	SCN7A	and	the	housekeeping	gene	ACTB	in	the	derived	neurons	of	a	control	line	at	D21	post	plating.	Expected	band	sizes	of	SCN1A,	
SCN7A	and	ACTB	are	220,	283	and	177	bp.	
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4.3.2	iPSC-derived	neuronal	cultures	contain	both	inhibitory	and	excitatory	neurons													We	previously	optimized	a	direct	differentiation	protocol	that	gives	rise	to	neuronal	cultures	containing	excitatory	and	inhibitory	neurons32,33.	With	this	protocol,	iPSCs	from	both	isogenic	pairs	were	differentiated	into	neural	progenitors	followed	by	plating	onto	astroglial	feeder	layers	for	neuronal	differentiation.	To	evaluate	the	morphology	of	neurons	and	quantify	the	proportion	of	inhibitory	GABAergic	and	excitatory	glutamatergic	neurons	in	the	cultures	derived	from	the	four	iPSC	lines,	cultures	were	fixed	at	D21-24	post	plating	and	stained	with	anti-βIII-tubulin	and	anti-GABA	or	anti-CaMKII	antibodies.	Cultures	from	all	lines	stained	βIII-tubulin	positive	cells	with	elongated	branched	neurites	(Figure	
IV.3A).	GABAergic	and	glutamatergic	neurons	comprised	30-40%	and	~50%	of	the	total	neuronal	population	respectively,	with	no	significance	between	genotypes	(Figure	IV.3B).													In	order	to	identify	inhibitory	and	excitatory	neurons	during	live	recording,	cells	were	transiently	transfected	with	GAD1-mCherry	and	CaMKII-eGFP	plasmids	at	D17	post	plating.	Visualization	of	the	cultures	with	fluorescent	illumination	at	D21-24	post	plating	was	used	to	identify	and	record	from	mCherry	expressing	GAD1-positive	inhibitory	neurons	and	eGFP	expressing	CaMKII-positive	excitatory	neurons	(white	arrows,	Figure	
IV.3C).	The	plasmid	labeling	strategy	accurately	identified	GABAergic	and	glutamatergic	neurons	based	on	the	colocalization	of	anti-GABA	staining	in	90.05%	±	3.26%	of	GAD1-mCherry+	and	anti-CaMKII	staining	in	97.15%	±	2.47%	of	CaMKII-eGFP+	neurons	examined.	Further,	SCN1A	was	expressed	in	both	inhibitory	and	excitatory	neurons	based	on	anti-Nav1.1	antibody	staining	in	both	GABAergic	and	glutamatergic	neurons	(Figure	IV.3D).	
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Figure	IV.3.	Cultures	from	two	isogenic	pairs	contain	a	similar	proportion	of	
GABAergic	and	glutamatergic	neurons.	(A)	Representative	micrographs	from	cultures	of	two	isogenic	pairs	of	iPSC-derived	neurons	stained	with	neuronal	subtype	markers	GABA	or	CaMKII	antibodies	to	identify	GABAergic	and	glutamatergic	neurons	at	D21-24	post	plating.	(B)	The	percentage	of	GABAergic	and	glutamatergic	neurons	(white	arrows)	in	neuronal	cultures	at	D21-24	post	plating	in	each	line.	(C)	Identification	of	inhibitory	(top)	and	excitatory	(bottom)	neurons	at	D21-24	post	plating	labeled	with	plasmids	via	transient	transfection	during	live	recording	(white	arrows).	At	least	3	coverslips	of	2-3	individual	platings	were	evaluated	for	each	line.	(D)	Localization	of	Nav1.1	in	GABAergic	and	glutamatergic	neurons	(white	arrows).	Data	represented	as	mean	+	s.e.m.	Ctrl	=	control,	mut	ctrl	=	mutated	control,	corr	pt	=	corrected	patient,	and	pt	=	patient.	Scale	bar	represents	50	µm.		
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4.3.3.	Inhibitory	neurons:	the	K1270T	mutation	reduces	evoked	firing	and	sodium	current	in	
dose-dependent	manner													To	determine	if	the	K1270T	mutation	causes	cell	type-specific	alterations	in	excitability,	evoked	action	potential	recordings	were	obtained	at	D21-D24	post	plating	from	iPSC-derived	inhibitory	neurons	in	cultures	from	two	isogenic	pairs:	1a)	control	(SCN1A+/+),	1b)	mutated	control,	homozygous	(SCN1AKT/KT);	2a)	corrected	patient	(SCN1A+/+),	2b)	patient,	heterozygous	(SCN1AKT/+).	To	account	for	variability	between	platings,	and	within	plating,	data	for	all	electrophysiological	properties	represent	recordings	from	multiple	cells	in	at	least	three	independent	platings,	and	these	values	are	presented	in	each	figure	or	table.														Over	90%	of	inhibitory	neurons	in	each	genotype	fired	action	potentials	(Figure	
IV.4A	and	4D).	Assessment	of	firing	frequency	vs	current	step	curves	in	each	line	demonstrated	that	the	mean	firing	frequency	was	significantly	lower	in	the	homozygous	mutated	control	line	compared	to	the	control	line	(interaction:	p	<	0.0001,	genotype:	p	=	0.0092,	two-way	ANOVA	with	repeated	measures;	Figure	IV.4B).	The	AP	amplitude	was	significantly	smaller	in	the	homozygous	mutated	control	line	compared	to	the	control	(p	=	0.0073,	two-tailed	unpaired	t	test;	Figure	IV.4C).														The	heterozygous	patient	line	compared	to	the	corrected	patient	line	had	decreased	firing	frequency	at	small	current	steps.	However,	at	current	steps	of	50	pA	and	above	the	firing	frequency	of	the	patient	and	the	corrected	patient	line	were	largely	overlapping	and	the	two	curves	were	not	significantly	different	(Figure	IV.4E).	The	AP	amplitude	in	the	heterozygous	patient	line	was	smaller	than	that	in	the	corrected	patient	line,	but	the	difference	was	not	significant	(Figure	IV.4F).	The	reduction	in	firing	frequency	and	AP	
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firing	in	the	heterozygous	patient	line	was	approximately	half	that	seen	in	the	homozygous	mutated	line	compared	to	the	control	line	at	the	low	current	steps	(Figure	IV.4B	and	
IV.4E).	These	data	suggest	that	the	impairment	of	action	potential	firing	in	inhibitory	neurons	is	gene	dose-dependent.	There	were	no	differences	in	AP	rheobase,	the	injected	current	that	first	elicited	AP	firing,	and	half	width	within	and	between	isogenic	pairs	(Table	IV.2).													The	control	and	the	mutated	control	had	similar	input	resistance	(IR),	whole	cell	capacitance	(Cm)	and	rest	membrane	potential	(RMP;	Table	IV.3).	Interestingly	while	the	patient	line	had	comparable	input	resistance	to	the	isogenic	corrected	line,	it	had	a	significantly	smaller	whole	cell	capacitance	and	a	more	depolarized	RMP	(p	=	0.024,	and	<	0.0001	respectively,	Mann-Whitney	U	test	for	Cm	and	unpaired	t	test	for	RMP;	Table	IV.3).														To	examine	whether	reduced	firing	frequency	and	AP	amplitude	is	associated	with	alterations	in	sodium	current,	isolated	sodium	currents	were	recorded	in	inhibitory	neurons	at	D21-24	post	plating.	All	inhibitory	neurons	in	each	genotype	expressed	sodium	currents.	Sodium	currents	were	not	well	space	clamped	at	this	age	in	culture	in	any	of	the	lines	(Figure	IV.4G	and	IV.4I),	consistent	with	the	localization	of	some	sodium	channels	at	sites	electrically	distant	from	the	neuronal	cell	bodies	as	is	typical	of	neurons	that	fire	multiple	APs.	This	is	also	consistent	with	many	other	studies	in	which	iPSC-derived	neurons	that	are	capable	of	firing	a	train	of	APs	do	not	have	well	clamped	sodium	currents20–23,40.	However,	comparative	analysis	of	sodium	current	properties	between	control	and	patient	lines	in	these	studies,	as	in	other	published	studies,	provide	insights	into	the	disease	mechanism.	Therefore,	our	study	focuses	on	comparing	sodium	current	properties	from	a	family	of	traces	within	and	between	isogenic	pairs.	While	the	absolute	
106		
values	may	not	be	reflective	of	the	biophysical	properties	of	sodium	currents	measured	from	single	channels	or	in	expression	systems	where	there	is	good	voltage	control,	they	allow	identification	of	properties	that	are	or	are	not	associated	with	the	mutation	in	the	native	environment.																The	mean	sodium	current	density	versus	voltage	curves,	generated	from	analysis	of	inhibitory	neurons	in	each	line	of	an	isogenic	pair,	were	compared.	In	the	mutated	control	line,	homozygous	for	K1270T,	the	sodium	current	density	was	significantly	reduced	compared	to	the	control	line	(interaction:	p	=	0.016,	genotype:	p	=	0.050,	two-way	ANOVA	with	repeated	measures;	Figure	IV.4G	and	IV.4H).	In	the	patient	line,	heterozygous	for	the	K1270T	mutation,	the	mean	sodium	current	density	versus	voltage	curve	was	smaller	at	each	voltage	than	the	corrected	line	(Figure	IV.4I	and	IV.4J).	While	the	difference	between	the	patient	and	the	corrected	patient	line	was	not	significant,	it	was	about	50%	less	than	that	seen	between	the	homozygous	mutant	and	the	control	line	(Figure	IV.4H	and	IV.4J).	This	suggests	that	the	K1270T	mutation	causes	a	gene	dose-dependent	reduction	in	sodium	current	density,	consistent	with	the	changes	in	firing	frequency	and	AP	amplitude.		
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Figure	IV.4.	In	inhibitory	neurons,	the	K1270T	mutation	causes	impaired	AP	firing	
and	reduced	sodium	current	density.	(A)	Traces	of	action	potential	firing	in	inhibitory	neurons	of	the	first	isogenic	pair	of	the	control	(ctrl)	and	the	homozygous	mutated	control	(mut	ctrl).	(B)	The	input-output	curves	of	action	potentials	in	inhibitory	neurons	of	the	first	isogenic	pair.	(C)	AP	amplitude	of	the	first	AP	at	rheobase	in	inhibitory	neurons	of	the	first	isogenic	pair.	**	denotes	p	<	0.001,	two-tailed	unpaired	t-test.	(D-F)	Same	as	A	and	B,	but	in	inhibitory	neurons	of	the	second	isogenic	pair	of	the	lines	from	the	corrected	patient	(corr	pt)	and	the	heterozygous	patient	(pt).	(G)	Traces	of	voltage-gated	sodium	currents	in	inhibitory	neurons	of	the	first	isogenic	pair.	The	activation	protocol	started	with	a	prepulse	at	-100	mV	followed	by	a	series	of	steps	ranging	from	-100	to	30	mV	in	10	mV	intervals.	(H)	Current-voltage	relationship	in	inhibitory	neurons	of	the	first	isogenic	pair.	Whole	cell	currents	were	normalized	to	capacitance.	(I-J)	Same	as	G	and	H,	but	in	inhibitory	neurons	of	the	second	isogenic	pair.	Data	presented	as	mean	+	s.e.m	in	C	and	F,	and	mean	±	s.e.m	with	total	number	of	neurons	evaluated	and	the	number	of	individual	platings	in	parentheses	for	each	line	in	B,E,H,	and	J.	*	and	#	represent	significant	differences	in	genotypes	and	interaction	within	an	isogenic	pair	respectively,	two-way	ANOVA	and	post	
hoc	Sidak’s	analysis.	One	to	four	symbols	denote	p	values	<	0.05,	0.01,	0.001,	0.0001	respectively.	
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Table	IV.2.	Measurements	of	excitability	in	two	
isogenic	pairs	Cell	type	 Genotype	 Rheobase	(pA)	 AP	half-width	(ms)	
Inhibitory	
Ctrl	 18.8	±	1.7	n	=	13	(3)	 3.6	±	0.2	n	=	16	(3)	Mut	ctrl	 22.5	±	3.8	n	=	16	(5)	 4.8	±	0.6	n	=	19	(5)	Corr	pt	 15.3	±	1.7	n	=	15	(4)	 4.6	±	0.7	n	=	16	(4)	Pt	 23.9	±	3.3	n	=	26	(6)	 6.1	±	0.8	n	=	25	(6)	
Excitatory	
Ctrl	 23.3	±	2.4	n	=	9	(3)	 3.9	±	0.4	n	=	15	(3)	Mut	ctrl	 21.3	±	1.9	n	=	15	(5)	 3.9	±	0.2	n	=	29	(5)	Corr	pt	 17.5	±	1.9	n	=	16	(5)	 4.0	±	0.5	n	=	16	(5)	Pt	 18.7	±	2.4	n	=	32	(8)	 4.2	±	0.2	n	=	33	(8)	a.	Data	reported	as	mean	±	s.e.m	with	total	number	of	neurons	(number	of	individual	platings)	underneath.	b.	Ctrl	=	control,	mut	ctrl	=	mutated	control,	corr	pt	=	corrected	patient,	and	pt	=	patient.	
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Table	IV.3.	Comparison	of	passive	membrane	properties	in	two	isogenic	
pairs	Cell	type	 Genotype	 		IR	(GΩ)	 	 Cm	(pF)	 	 RMP	(mV)		 	
Inhibitory		
Ctrl	 1.6	±	0.1	n	=	16	(3)	 	 27.3	±	2.8	n	=	15	(3)	 	 -43.0	±	2.7	n	=	13	(3)	Mut	ctrl	 1.6	±	0.1	n	=	21	(5)	 	 27.8	±	2.8	n	=	22	(5)	 	 -44.3	±	2.7	n	=	18	(5)	Corr	pt	 1.6	±	0.2	n	=	22	(4)	 	 32.1	±	2.4*	n	=	22	(4)	 	 -57.8	±	1.3****	n	=	17	(2)	Pt	 1.6	±	0.1	n	=	26	(6)	 	 24.9	±	2.3	n	=	26	(6)	 	 -45.8	±	2.3	n	=	13	(2)	
Excitatory		
Ctrl	 1.0 ±	0.1	n	=	16	(3)	 	 30.5	±	2.5	n	=	15	(3)	 	 -47.0	±	0.3	n	=	9	(3)	Mut	ctrl	 1.3	±	0.09*	n	=	30	(5)	 	 32.6	±	2.9	n	=	28	(5)	 	 -44.9	±	2.3	n	=	17	(5)	Corr	pt	 1.3	±	0.09		n	=	24	(5)	 	 31.3	±	1.4	n	=	24	(5)	 	 -51.1	±	2.0	n	=	14	(2)	Pt	 1.5	±	0.09	n	=	48	(8)	 	 36.7	±	1.8	n	=	48	(8)	 	 -49.1	±	2.4	n	=	12	(2)	a.	Data	reported	as	mean	±	s.e.m	with	total	number	of	neurons	and	number	of	individual	platings	in	parentheses.		b.	Ctrl	=	control,	mut	ctrl	=	mutated	control,	corr	pt	=	corrected	patient,	and	pt	=	patient.		c.	Statistically	significant	differences	within	isogenic	pair:	*	p	<	0.05	and	****	p	<	0.0001,	two-tailed	Mann-Whitney	U	test	for	IR	and	Cm	and	unpaired	t-test	for	RMP.		
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												No	differences	were	observed	in	the	voltage-dependence	of	activation,	steady-state	inactivation,	or	recovery	from	inactivation	within	the	isogenic	pairs	(the	mutated	control	line	compared	to	the	control;	the	patient	compared	to	the	corrected	patient	line;	Figure	S2).	However,	comparison	between	the	isogenic	pairs	revealed	a	~4	mV	depolarized	shift	in	voltage	dependence	of	activation	in	the	pair	derived	from	the	control	compared	to	the	pair	derived	from	the	patient	(interaction:	p	<	0.0001,	genotype:	p	=	0.0065,	two-way	ANOVA	with	repeated	measures;	Table	IV.4	and	Figure	IV.5A	and	5B).	There	was	also	a	3	mV	depolarized	shift	in	the	voltage	dependence	of	steady-state	inactivation	in	the	control	vs	the	patient	derived	lines	(interaction:	p	<	0.0001,	genotype:	p	=	0.2847,	two-way	ANOVA	with	repeated	measures;	Table	IV.4	and	Figure	IV.5C	and	5D).	Shifts	between	pairs	are	likely	associated	with	the	genetic	background	of	the	GEFS+	patient	which	would	not	be	found	if	using	unrelated	control	and	patient	cell	lines.	Time	constant	of	recovery	from	inactivation	was	similar	within	isogenic	pairs	(Table	IV.4	and	Figure	IV.5E	and	5F).														Overall	the	differences	within	the	isogenic	pairs	demonstrate	that	the	K1270T	mutation	causes	evoked	firing,	action	potential	amplitude	and	sodium	current	density	recorded	at	the	cell	body	in	a	gene	dose-dependent	manner	in	inhibitory	neurons.	The	alterations	observed	in	voltage	dependence	of	activation	and	steady-state	inactivation	of	sodium	currents	between	isogenic	pairs	suggest	these	changes	are	associated	with	the	genetic	background,	independent	of	the	mutation.						
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Table	IV.4.	Comparison	of	voltage	dependence	of	Nav	in	isogenic	pairs	Cell	type	 Line	 Activation	 	 Inactivation	 	 Recovery	V1/2	(mV)	 k	(mV)	 	 V1/2	(mV)	 k	(mV)	 	 τ	(ms)	
Inhibitory	 Ctrl,	n	=	32	(4)	 -38.2	±	1.4	 1.7	±	0.3	 	 -44.0	±	1.0	 5.5	±	0.2	 	 3.0	±	0.2		Mut	ctrl,	n	=	29	(4)	 -35.1	±	1.4	 2.1	±	0.3	 	 -43.3	±	0.6	 6.3	±	0.3	 	 3.2	±	0.2	Corr	pt,	n	=	27	(5)	 -32.0	±	0.9	 2.2	±	0.3	 	 -41.0	±	0.4	 6.3	±	0.3	 	 2.8	±	0.1	Pt,	n	=24	(4)	 -31.3	±	1.3	 2.5	±	0.4	 	 -41.0	±	0.8	 6.1	±	0.3	 	 2.9	±	0.2	
Excitatory	 Ctrl,	n	=	36	(4)	 -35.4	±	1.1		 1.7	±	0.2	 	 -43.2	±	0.5	 5.7	±	0.1	 	 3.0	±	0.1	Mut	ctrl,	n	=	27	(4)	 -35.3	±	1.3	 2.2	±	0.3	 	 -44.0	±	0.9	 5.8	±	0.2	 	 3.4	±	0.2	Corr	pt,	n	=	26	(5)	 -31.5	±	1.0*	 2.3	±	0.3	 	 -42.5	±	0.7*	 7.2	±	0.5**	 	 2.9	±	0.1	Pt,	n	=	26	(4)	 -34.7	±	1.0	 2.0	±	0.3	 	 -40.5	±	0.4	 5.4	±	0.2	 	 3.1	±	0.1	a.	Data	reported	as	mean	±	s.e.m	with	total	number	of	neurons	and	number	of	individual	platings	in	parentheses	for	each	line.		b.	Ctrl	=	control,	mut	ctrl	=	mutated	control,	corr	pt	=	corrected	patient,	and	pt	=	patient.		c.	Statistically	significant	differences	within	isogenic	pairs:	*	p	<	0.05	and	***	p	<	0.001,	two-tailed	unpaired	t-test	for	activation	and	inactivation	V1/2,	and	Mann-Whitney	U	test	for	inactivation	k.		
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Figure	IV.5.	Properties	of	Nav	in	inhibitory	neurons.	(A-B)	Conductance	vs	voltage	curves	of	activation	in	inhibitory	neurons	of	the	control	vs	the	mutated	control	lines,	and	the	corrected	patient	vs	the	patient	lines	respectively.	(C-D)	Current	vs	voltage	curves	of	steady-state	inactivation	in	inhibitory	neurons	of	isogenic	pairs.	(E-F)	Recovery	of	inactivation	in	both	isogenic	pairs.	Data	presented	as	mean	±	s.e.m	with	total	number	of	neurons	and	number	of	individual	platings	in	parentheses	evaluated	in	each	line.	Two-way	ANOVA	and	post	hoc	Sidak’s	analysis.	
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4.3.4	Excitatory	neurons:	the	K1270T	SCN1A	mutation	reduces	sodium	current	density	but	
does	not	reduce	firing.													Previous	studies	in	iPSC	and	mouse	models	have	suggested	that	SCN1A	mutations	reduce	evoked	firing	and	sodium	currents	specifically	in	inhibitory	neurons21,35,36,41.	However,	some	studies	in	other	SCN1A	mutations	showed	excitability	and	sodium	currents	of	both	excitatory	and	inhibitory	neurons	are	affected	by	SCN1A	mutations22,23,42.	Antibody	staining	demonstrated	that	both	excitatory	and	inhibitory	iPSC-derived	neurons	in	our	cultures	express	Nav1.1	channels.	Therefore,	it	was	important	to	evaluate	evoked	firing	and	sodium	currents	in	iPSC-derived	excitatory	neurons	in	the	same	two	isogenic	pairs	examined	in	the	previous	section	at	D21-24	post	plating.														Over	93%	of	excitatory	neurons	in	each	genotype	fired	action	potentials	with	injection	of	depolarizing	currents	(Figure	IV.6A	and	6D).	The	firing	frequency	versus	injected	current	curves	demonstrated	the	firing	frequency	in	the	homozygous	mutated	control	was	not	different	from	the	control	(Figure	IV.6B).	Interestingly,	the	heterozygous	patient	line	had	a	higher	firing	frequency	at	current	injections	over	30	pA	(interaction:	p	=	0.0042,	genotype:	p	=	0.041,	two-way	ANOVA	with	repeated	measures;	Figure	IV.6E).	Since	increased	firing	frequency	in	excitatory	neurons	was	only	identified	by	comparing	the	two	lines	in	the	second	isogenic	pair	and	it	was	not	observed	in	the	first	pair,	it	suggested	that	alteration	in	this	property	is	associated	with	the	interaction	between	the	mutation	and	the	patient	genetic	background	which	would	not	be	found	without	using	the	dual	isogenic	pairs.	There	was	no	significant	difference	in	the	AP	amplitude,	rheobase	and	AP	half-width	within	or	between	the	isogenic	pairs	(Figure	IV.5C,	IV.5F	and	Table	IV.2).		
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												The	input	resistance	in	the	mutated	control	was	slightly	higher	than	that	of	the	control	(p	=	0.025,	two-tailed	Mann-Whitney	U	test;	Table	IV.3).	However,	there	was	no	difference	in	the	input	resistance	between	the	patient	vs	the	corrected	patient	line	(Table	
IV.3).	The	whole	cell	capacitance	and	RMP	were	similar	within	the	isogenic	pairs	(Table	
IV.3).													Based	on	the	lack	of	decrease	in	firing	in	excitatory	neurons,	and	the	increase	in	firing	in	the	patient	line,	it	seemed	likely	there	would	be	no	decrease	in	sodium	current	density	in	the	mutated	control	and	possibly	an	increase	in	the	patient	line.	To	evaluate	this,	isolated	sodium	currents	were	recorded	at	D21-24	post	plating	and	like	inhibitory	neurons,	all	excitatory	cells	expressed	sodium	currents	that	were	not	well	clamped	(Figure	IV.5G	
and	IV.5I).	Unexpectedly	the	current	density	vs	voltage	curve	demonstrated	a	significant	reduction	in	sodium	current	density	recorded	in	the	cell	body	in	the	homozygous	mutated	control	line	compared	to	the	control	line	(interaction:	p	<	0.0001,	genotype:	p	=	0.0025,	two-way	ANOVA	with	repeated	measures;	Figure	IV.5H).	The	sodium	current	density	in	the	heterozygous	patient	line	was	also	smaller	compared	to	the	corrected	patient	line,	but	the	differences	was	not	significant	(interaction:	p	<	0.0001,	genotype:	p	=	0.056,	two-way	ANOVA	with	repeated	measures;	Figure	IV.5J).	The	reduction	of	sodium	current	density	in	the	heterozygous	patient	line	was	half	the	magnitude	seen	in	the	homozygous	mutated	control	line	(Figure	IV.5H	and	5J).	This	is	similar	to	the	dose-dependent	reduction	in	sodium	current	seen	in	inhibitory	neurons.														Since	there	was	no	concomitant	reduction	in	firing	frequency	in	the	excitatory	neurons	in	the	homozygous	mutant	line,	this	suggests	that	the	properties	of	other	channels,	for	example	potassium	channels,	in	excitatory	neurons	are	more	influential	in	determining	
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the	firing	phenotype.	However,	this	does	not	address	how	a	decrease	in	sodium	current	in	the	patient	line	is	consistent	with	a	small	but	significant	increase	in	excitatory	neuron	firing	frequency.	Comparison	of	other	sodium	current	properties	revealed	two	additional	changes	in	the	heterozygous	patient	line	that	were	not	seen	in	any	of	the	other	three	lines.	There	was	a	hyperpolarized	shift	in	the	voltage-dependence	of	activation	and	a	depolarized	shift	in	steady-state	inactivation	in	the	heterozygous	patient	compared	to	the	corrected	patient	line	(p	=	0.028	and	0.015	respectively,	two-tailed	unpaired	t	test;	Table	IV.4	and	
Figure	IV.7B	and	IV.7D).	These	alterations	are	both	likely	to	lead	to	increased	channel	opening	probability	over	a	larger	voltage	range	that	would	result	in	an	increased	evoked	firing	rate	only	in	this	line	(Figure	IV.6F).	The	differences	in	activation	and	steady-state	inactivation	in	only	one	of	the	four	lines	indicate	this	results	from	an	interaction	between	the	K1270T	mutation	and	the	patient	genetic	background.														Taken	together,	similar	to	the	inhibitory	neurons,	the	K1270T	mutation	causes	reduced	sodium	current	density	in	excitatory	neurons	in	a	dose-dependent	manner.	However,	the	decreased	sodium	current	density	caused	by	the	mutation	in	excitatory	neurons	is	not	sufficient	to	reduce	the	evoked	firing	or	AP	waveforms	in	the	mutated	control	line.	Further,	interactions	between	the	mutation	and	the	patient	background	appear	to	alter	other	properties	of	the	sodium	channel	that	increase	firing	in	excitatory	neurons	of	the	patient	line	which	may	contribute	to	increased	network	activity.						
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Figure	IV.6.	In	excitatory	neurons,	the	K1270T	mutation	affects	AP	firing	and	
decreases	sodium	current	density.	(A)	Traces	of	action	potential	firing	in	excitatory	neurons	of	the	first	isogenic	pair	of	the	control	(ctrl)	and	the	homozygous	mutated	control	(mut	ctrl).	(B)	The	input-output	curves	of	action	potentials	in	excitatory	neurons	of	the	first	isogenic	pair.	(C)	AP	amplitude	of	the	first	AP	at	rheobase	in	excitatory	neurons	of	the	first	isogenic	pair.	(D-F)	Same	as	A	and	B,	but	in	excitatory	neurons	of	the	second	isogenic	pair	of	the	lines	of	corrected	patient	(corr	pt)	and	the	heterozygous	patient	(pt).	(G)	Traces	of	voltage-gated	sodium	currents	in	excitatory	neurons	of	the	first	isogenic	pair.	The	activation	protocol	started	with	a	prepulse	at	-100	mV	followed	by	a	series	of	steps	ranging	from	-100	to	30	mV	with	a	10	mV	interval.	(H)	Current-voltage	relationship	in	excitatory	neurons	of	the	first	isogenic	pair.	Whole	cell	currents	were	normalized	to	capacitance.	(I-J)	Same	as	G	and	H,	but	in	excitatory	neurons	of	the	second	isogenic	pair.	Data	presented	as	mean	+	s.e.m	in	C	and	F,	and	mean	±	s.e.m	with	total	number	of	neurons	evaluated	and	the	number	of	individual	platings	in	parentheses	for	each	line	in	B,E,H,	and	J.	*	and	#	represent	significant	differences	in	genotypes	and	interaction	within	an	isogenic	pair	respectively,	two-way	ANOVA	and	post	hoc	Sidak’s	analysis.	One	to	four	symbols	denote	p	values	<	0.05,	0.01,	0.001,	0.0001	respectively.	
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Figure	IV.7.	Properties	of	Nav	in	excitatory	neurons.	(A-B)	Conductance	vs	voltage	curves	of	activation	in	excitatory	neurons	of	the	control	vs	the	mutated	control	lines,	and	the	corrected	patient	vs	the	patient	lines	respectively.	(C-D)	Current	vs	voltage	curves	of	steady-state	inactivation	in	excitatory	neurons	of	isogenic	pairs.	(E-F)	Recovery	of	inactivation	in	both	isogenic	pairs.	Data	presented	as	mean	±	s.e.m	with	total	number	of	neurons	and	number	of	individual	platings	in	parentheses.	*	and	#	represent	significant	differences	in	genotypes	and	interaction	within	an	isogenic	pair	respectively,	two-way	ANOVA	and	post	hoc	Sidak’s	analysis.	One	and	four	symbols	denote	p	values	<	0.05,	and	0.0001	respectively.		
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4.3.5.	The	K1270T	mutation	results	in	a	hyperexcitable	network.													A	previous	study	from	our	laboratory	found	that	the	large	majority	of	neurons	in	iPSC-derived	cultures	receive	spontaneous	glutamatergic	and	GABAergic	synaptic	input	at	D21-24	post	plating32.	To	determine	if	the	K1270T	mutation,	that	specifically	reduces	firing	of	inhibitory	neurons	or	increases	firing	of	excitatory	neurons	in	the	patient	line,	causes	an	increase	in	excitability	of	the	neuronal	network,	spontaneous	excitatory	and	inhibitory	post-synaptic	currents	(sEPSCs	and	sIPSCs)	were	recorded	from	excitatory	neurons	in	each	genotype.														All	neurons	that	received	both	sEPSCs	and	sIPSCs	were	included	for	analysis.	Recordings	were	obtained	at	two	different	holding	potentials,	-2	mV	and	-49	mV	in	each	neuron	corresponding	to	the	reversal	potential	for	EPSCs	and	IPSCs,	respectively	(Figure	
IV.8A	and	8D).	To	determine	whether	there	was	any	change	in	the	balance	of	excitation	vs	inhibition,	an	index,	(E-I)/(E+I)	was	used,	where	E	and	I	represented	amplitude	or	charge	transfer	of	sEPSC	and	sIPSC	respectively	in	excitatory	neurons.	This	symmetric	index	ensures	that	E	and	I	have	the	same	scale,	in	contrast	to	an	E/I	ratio	where	the	range	is	asymmetrical.	An	increase	in	the	(E-I)/(E+I)	index	indicates	an	increase	in	excitatory	drive	or	a	decrease	in	inhibitory	drive,	and	vice	versa.														The	(E-I)/(E+I)	index	based	both	on	synaptic	current	amplitude	and	charge	transfer,	was	significantly	larger	(p	=	0.0002	and	0.0464	respectively,	two-tailed	Mann-Whitney	U	test)	in	the	homozygous	mutated	control	line	compared	to	the	control	and	these	differences	were	significant	(p	=	0.0002	and	0.0464	respectively,	two-tailed	Mann-Whitney	test;	Figure	IV.8B	and	8C).	There	was	a	similar	trend	of	larger	(E-I)/(E+I)	index	in	the	heterozygous	patient	line	compared	to	the	corrected	patient	line	but	these	differences	were	
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not	significant	(Figure	IV.8E	and	8F).	This	indicates	the	mutation	results	in	a	dose-dependent	increase	of	excitability	in	the	neural	networks	formed	in	these	cultures,	consistent	with	the	effects	of	mutation	on	sodium	currents	and	evoked	firing	in	inhibitory	neurons.	It	also	suggests	that	the	increased	firing	frequency	in	the	excitatory	neurons	in	the	patient	line	does	not	significantly	affect	network	activity.	To	test	whether	the	increased	excitatory	drive	in	the	network	was	also	influenced	by	alterations	in	synaptic	vesicle	release,	miniature	excitatory	and	inhibitory	PSCs	(mEPSCs	and	mIPSCs)	were	recorded	in	excitatory	neurons	in	the	presence	of	1	µM	tetrodotoxin	to	block	action	potentials.	The	frequency,	amplitude,	and	charge	transfer	of	mEPSCs	were	similar	between	genotypes	with	the	same	genetic	background	(Figure	IV.9A-C).	There	were	also	no	changes	in	the	mIPSCs	(Figure	IV.9D-F).	This	suggests	that	the	K1270T	mutation	does	not	affect	the	synaptic	vesicle	release.			Together	these	data	indicate	that	the	K1270T	mutation	results	in	a	dosage-dependent	imbalance	in	excitation	and	inhibition	that	leads	to	hyperactivity	in	the	neural	network.		
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Figure	IV.8.	The	K1270T	mutation	gives	rise	to	a	hyperactive	neural	network.	(A)	Spontaneous	excitatory	and	inhibitory	post-synaptic	currents	received	by	excitatory	neurons	in	the	first	isogenic	pair	of	the	control	(ctrl)	and	the	mutated	control	(mut	ctrl)	line.	(B)	The	ratio	of	spontaneous	(E-I)/(E+I)	amplitude	in	excitatory	neurons	of	the	first	isogenic	pair.	(C)	The	ratio	of	spontaneous	(E-I)/(E+I)	of	charge	transfer	in	excitatory	neurons	of	the	first	isogenic	pair.	(D-F)	Same	as	A-C,	but	in	excitatory	neurons	of	the	second	isogenic	pair	of	the	corrected	patient	(corr	pt)	and	the	patient	(pt)	lines.	Data	reported	as	mean	±	s.e.m.	The	total	number	of	neurons	and	number	of	platings	in	parentheses	for	all	four	lines	are	29	(7),	17	(4),	13	(3),	and	18	(3)	respectively.	*p	<	0.05	and	***p	<	0.0001,	two-tailed	Mann-Whitney	U	test.		
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Figure	IV.9.	Miniature	EPSCs	and	IPSCs	received	by	excitatory	neurons	were	
unaltered	by	the	K1270T	mutation.	(A-C)	The	frequency,	amplitude	and	charge	transfer	of	mEPSCs	in	the	control	(ctrl)	vs	the	mutated	control	(mut	ctrl),	and	the	corrected	patient	(corr	pt)	vs	the	patient	(pt)	lines.	(D-F)	Same	as	A-C,	but	for	mIPSCs.	Data	reported	as	mean	+	s.e.m.	The	total	number	of	neurons	and	number	of	individual	platings	in	parentheses	for	all	four	lines	are	ctrl:	9	(5),	mut	ctrl:	7	(3),	corr	pt:10	(4),	and	pt:10	(3).	
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4.4. Discussion 
4.4.1	Advantages	of	dual	isogenic	pair	approach													Previous	studies	have	used	pairs	of	isogenic	human	iPSCs	to	explore	relationship	between	gene	mutations	and	phenotypes29,43,44.	To	our	knowledge,	ours	is	the	first	study	to	use	two	pairs	of	isogenic	iPSCs	(control	sibling	vs	mutated	control,	and	corrected	patient	vs	patient	sibling)	to	examine	the	direct	relationship,	independent	of	genetic	background,	between	a	single	ion	channel	mutation	and	cellular	mechanisms	of	genetic	epilepsy.	This	approach	is	an	efficient	strategy	to	evaluate	the	causality	of	single	gene	mutations	that	require	analysis	at	the	single	cell	level	to	understand	cellular	mechanisms	as	is	the	case	for	the	many	different	ion	channel	mutations	linked	to	epilepsy.														Mutations	that	are	not	only	necessary	but	sufficient	to	cause	the	functional	change	are	identified	as	alterations	that	occur	in	both	mutant	lines,	the	patient	line	that	carries	the	endogenous	mutation	and	the	mutated	control	line	where	K1270T	was	introduced	by	CRISPR,	and	not	in	the	control	or	corrected	patient	lines	that	both	lack	the	mutation	but	the	corrected	line	has	been	subjected	to	CRISPR.	In	addition,	since	the	patient	line	is	heterozygous	and	the	control	mutated	line	is	homozygous,	this	allows	examination	of	the	dose	dependence	on	expression	of	specific	properties.	In	the	present	study,	decreases	in	firing	frequency,	AP	amplitude,	and	sodium	current	density	in	inhibitory	neurons,	and	reduction	of	sodium	current	density	and	increases	in	the	(E-I)/(E+I)	index	of	PSC	amplitude	and	charge	transfer	in	excitatory	neurons	in	both	mutant	lines	and	not	in	either	control	lines,	with	the	magnitude	of	effect	all	correlated	with	zygosity	demonstrate	they	result	from	a	dose-dependent	effect	of	the	K1270T	mutation,	independent	of	genetic	background	(Table	IV.5).	This	comparative	strategy	also	allows	for	identification	of	
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alterations	due	to	the	genetic	background	based	on	changes	that	are	found	in	both	lines	of	one	isogenic	pair	but	not	in	the	other	isogenic	pair29,	as	is	seen	in	the	voltage	dependence	of	Nav	activation	and	inactivation	in	inhibitory	neurons	of	the	patient-derived	pair	only	(Table	IV.5).	Further,	a	change	in	one	mutant	line	that	is	not	seen	in	the	other	mutant	line	or	the	controls,	identifies	alterations	associated	with	an	interaction	between	the	mutation	and	the	genetic	background,	as	is	observed	in	the	voltage	dependence	of	Nav	activation	and	inactivation	and	increased	firing	frequency	in	excitatory	neurons	of	the	patient	line	(Table	
IV.5).														The	GEFS+	patient	from	whom	we	collected	skin	fibroblast	had	prolonged	febrile	seizures	and	generalized	afebrile	absence	seizures	that	are	more	severe	than	other	members	with	the	same	SCN1A	mutation	in	the	pedigree14.	It	is	likely	that	genetic	background-dependent	functional	alterations	that	were	observed	in	the	patient	line	in	the	current	study	contribute	to	the	differences	in	seizure	phenotypes	between	patients	in	the	GEFS+	family.	It	will	be	interesting	to	compare	the	genetic	background	of	this	individual	to	other	GEFS+	family	members	to	identify	specific	genetic	modifiers	that	exacerbate	or	ameliorate	the	cellular	defects.	For	instance,	a	missense	mutation	in	SCN9A	that	encodes	Nav1.7	has	been	identified	in	other	SCN1A-associated	epilepsy	patients45.	To	identify	genetic	modifiers	that	are	altered	in	the	SCN1A	GEFS+	mutants,	single	cell	RNA	sequencing	or	exome	sequencing	will	be	useful	for	screening	candidates	in	a	high-throughput	manner46,47.	Transcriptomic	analysis	in	multiple	iPSC	lines	generated	from	different	individuals	reveals	genetic	background	variation	accounts	for	differences	between	lines48,49.	Therefore,	it	will	be	interesting	to	generate	additional	cell	lines	and	multiple	clones	from	each	line	via	
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genome	editing	to	robustly	interrogate	the	interaction	between	the	mutation	and	genetic	background	in	determining	cellular	phenotypes.		
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Table	IV.5.	Origins	of	effects	Origin	 Mutation	independent	of	background	 	 Genetic	background	 	 Interaction	between	mutation	and	background	Cell	types	 In	 	 Ex	 	 In	 	 Ex	Property	 AP	freq	 AP	amp	 INa+	 	 INa+	 E/I		(amp)	 E/I	(Q)	 	 Nav	act	 Nav	inact	 	 AP	freq	 Nav	act	 Nav	inact	Ctrl	 	-	 -	 -	 	 -	 -	 -	 	 -	 -	 	 -	 -	 -	
Mut	Ctrl	(SCN1AKT/KT)	 ↓↓	 ↓↓	 ↓↓	 	 ↓↓	 ↑↑	 ↑↑	 	 -	 -	 	 -	 -	 -	
Corr	pt	 -	 -	 -	 	 -	 -	 -	 	 ↓	 ↓	 	 -	 -	 -	
Pt	(SCN1AKT/+)	 ↓	 ↓	 ↓	 	 ↓	 ↑	 ↑	 	 ↓	 ↓	 	 ↑	 ↓	 ↑	a.	Ctrl	=	control,	mut	ctrl	=	mutated	control,	corr	pt	=	corrected	patient,	and	pt	=	patient.		b.	In	=	inhibitory	neurons,	ex	=	excitatory	neurons.	c.	Amp	=	amplitude	of	synaptic	currents,	Q	=	charge	transfer	of	synaptic	currents.	d.	Nav	act	=	voltage	dependence	of	activation	of	Nav,	Nav	inact	=	voltage	dependence	of	steady-state	inactivation	of	Nav	e.	Number	of	arrows	represent	dosage	dependent	effects.	In	properties	related	to	voltage,	↑	and	↓	represent	more	depolarized	and	hyperpolarized	respectively.							
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4.4.2	Alterations	in	excitability	and	sodium	current	density	in	inhibitory	neurons													Our	results	demonstrate	that	in	inhibitory	neurons,	the	K1270T	SCN1A	mutation	causes	dosage-dependent	decrease	in	evoked	firing	frequency	and	AP	amplitude.	The	reduced	excitability	and	sodium	currents	in	inhibitory	neurons	is	consistent	with	a	number	of	studies	in	mouse	and	iPSC	model	systems21,35,36.	In	particular,	previous	studies	have	shown	impaired	excitability	in	two	subtypes	of	GABAergic	neurons,	parvalbumin	(PV)-	and	somatostatin	(SST)-expressing	interneurons	in	mouse	models	of	SCN1A	epilepsy50,51.	Selective	deletion	of	Scn1a	in	PV	and	SST	interneurons	causes	hyperactivity	in	neural	networks	and	seizure	behaviors,	suggesting	the	importance	of	Nav1.1	in	regulating	inhibitory	neuron	activity	and	the	E/I	balance52–54.	Our	preliminary	data	reveal	that	GABAergic	neurons	in	our	cultures	can	be	divided	into	at	least	two	groups	staining	iPSC-derived	neurons	with	anti-βIII-tubulin	and	PV	or	SST	antibodies	(data	not	shown).	However,	we	did	not	observe	fast	spiking,	bursting	or	adapting	firing	patterns	characteristic	of	PV	and	SST	interneurons	in	recorded	GAD1-mCherry+	neurons.	This	suggests	that	functional	maturation	of	interneuron	subtypes	require	a	longer	time	in	culture.	Future	studies	will	be	directed	to	determine	the	effect	of	SCN1A	mutation	in	the	electrophysiological	properties	of	identified	PV	and	SST	interneurons.													iPSC-derived	inhibitory	neurons	in	the	present	study	had	large	sodium	currents,	but	they	were	not	well	space	clamped.	This	is	typical	in	neurons	that	are	capable	of	firing	multiple	APs20–23,40.	While	evaluation	of	sodium	currents	that	are	not	well	space	clamped	does	not	resolve	absolute	biophysical	properties,	comparisons	of	sodium	current	properties	within	and	between	isogenic	pairs	are	still	informative	in	identifying	alterations	caused	by	the	mutation.	For	example,	pair	wise	comparisons	demonstrate	that	the	K1270T	
129		
mutation	causes	a	decrease	in	sodium	current	density,	independent	of	genetic	background,	in	inhibitory	neurons.	Further	studies	will	be	necessary	to	determine	if	the	reduction	in	sodium	current	density	recorded	at	the	cell	bodies	is	due	to	a	decrease	in	total	number	of	sodium	channels	expressed	or	a	change	in	localization	of	channels	as	channels	distant	from	the	cell	soma	might	reduce	their	contribution	to	the	recorded	currents.	This	could	be	addressed	by	immune-electron	microscopy	to	evaluate	voltage-gated	sodium	channel	localization	in	neurons	from	the	different	genotypes.														The	dosage-dependent	effect	of	the	K1270T	mutation	is	similar	to	the	observations	of	sodium	currents	and	evoked	firing	rate	of	bipolar	cells	that	were	selectively	affected	in	the	mouse	model	of	Dravet	Syndrome	with	partial	deletion	of	Scn1a36.	In	another	mouse	model	with	GEFS+	SCN1A	R1648H	mutation,	although	dosage-dependent	cellular	effects	were	not	observed,	the	homozygous	mice	had	a	higher	susceptibility	to	seizures	than	the	heterozygous	mice	in	comparison	to	the	wild	types35.	Therefore,	our	study	is	consistent	with	the	findings	in	vivo	and	predicts	a	functional	outcome	of	the	K1270T	mutation	on	the	seizure	generation	in	animal	models.		
4.4.3	Alterations	in	excitability	and	sodium	current	density	in	excitatory	neurons													Previous	studies	have	reported	mutation	of	SCN1A	has	little	effect	on	sodium	currents	in	excitatory	neurons21,35,36.	In	contrast	we	report	that	the	K1270T	mutation	results	in	a	similar	dose-dependent	decrease	in	sodium	current	density	in	excitatory	and	inhibitory	neurons.	This	is	consistent	with	Nav1.1	staining	not	only	in	GABAergic	neurons	but	in	our	CaMKII-eGFP+	neurons.	While	previous	studies	suggest	that	Nav1.1	is	strongly	
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expressed	in	inhibitory	neurons55,	other	studies	report	that	Nav1.1	is	present	in	a	subset	of	excitatory	neurons53,56.				Interestingly,	the	decrease	in	sodium	current	density	does	not	result	in	reduced	firing	in	the	excitatory	neurons	as	it	does	in	inhibitory	neurons.	This	indicates	that	the	changes	in	the	sodium	current	density	were	not	sufficient	to	reduce	excitability	in	this	cell	type.	This	could	be	due	to	compensation	from	potassium	currents,	as	a	voltage-gated	potassium	channel	Kv8.2	has	been	shown	to	function	as	a	genetic	modifier	increasing	the	susceptibility	of	an	Scn2a	mutant	mouse	to	epilepsy57,58.	Altered	currents	of	Kv1	and	Kv4	are	associated	with	increased	excitability	in	a	subset	of	pyramidal	neurons	in	a	mouse	model	of	fragile	X	syndrome59.	CACNB4	and	CACNA1A	that	encode	Cav	have	also	been	identified	as	genetic	modifiers	that	result	in	a	gain	of	function	in	families	with	SCN1A	Dravet	syndrome60,61.													Further,	the	AP	firing	frequency	is	actually	increased	in	the	excitatory	neurons	in	the	patient	line	resulting	from	an	interaction	between	the	mutation	and	the	patient	genetic	background.	This	is	consistent	with	changes	in	the	voltage-dependence	of	sodium	current	activation	and	inactivation	only	in	the	patient	excitatory	neurons.	These	changes	predict	that	the	channel	is	open	over	a	wider	voltage	range	and	is	thus	consistent	with	the	increase	in	AP	firing	seen	in	patient	excitatory	neurons.	To	explore	the	biophysical	changes	in	finer	detail	it	would	be	possible	to	lower	the	external	sodium	concentration	to	reduce	the	size	of	the	sodium	currents	and	increase	potential	for	good	voltage	control62.	One	could	also	examine	the	biophysical	properties	of	single	sodium	channels	in	excised	or	cell	attached	patches	from	the	cell	body63,64.	Both	of	these	would	provide	additional	insight,	but	they	also	have	the	limitation	of	restricting	analysis	to	a	small	population	of	channels	in	a	restricted	
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location	(on	or	near	cell	body)	that	may	not	represent	the	full	population	of	channels	that	define	the	firing	properties	of	the	neurons.			
	
4.4.4	Hyperactive	neural	network													Our	previous	study	demonstrates	that	iPSC-derived	neurons	form	functionally	active	neural	networks	that	contain	GABAergic	and	glutamatergic	synaptic	connections32,	allowing	us	to	evaluate	the	effect	the	K1270T	mutation	on	the	network	activity	of	the	neuronal	cultures.	Our	results	reveal	a	gene	dosage-dependent	increase	in	excitatory	drive	relative	to	inhibitory	drive	in	excitatory	neurons,	consist	with	decreased	evoked	firing	in	inhibitory	neurons	and/or	increased	evoked	firing	in	excitatory	neurons.	These	alterations	in	synaptic	activity	were	identified	only	in	the	mutant	lines,	suggesting	they	are	caused	by	the	K1270T	mutation,	independent	of	the	genetic	background.	It	also	indicates	that	the	increased	firing	frequency	in	the	excitatory	neurons	in	the	patient	line	due	to	the	interaction	between	the	mutation	and	the	genetic	background	does	not	significantly	affect	network	activity.													Hyperexcitable	neural	networks	are	implicated	in	epileptic	disorders65.	Therefore,	our	iPSC-derived	neuronal	cultures	provide	insights	into	the	underlying	mechanism	of	how	an	epilepsy-associated	SCN1A	mutation	gives	rise	to	increased	probability	of	seizures	in	patients.	To	understand	the	effect	of	the	mutation	on	the	spontaneous	network	activity	and	network	synchrony	more	broadly,	our	future	studies	will	use	multi-electrode	arrays	that	allow	for	mechanistic	study	and	anti-epileptic	drug	screening	in	a	high-throughput	manner66.		
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4.4.5	Developmental	maturation				Using	our	neuronal	differentiation	protocol	that	includes	plating	iPSC-derived	neural	progenitors	onto	astroglial	feeder	layers,	the	large	majority	of	neurons	fire	multiple	action	potentials32,33.	The	derived	neurons	not	only	have	sodium	currents	larger	than	1	nA	in	average	and	fire	multiple	action	potentials	at	7-8	Hz	comparable	to	other	iPSC	studies21,23,	but	they	also	receive	glutamatergic	and	GABAergic	synaptic	input	within	3	weeks	of	plating.	However,	their	electrophysiological	properties	are	less	mature	than	neurons	expected	in	an	adult	brain,	based	on	lower	firing	frequency,	larger	input	resistance,	and	depolarized	RMP.	Single-cell	transcriptome	analysis	reveals	development	of	interneurons	at	D54	in	vitro	recapitulates	those	in	human	fetal	cortex	at	100	dpc67.	While	we	cannot	rule	out	the	possibility	that	the	K1270T	mutation	causes	a	developmental	delay	in	neuronal	development	in	culture,	it	seems	unlikely	to	explain	our	results	of	reduced	firing	frequency	and	action	potential	AP	in	inhibitory	neurons	associated	with	the	mutation	because	1)	there	was	no	consistent	change	in	RMP	or	input	resistance	and	2)	the	excitatory	neurons	of	the	mutated	control	and	the	patient	lines	were	able	to	fire	APs	in	similar	or	higher	frequency	compared	to	their	controls.	However	future	studies	could	evaluate	effects	of	the	mutation	on	further	maturation	in	long-term	cultures.		
4.4.6	Off-target	mutation													Sequences	of	the	top	five	off-target	sites	from	CRISPR/Cas9	editing,	including	SCN7A,	
FLII,	SCN2A,	SCN3A	and	SCN9A	were	examined.	The	corrected	patient	line	did	not	have	off-target	mutations	in	the	candidate	genes	(Figure	IV.2A).	While	the	mutated	control	line	did	not	have	off-target	mutations	in	the	other	genes,	it	harbored	one	in	SCN7A.	It	is	very	
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unlikely	that	this	mutation	affected	the	results	reported	based	on	the	following	considerations.	First,	SCN7A	encodes	the	Nax	sodium	channel	in	heart,	uterus,	skeletal	muscle,	and	peripheral	nervous	system	and	RT-PCR	analysis	demonstrated	that	it	is	not	expressed	in	our	iPSC-derived	neurons.	Secondly,	the	channel	is	insensitive	to	changes	in	membrane	potential	and	TTX,	a	voltage-gated	sodium	channel	blocker68.	Isolated	sodium	currents	in	iPSC-derived	neurons	at	D21-24	post	plating	were	completely	eliminated	in	the	presence	of	1	µM	TTX	(Figure	IV.4B).	Third,	while	it	is	possible	that	the	off-target	mutation	in	SCN7A	could	trigger	homeostatic	regulation	by	up-	or	down-regulating	SCN1A	expression,	this	is	unlikely	as	the	alterations	in	sodium	currents/evoked	firing	in	the	homozygous	mutated	control	line	were	in	the	same	direction	and	twice	as	large	as	the	heterozygous	patient	line	that	did	not	undergo	editing	process.		
4.4.7	Comparison	with	the	previous	knock-in	fly	model													The	reduced	excitability	observed	specifically	in	iPSC-derived	inhibitory	neurons	is	consistent	with	the	decreased	excitability	specifically	in	inhibitory	neurons	in	the	brains	of	K1270T	GEFS+	knock-in	Drosophila69.		Since	both	flies	and	patients	exhibit	heat-induced	seizures,	this	provides	additional	support	to	the	hypothesis	that	reduced	firing	specifically	in	inhibitory	neurons	is	critical	to	the	disease	phenotype	in	humans.	However,	the	cellular	defect	associated	with	reduced	excitability	is	distinct	between	the	models	demonstrating	two	independent	mechanisms	that	result	in	a	similar	phenotype.	In	the	iPSC-derived	neurons	there	is	a	significant	decrease	in	the	amplitude	of	the	transient	currents	that	are	the	dominant	form	of	sodium	current	in	these	neurons.	In	flies	the	reduced	firing	is	associated	with	a	hyperpolarized	shift	in	the	deactivation	threshold	of	the	large	persistent	
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sodium	currents	characteristic	of	inhibitory	neurons	in	the	adult	fly	brain.	It	is	possible	that	modifying	the	persistent	currents	in	iPSCs	by	shifting	their	voltage	dependence	could	moderate	the	deficits	associated	with	a	reduced	transient	sodium	current.														In	addition,	an	increase	in	excitability	was	observed	in	excitatory	neurons	of	the	patient	line,	consistent	with	the	higher	firing	rate	in	excitatory	neurons	in	the	GEFS+	flies16.	The	alterations	in	fly	are	seen	predominantly	at	high	temperature,	so	it	is	possible	that	elevated	temperatures	will	reveal	additional	or	more	severe	alterations	in	sodium	currents	in	iPSC-derived	neurons,	as	the	patient	sibling	from	whom	the	skin	fibroblast	was	collected	showed	more	severe	seizure	phenotypes	of	febrile	seizures	compared	to	afebrile	seizures14.		
4.4.8	Summary	Overall	the	CRISPR/Cas9-based	disease	modeling	strategy	with	iPSC-derived	neurons	can	validate	clinically	relevant	phenotypes	and	reveal	the	sufficiency	and	necessity	of	
SCN1A	mutations	for	specific	phenotypes	in	the	human	genetic	background.	Furthermore,	a	library	of	patient	iPSCs	with	a	variety	of	SCN1A	mutations	built	using	this	approach,	in	combination	with	a	high-throughput	drug	screening	method	such	as	multi-electrode	array	(MEA),	will	facilitate	the	development	of	personalized	anti-epileptic	medicine70–72.		
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5.1	Summary	
												A	myriad	of	SCN1A	mutations	are	associated	with	epilepsies.	However,	how	specific	mutations	give	rise	to	seizures	in	epilepsy	patients	remains	elusive.	To	detect	mutation-associated	alterations	in	electrophysiological	properties	of	human	iPSC-derived	neurons,	we	developed	reproducible	and	efficient	differentiation	protocols	that	generate	functionally	active	neurons	by	growing	them	on	top	of	mouse	astroglial	feeder	layers.	Neuronal	cultures	contain	inhibitory	and	excitatory	neurons	that	are	capable	of	firing	multiple	action	potentials	and	forming	functional	connections.	To	determine	the	cellular	effect	of	a	single	SCN1A	mutation,	independent	of	genetic	background,	we	generated	dual	pairs	of	human	iPSCs	using	CRISPR/Cas9	editing	and	differentiated	them	into	functional	neurons	using	our	optimized	protocols.	Comparison	of	electrophysiological	properties	of	inhibitory	and	excitatory	neurons	revealed	gene	dosage-dependent	and	cell	type-specific	alterations	in	sodium	currents	and	evoked	firing,	resulting	in	a	hyper-excitable	neural	network.	We	also	identified	alterations	associated	with	the	genetic	background	and	the	interaction	between	the	mutation	and	the	background.		
	
5.2	Future	directions	
5.2.1.	Identify	genetic	modifiers	using	RNA	sequencing													Our	results	identified	alterations	due	to	the	genetic	background,	as	is	seen	in	the	voltage	dependence	of	Nav	activation	and	inactivation	in	inhibitory	neurons	of	both	of	the	patient-derived	lines	when	compared	to	both	of	the	lines	from	the	control.	We	have	also	found	alterations	due	to	the	interatction	between	the	mutation	and	the	genetic	background,	as	is	seen	in	the	voltage	dependence	of	Nav	activation	and	inactivation	and	
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evoked	firing	frequency	in	excitatory	neurons	of	the	patient	line.	Thess	suggest	that	genetic	modifiers	in	the	patient	background	alter	the	phenotypic	expression	of	the	SCN1A	gene.	Indeed,	individuals	in	the	multigenerational	family	where	the	K1270T	SCN1A	mutation	was	identified	exhibit	seizure	phenotypes	in	different	severity1.												Sequencing	in	combination	with	dual	isogenic	pairs	of	human	iPSCs	is	a	promising	system	for	identifying	alterations	due	to	the	genetic	background.	Using	a	reverse	genetics	approach,	the	mechanism	underlying	the	differences	between	the	two	pairs	pinpoint	the	potential	genetic	modifiers	that	might	be	involved	in	regulating	this	property2.	As	we	found	genetic	background-dependent	alterations	in	the	patient-derived	isogenic	pair,	sequencing	analysis	in	the	candidate	genes	in	the	patient-derived	vs	the	control-derived	isogenic	pairs	can	be	used	to	identify	mutations	in	other	genes	that	are	involved	in	regulating	neuronal	activity	or	network	activity.	For	instance,	missense	mutations	in	SCN9A	that	encodes	Nav1.7	has	been	identified	in	other	SCN1A-associated	epilepsy	patients3.	In	addition,	single-cell	RNA	sequencing	is	a	powerful	tool	to	identify	genes	with	altered	expression	level	that	might	contribute	to	the	modification	of	the	disease	phenotypes.	For	example,	altered	expression	of	Gabra2	that	encodes	GABAA	receptor	has	been	identified	in	DS	mice	with	a	
SCN1A	mutation4.	Further	pharmacological	manipulation	using	an	anti-convulsant	drug	with	higher	affinity	with	GABAA	receptor	ameliorates	the	susceptibility	to	heat-induced	seizures	in	mice4.	This	can	be	applied	to	our	current	study	by	comparing	the	transcriptome	in	dual	isogenic	pairs	of	human	iPSCs.														Inbred	mice	are	also	an	excellent	model	system	for	identification	of	genetic	modifiers	based	on	a	forward	genetics	approach5.	Mutant	mice	that	exhibit	seizure	phenotypes	are	crossed	with	different	inbred	wild-type	mice.	Based	on	the	outcome	in	survival	and	seizure	
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phenotypes	in	the	offspring,	candidate	genes	can	be	identified	using	genetic	mapping	tools	such	as	positional	cloning	or	quantitative	trait	loci	mapping,	followed	by	sequencing	and	expression	analysis	to	find	out	strong	modifier	candidates.	Using	this	strategy,	the	Kcnv2	gene	that	encodes	voltage-gated	potassium	channel	subfamily	V	member	2	have	been	identified	as	genetic	modifiers	in	SCN2A	epilepsy6.			
5.2.2.	Screen	drugs	using	high-throughput	multi-electrode	array	
												The	prescription	of	drugs	to	epilepsy	patients	is	largely	based	on	an	empirical	approach	with	little	understanding	in	the	underlying	mechanism	of	action	in	each	individual.	Two	GEFS+	siblings	with	the	same	K1270T	SCN1A	mutation,	exhibited	different	seizure	phenotypes.	One	of	these	individuals	was	most	effectively	treated	with	valproic	acid	and	levetiracetam,	while	the	second	responded	well	to	ethosuximide1.	This	supports	the	interpretation	that	genetic	background	contributes	to	the	variation	in	the	efficacy	of	the	anti-epileptic	drugs	(AEDs).	Polymorphism	in	genes	involved	in	drug	metabolism	has	been	identified	to	induce	resistance	to	AEDs	due	to	altered	drug	concentration	and	drug	toxicity7.	Therefore,	it	is	important	to	develop	targeted	treatment	for	patient	precision	medicine	based	on	the	underlying	cellular	mechanism	of	epilepsy-causing	mutations.	Patient	iPSC-derived	neuronal	cultures	in	combination	with	a	new	multi-electrode	array	(MEA)	is	emerging	as	a	useful	platform	for	mechanistic	study	and	drug	screening	in	a	high-throughput	manner8.														MEA	systems	enable	real-time	analysis	in	neuronal	activity	by	converting	changes	in	voltages	due	to	ion	flow	during	action	potential	firing	into	currents9.	MEAs	have	been	used	to	evaluate	spontaneous	activity,	bursting,	synchronous	network	activity,	toxicity	of	anti-
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convulsant	drugs,	drug	responses	and	inducing	long-term	potentiation	and	depression	in	human	iPSC-derived	neuronal	cultures10–13.														In	our	lab,	preliminary	results	demonstrate	that	iPSC-derived	neurons	could	be	co-cultured	on	top	of	astroglial	feeder	layers	on	the	MEA	platform.	They	are	capable	of	forming	spontaneously	active	neural	networks	with	burst	firing	and	synchrony	(Figure	
V.1).		Based	on	the	cellular	mechanism	that	was	identified	in	Chapter	3,	candidates	involved	in	future	studies	include	GABAA	agonists	(clonazepam	and	clobazam),	GABA	reuptake	inhibitors	(sodium	valproate	and	vigabatrin),	and	glutamate	blockers	(perampanel	and	topiramate).	Additionally,	it	would	be	interesting	to	test	compounds	used	alternatively	or	for	other	disorders	but	attenuating	seizures	effectively,	such	as	cannabidiol	and	riluzole14,15.	By	evaluating	the	network	activity	and	synchrony	in	the	patient	iPSC-derived	neuronal	cultures	in	response	to	drug	treatment,	it	is	possible	to	identify	the	candidate	compound	that	can	dampen	the	hyperactivity	in	networks	for	the	development	of	patient	precision	medicine.														MEA	systems	also	allow	for	mechanistic	study	on	the	effect	of	SCN1A	mutations	on	the	GESF+	patient	iPSC-derived	neurons	at	elevated	temperature.	The	GEFS+	individual	with	the	K1270T	SCN1A	mutation	in	our	current	study	was	diagnosed	with	febrile	seizures	that	occur	during	fever1.	A	previous	study	in	our	lab	using	a	knock-in	Drosophila	model	with	the	human	K1270T	mutation	identified	alterations	in	the	Nav	function	at	elevated	temperature	as	a	possible	mechanism	that	contributes	to	the	heat-induced	seizures16.	We	attempted	to	examine	the	effect	of	the	mutation	in	our	iPSC-derived	neurons	at	higher	temperature.	However,	the	viability	of	cells	rapidly	decreased	as	the	recording	environment	was	not	favorable	to	cells	probably	due	to	a	lack	of	5%	CO2	as	in	the	
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incubator.	As	the	chamber	of	the	MEA	system	is	capable	of	maintaining	at	stable	temperature,	humidity	and	CO2	concentration,	it	has	been	used	to	investigate	the	effect	of	Nav1.7	mutations	in	spontaneous	firing	at	elevated	temperatures	and	evaluate	the	efficacy	of	a	candidate	drug	on	attenuating	the	hyperactivity	of	neurons17,18.	It	would	be	interesting	to	assess	how	the	K1270T	mutation	alters	the	spontaneous	network	activity	at	temperatures	during	which	febrile	seizure	occur	in	GEFS+	patients.		
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Figure	V.1.	Spontaneous	neural	network	activity	recorded	by	the	MEA	system.	Spontaneously	active	network	activity	with	burst	firing	and	synchrony	in	the	iPSC-derived	neuronal	cultures.	Each	row	represents	electrical	activity	recorded	by	each	electrode.	Each	spike	represents	a	spontaneous	firing	event.	Scale	bar	represents	10	seconds.		
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5.2.3.	Determine	the	functional	consequence	of	the	SCN1A	mutation	in	vivo													Due	to	the	large	diversity	of	hippocampal	pyramidal	and	inhibitory	neurons	based	on	their	anatomy,	location	and	electrophysiology,	understanding	how	different	cell	types	contribute	to	dysfunctional	neural	circuit	in	epilepsy	is	important19–21.		A	number	of	studies	on	SCN1A	epilepsy	in	mouse	models	have	proposed	an	attractive	interneuron	hypothesis	which	suggests	that	Scn1a	mutations	did	not	alter	the	excitability	of	hippocampal	pyramidal	neurons,	but	the	excitability	of	hippocampal	inhibitory	interneurons	is	impaired22,23.													Both	our	Drosophila	and	iPSC	models	have	shown	the	K1270T	SCN1A	mutation	preferentially	reduces	action	potential	firing	in	inhibitory	neurons	but	not	excitatory	neurons.	As	comparing	across	multiple	organisms	might	unveil	conserved	mechanism,	we	have	generated	a	knock-in	mouse	model	with	the	human	K1270T	SCN1A	mutation	using	CRISPR/Cas9	editing.	Through	collaborative	efforts	with	Dr.	Antara	Das	in	our	lab,	excitability	of	pyramidal	excitatory	neurons	in	the	CA1	of	the	hippocampus	was	recorded	at	P25-40.	Preliminary	data	showed	that	in	the	firing	frequency	versus	current	step	curves,	the	firing	frequency	in	pyramidal	neurons	of	the	heterozygous	Scn1aKT/+	mice	was	not	different	from	the	wild-types	(Figure	V.2A	and	B).	The	two	genotypes	also	had	similar	action	potential	threshold,	amplitude,	half-width	and	rheobase	(Figure	V.2C-F).	There	were	no	differences	between	Scn1aKT/+	and	the	wild-type	in	the	passive	membrane	properties	including	input	resistance,	whole-cell	capacitance	and	rest	membrane	potential	(Table	V.1).	Based	on	the	interneuron	hypothesis,	it	is	expected	to	observe	reduced	activity	in	hippocampal	parvalbumin	(PV)-expressing	interneurons	in	our	mouse	model.	If	this	is	not	true,	it	is	likely	that	the	age	of	mice	examined	has	passed	the	transient	time	
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window	of	dysfunctional	inhibitory	neurons	(P18-P21)24.	Therefore,	it	will	require	evaluation	of	the	effect	of	the	mutation	at	multiple	time	points	during	development	and	the	underlying	mechanism	of	this	compensatory	plasticity	mechanism.	In	addition,	it	will	also	be	interesting	to	examine	the	excitability	of	somatostatin	(SST)-	and	VIP	(vasointestinal	peptide)-expressing	neurons	as	they	are	also	two	major	interneurons	in	hippocampus19.													How	does	altered	excitability	of	hippocampal	interneurons	affect	the	neural	circuitry	in	the	Scn1a	mutant	mice?	There	are	common	circuit	motifs	of	inhibition	within	hippocampus:	feedforward	and	feedback	inhibition25.	Different	types	of	interneurons	have	distinct	roles	in	these	motifs	that	modulate	the	neural	network	activity.	Studies	in	the	mouse	cortex	have	revealed	the	logic	of	connections	in	distinct	interneurons.	Vasointestinal	peptide	(VIP)-expressing	interneurons	preferentially	inhibit	somatostatin	(SST)-expressing	interneuron	that	target	the	distal	dendrites	of	pyramidal	neurons,	SST	interneurons	also	inhibit	other	types	of	interneurons,	and	PV	and	SST	neurons	make	monosynaptic	inhibitory	connection	to	a	pyramidal	neuron26,27.	We	hope	to	understand	whether	the	K1270T	mutation	that	alters	the	excitability	of	inhibitory	neurons	will	rewire	the	network	by	changing	the	connectivity	between	interneurons	and	pyramidal	neurons,	giving	rise	to	a	hyperactive	network.																																											
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Figure	V.2.	Unaltered	excitability	of	hippocampal	pyramidal	cells	in	SCN1AKT/+	mice.	(A)	Representative	traces	of	evoked	action	potentials	at	different	current	injection	steps	in	hippocampal	pyramidal	cells	in	WT	vs	SCN1AKT/+.	(B)	The	input-output	curve	of	evoked	action	potentials.	(C)	Action	potential	threshold.	(D)	Action	potential	amplitude.	(E)	Action	potential	half-width.	(F)	Rheobase	of	evoked	action	potential	defined	as	the	current	step	when	action	potentials	first	appeared.	Data	reported	as	mean	±	s.e.m	with	total	10-12	neurons	from	6	mice	in	each	group.	Two-way	ANOVA	with	repeated	measures	for	B,	two-tailed	unpaired	t-test	for	C-F.		
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Table	V.1.	Passive	membrane	properties	of	pyramidal	neurons	Cell	type	 Genotype	 Rm	(MΩ)	 	 Cm	(pF)	 	 RMP	(mV)		 	Pyramidal	 WT	 48.9	±	11	 	 34.1	±	5.2	 	 -66.1	±	1.0	Scn1aKT/+	 51.8	±	9	 	 32.4	±	4.1	 	 -65.7	±	0.8	a.	Data	reported	as	mean	±	s.e.m	with	total	10-12	neurons	from	6	mice	in	each	group.		b.	Two-tailed	Mann-Whitney	U	test	for	Cm	and	unpaired	t-test	for	Rm	and	RMP.		
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5.3	Significance													We	developed	reproducible	and	efficient	protocols	that	generate	neuronal	cultures	that	contain	excitatory	and	inhibitory	neurons	from	human	iPSCs.	The	derived	neurons	are	capable	of	firing	action	potentials	and	forming	functional	synaptic	connections.	This	allows	for	identification	of	mutation-associated	alterations	in	electrophysiological	properties	for	neurological	disease	modeling.													We	used	CRISPR/Cas9	editing	to	generate	dual	isogenic	pairs.	This	strategy	facilitates	elucidating	the	causality	of	a	genetic	mutation	to	disease	phenotypes	in	neurological	disorders.	Further,	it	provides	insight	into	the	development	of	patient-specific	medicine.		
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